<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Carbohydrate Metabolism - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / qBank / Biochemistry
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">148</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 6103,
    "choices": [
      {
        "id": 24381,
        "text": "<p><span style=\"font-size:12.0pt;\">Lactate</span></p>"
      },
      {
        "id": 24382,
        "text": "<p><span style=\"font-size:12.0pt;\">Oxaloacetate</span></p>"
      },
      {
        "id": 24383,
        "text": "<p><span style=\"font-size:12.0pt;\">Acetyl-CoA</span></p>"
      },
      {
        "id": 24384,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A young woman with laboratory picture of normocytic anaemia and jaundice with splenomegaly was diagnosed to have RBC pyruvate kinase deficiency after a PBS showed spiculated cells. Due to the abnormal function of pyruvate kinase, less pyruvate is formed and the intermediates above pyruvate in the glycolytic pathway get accumulated. Which of the following products is not formed in appropriate amounts in the RBC due to the deficiency of pyruvate?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture3_vhplgH7.jpg\" alt=\"\" width=\"300\" height=\"225\"></span></p>",
    "unique_key": "Q9904988",
    "question_audio": null,
    "question_video": null,
    "map_id": 29829,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Lactate&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyruvate kinase catalyzes the conversion of phosphoenolpyruvate (PEP) to pyruvate in the final step of glycolysis, generating ATP. In pyruvate kinase deficiency, this reaction is impaired, resulting in reduced pyruvate production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In red blood cells, which rely exclusively on anaerobic glycolysis for energy production, pyruvate is normally converted to lactate by lactate dehydrogenase (LDH). This reaction regenerates NAD+ from NADH, allowing glycolysis to continue. When pyruvate kinase is deficient, less pyruvate is produced, consequently leading to decreased lactate formation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture4_OJApgRI.jpg\" alt=\"\" width=\"500\" height=\"166\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Oxaloacetate</strong>: Mature RBCs lack mitochondria and therefore do not contain the enzymes needed to convert pyruvate to oxaloacetate (via pyruvate carboxylase). Oxaloacetate is not normally produced in RBCs regardless of pyruvate kinase function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Acetyl-CoA</strong>: Similar to oxaloacetate, acetyl-CoA formation from pyruvate requires the pyruvate dehydrogenase complex, which is located in mitochondria. Since mature RBCs lack mitochondria, they do not produce acetyl-CoA from pyruvate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glucose</strong>: RBCs do not synthesize glucose from pyruvate (gluconeogenesis). This process requires several enzymes that are not present in RBCs and also occurs primarily in the liver and kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This question tests understanding of RBC metabolism, particularly the consequences of pyruvate kinase deficiency. Pyruvate kinase deficiency is an inherited disorder that affects glycolysis in RBCs, leading to premature destruction of red blood cells (hemolytic anemia). The spiculated RBCs seen on peripheral blood smear are characteristic of this condition. The defect causes ATP depletion, accumulation of glycolytic intermediates upstream of the enzyme defect, and reduced production of downstream metabolites like lactate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 170; Vasudevan 9/e: 111.</span></p>",
    "correct_choice_id": 24381,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 6070,
    "choices": [
      {
        "id": 24250,
        "text": "<p><span style=\"font-size:12pt;\">Enolase</span></p>"
      },
      {
        "id": 24251,
        "text": "<p><span style=\"font-size:12pt;\">Phosphofructokinase</span></p>"
      },
      {
        "id": 24252,
        "text": "<p><span style=\"font-size:12pt;\">Pyruvate Kinase</span></p>"
      },
      {
        "id": 24253,
        "text": "<p><span style=\"font-size:12pt;\">Hexokinase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A medical student is reviewing the glycolytic pathway and is attempting to identify the points of regulation within the process. She notes that certain steps are irreversible and thus play a key role in the regulation of glycolysis. Which of the following enzymes catalyzes a reaction in glycolysis that is not considered irreversible and therefore not a major regulatory point?</span></p>",
    "unique_key": "Q1805491",
    "question_audio": null,
    "question_video": null,
    "map_id": 29828,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Enolase</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Enolase catalyzes the second-to-last step in aerobic glycolysis, converting 2-phosphoglycerate into phosphoenolpyruvate. This step is reversible and not a major control point in the pathway. In contrast, the other enzymes listed catalyze irreversible steps and are tightly regulated to control the flow through the glycolytic pathway.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Explanation</u></strong>:</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Phosphofructokinase</strong>: Catalyzes an irreversible step by converting fructose-6-phosphate to fructose-1,6-bisphosphate and is a major regulatory point of glycolysis.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Pyruvate Kinase</strong>: Irreversibly Catalyzes the conversion of phosphoenolpyruvate to pyruvate, another regulatory step in glycolysis.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hexokinase</strong>: Irreversibly phosphorylates glucose to glucose-6-phosphate at the start of the glycolytic pathway and is allosterically inhibited by its product, making it a key regulatory enzyme.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Irreversible Steps of Glycolysis:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Hexokinase</span></li><li><span style=\"font-size:12.0pt;\">Phosphofructokinase</span></li><li><span style=\"font-size:12.0pt;\">Pyruvate Kinase</span></li></ul><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p170-172.</span></p>",
    "correct_choice_id": 24250,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6055,
    "choices": [
      {
        "id": 24190,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Aldolase and Pyruvate kinase</span></span></span></span></p>"
      },
      {
        "id": 24191,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Phosphofructokinase</span></span></span></span></p>"
      },
      {
        "id": 24192,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Hexokinase&nbsp;&nbsp; </span></span></span></span></p>"
      },
      {
        "id": 24193,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Phosphoglucose isomerase&nbsp;&nbsp; </span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 58-year-old male with type 2 diabetes starts a new oral hypoglycemic regimen. Soon after, he presents with anxiety, diaphoresis, and hunger, which quickly resolves upon consuming glucose. This clinical scenario underscores the importance of the initial enzymatic step in glycolysis following glucose ingestion. In the context of glycolytic pathway activation for immediate energy production, which enzyme is responsible for catalyzing the first reaction that glucose undergoes in this metabolic pathway?</span></span></span></span></span></p>",
    "unique_key": "Q2572587",
    "question_audio": null,
    "question_video": null,
    "map_id": 29821,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Hexokinase&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><strong>Glycolysis </strong>is a process which <strong>converts glucose into pyruvate </strong>with production of <strong>ATP.&nbsp; </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The <strong>first step</strong> is when <strong>glucose</strong> is <strong>converted </strong>by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">hexokinase (option C)</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> to <strong>glucose-6-phosphate.&nbsp; </strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">When this compound interacts with enzyme </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Phosphoglucose isomerase (option D)</span></span></strong><span style=\"font-size:12.0pt\">, it<span style=\"color:black\"> forms<strong> fructose-6-phosphate </strong></span>which gets<span style=\"color:black\"> converted by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">phosphofructokinase</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> (</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">B</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">) to <strong>fructose 1,6-bisphosphate</strong>, which is then converted to <strong>glyceraldehyde </strong></span></span><span style=\"font-size:12.0pt\"><strong>3-phosphate</strong><span style=\"color:black\"><strong> </strong>by </span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">aldolase</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> (</span></span><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">option</span></span></strong> <strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">A</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">)</span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">After a <strong>number of enzymatic reactions,</strong> <strong>phosphoenol pyruvate</strong> is formed, which is converted to <strong>pyruvate-by-pyruvate</strong> <strong>kinase </strong>(option a) at the end.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aldolase and Pyruvate kinase</span></strong><span style=\"font-size:12.0pt\">: These enzymes function in the <strong>intermediate to later stages of glycolysis</strong> and are <strong>not</strong> involved in the<strong> initial phosphorylation of glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Phosphofructokinase</span></strong><span style=\"font-size:12.0pt\">: This enzyme plays a<strong> key</strong> regulatory role in<strong> glycolysis</strong> by converting<strong> fructose-6-phosphate to fructose-1,6-bisphosphate</strong>, but it is<strong> not</strong> the first enzyme in the pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Phosphoglucose isomerase</span></strong><span style=\"font-size:12.0pt\">: This <strong>enzyme acts</strong> second in the<strong> glycolytic pathway</strong>, converting <strong>glucose-6-phosphate</strong> <strong>to</strong> <strong>fructose-6-phosphate</strong>, following the action of<strong> hexokinase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\"><strong>Hexokinase catalyzes</strong> the<strong> first</strong> critical step in the<strong> glycolytic pathway</strong> by<strong> phosphorylating glucose</strong> to form <strong>glucose-6-phosphate</strong>. This reaction is essential for <strong>trapping glucose </strong>within the cell, <strong>enabling</strong> its subsequent metabolism in the <strong>glycolytic pathway </strong>to produce <strong>energy,</strong> particularly important in the context of<strong> restoring normal blood glucose levels</strong> after <strong>hypoglycemic</strong> episodes in <strong>diabetic</strong> <strong>patients.</strong></span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">: Harper 30/e: p 168-172</span></span></strong></span></span></p>",
    "correct_choice_id": 24192,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6034,
    "choices": [
      {
        "id": 24106,
        "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate dehydrogenase</span></p>"
      },
      {
        "id": 24107,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucokinase</span></p>"
      },
      {
        "id": 24108,
        "text": "<p><span style=\"font-size:12.0pt;\">Hexokinase</span></p>"
      },
      {
        "id": 24109,
        "text": "<p><span style=\"font-size:12.0pt;\">Phosphofructokinase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During a lecture on metabolic pathways, medical students were asked to identify the first committed step in glycolysis and the enzyme that catalyzes it. This step is crucial because it irreversibly commits the substrate to the glycolytic pathway. Which enzyme is responsible for this committed step in glycolysis?</span></p>",
    "unique_key": "Q5584516",
    "question_audio": null,
    "question_video": null,
    "map_id": 29826,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D) Phosphofructokinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The <strong>first committed step</strong> in glycolysis is catalyzed by <strong>phosphofructokinase-1 (PFK-1)</strong>, which converts:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Fructose-6-phosphate \u2192 Fructose-1,6-bisphosphate</strong></span></p><p><span style=\"font-size:12.0pt;\">This step is considered \"committed\" because, after this conversion, the sugar molecule is no longer available for alternative pathways (such as glycogenesis or the pentose phosphate pathway). It must proceed through glycolysis.</span></p><p><span style=\"font-size:12.0pt;\">Additionally, this step is <strong>irreversible</strong> under cellular conditions and is <strong>highly regulated</strong> \u2014 it represents the <strong>rate-limiting step</strong> of glycolysis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A \u2014 Pyruvate dehydrogenase:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">This enzyme catalyzes the decarboxylation of pyruvate to acetyl-CoA, which is part of the <strong>linking step</strong> between glycolysis and the citric acid cycle, not glycolysis itself.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B \u2014 Glucokinase:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">Glucokinase catalyzes <strong>glucose \u2192 glucose-6-phosphate</strong> in the <strong>liver and pancreas</strong>, and the product can still be shunted into other pathways like glycogenesis or the pentose phosphate pathway.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C \u2014 Hexokinase:&nbsp;</strong>Incorrect.</span><br><span style=\"font-size:12.0pt;\">Hexokinase also converts <strong>glucose to glucose-6-phosphate</strong> in most tissues, but this is not the committed step because glucose-6-phosphate is a central intermediate that can enter multiple pathways beyond glycolysis.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The <strong>first committed step</strong> of glycolysis is catalyzed by <strong>phosphofructokinase-1 (PFK-1)</strong>. It ensures that glucose carbons are committed to energy production via glycolysis. This step is irreversible, highly regulated, and marks a metabolic \"point of no return\" for the glucose molecule.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">PFK-1 is a key <strong>allosteric enzyme</strong> \u2014 activated by AMP and fructose-2,6-bisphosphate and inhibited by ATP and citrate.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref:&nbsp;Harper 30/e p173</span></p>",
    "correct_choice_id": 24109,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "InvestigationBased"
    ]
  },
  {
    "id": 6075,
    "choices": [
      {
        "id": 24269,
        "text": "<p>1</p>"
      },
      {
        "id": 24270,
        "text": "<p>2</p>"
      },
      {
        "id": 24271,
        "text": "<p>0</p>"
      },
      {
        "id": 24272,
        "text": "<p>4</p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A medical student is studying the unique metabolic pathways of erythrocytes (red blood cells). Due to the absence of mitochondria, erythrocytes rely on glycolysis for ATP production. Within this context, the student is interested in the yield of ATP from glucose through the Rapoport-Luebering cycle. What is the net gain of ATP by this cycle in red blood cells from one molecule of glucose?</span></p>",
    "unique_key": "Q6857388",
    "question_audio": null,
    "question_video": null,
    "map_id": 29830,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Correct Answer: C. 0</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Red blood cells (erythrocytes) are unique in that they lack mitochondria, so they rely entirely on anaerobic glycolysis for ATP production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the normal Embden-Meyerhof glycolytic pathway:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">From 1 molecule of glucose, red blood cells normally produce:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">2 ATP (net gain).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">However, erythrocytes have a special side pathway called the Rapoport-Luebering shunt (or cycle), which diverts 1,3-bisphosphoglycerate (1,3-BPG) into 2,3-bisphosphoglycerate (2,3-BPG) instead of continuing down the standard glycolytic path.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is crucial for regulating hemoglobin\u2019s oxygen affinity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this shunt:</span></p><ol><li><span style=\"font-size:12.0pt;\">1,3-BPG is converted to 2,3-BPG by bisphosphoglycerate mutase.</span></li><li><span style=\"font-size:12.0pt;\">2,3-BPG is then hydrolyzed to 3-phosphoglycerate by 2,3-BPG phosphatase.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key point:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In the normal glycolytic pathway, the conversion of 1,3-BPG to 3-phosphoglycerate yields 1 ATP (via substrate-level phosphorylation).</span></li><li><span style=\"font-size:12.0pt;\">In the Rapoport-Luebering cycle, this ATP production step is bypassed, meaning no ATP is generated in this part of the cycle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, when glucose is metabolized exclusively via the Rapoport-Luebering cycle, the net ATP gain is 0.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">Understand RBC Metabolism:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Recognize that red blood cells lack mitochondria and rely exclusively on anaerobic glycolysis.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Learn the Rapoport-Luebering Cycle:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Know that this shunt allows RBCs to produce 2,3-BPG, regulating oxygen release from hemoglobin but at the cost of losing ATP production.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p173, 174</span></p>",
    "correct_choice_id": 24271,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6354,
    "choices": [
      {
        "id": 25385,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5&rsquo;AMP </span></span></span></p>"
      },
      {
        "id": 25386,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose 2, 6 Bisphosphate</span></span></span></p>"
      },
      {
        "id": 25387,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose 6 Phosphate</span></span></span></p>"
      },
      {
        "id": 25388,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citrate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a competitive quiz on cellular metabolism among medical students, a challenging question is posed regarding the regulation of Phosphofructokinase-1 (PFK-1), a key enzyme in the glycolytic pathway. The quizmaster asks which of the following molecules does not serve as an activator for PFK-1, contrary to the common regulatory mechanisms of this crucial enzyme. The options given are:</span></span></span></p>",
    "unique_key": "Q2904756",
    "question_audio": null,
    "question_video": null,
    "map_id": 29827,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Citrate. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate </strong>is actually an <strong>inhibitor of Phosphofructokinase-1 (PFK-1),</strong> <strong>not an activator.</strong> It serves as a <strong>signal of abundant energy </strong>supply, thus<strong> inhibiting PFK-1</strong> to slow down <strong>glycolysis</strong> when the<strong> cell&#39;s energy</strong> needs are<strong> low</strong> or when<strong> biosynthetic precursors are abundan</strong>t. <strong>Citrate accumulation</strong> in the <strong>cytosol,</strong> indicative of a<strong> high rate </strong>of <strong>oxidative metabolism </strong>and <strong>sufficient energy levels</strong>, leads to the <strong>inhibition of PFK-1,</strong> thereby <strong>reducing glycolytic flux.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>other options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 5&rsquo;AMP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acts as an <strong>activator of PFK-1,</strong> signaling<strong> low energy </strong>status in the cell and thus <strong>promoting glycolysis</strong> to generate <strong>ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fructose 2,6-Bisphosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> One of the most <strong>potent activators</strong> of <strong>PFK-1</strong>, it enhances <strong>glycolysis</strong> even in the <strong>presence of ATP,</strong> thus allowing <strong>glycolysis</strong> to continue under various conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fructose 6-Phosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>not </strong>as direct an <strong>activator as fructose 2,6-bisphosphate</strong>, it is the <strong>substrate</strong> for<strong> PFK-1 </strong>and thus necessary for <strong>its activity; </strong>however, its role as <strong>an activator</strong> is<strong> not</strong> as significant as the <strong>other molecules</strong> listed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citrate is an Inhibitor of Phosphofructokinase-I.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture10.jpg\" style=\"height:336px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Harper 30/e p188.</span></strong></span></span></p>",
    "correct_choice_id": 25388,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6417,
    "choices": [
      {
        "id": 25637,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></span></p>"
      },
      {
        "id": 25638,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amino Acids</span></span></span></p>"
      },
      {
        "id": 25639,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketone body</span></span></span></p>"
      },
      {
        "id": 25640,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a fasting state, which substrate is primarily used by Red Blood Cells (RBCs) for energy? </span></span></p>",
    "unique_key": "Q9054273",
    "question_audio": null,
    "question_video": null,
    "map_id": 29825,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Glucose </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>RBCs</strong> are always <strong>dependent </strong>on use of <strong>glucose for energy</strong> irrespective of fed or fasting state of the body due to<strong> lack of mitochondria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Amino Acids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RBCs do not</strong> utilize<strong> amino acids</strong> for <strong>energy production. Amino acids</strong> are primarily<strong> used by muscles</strong> and other <strong>tissues for protein synthesis </strong>or as an <strong>energy source</strong> through<strong> gluconeogenesis in the liver.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ketone Body:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ketone bodies are <strong>used as</strong> an<strong> alternative energy source</strong> by<strong> </strong>many tissues, including the <strong>brain,</strong> during <strong>prolonged fasting or starvation</strong>. However,<strong> RBCs do not </strong>use <strong>ketone bodies </strong>for energy due to their <strong>lack of mitochondria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fatty Acid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>RBCs</strong> are also <strong>unable to oxidize fatty acids </strong>for energy. <strong>Fatty acid oxidation</strong> occurs in the <strong>mitochondria,</strong> which <strong>RBCs lack.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1_BuSFrTM.jpg\" style=\"height:514px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harper 30/e p150.</span></strong></span></span></p>",
    "correct_choice_id": 25637,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 7690,
    "choices": [
      {
        "id": 30728,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency</span></span></span></p>"
      },
      {
        "id": 30729,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase deficiency</span></span></span></p>"
      },
      {
        "id": 30730,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia</span></span></span></p>"
      },
      {
        "id": 30731,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-Thalassemia</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 23 days old infant with severe neonatal jaundice receives an exchange blood transfusion. Advised monthly red blood cell transfusion and splenectomy at 6 months of age. Histologic examination of the spleen reveals marked hemosiderosis and laboratory studies shows:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/19/picture15.jpg\" style=\"height:449px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Analysis of red cell glycolytic intermediates shows markedly elevated concentrations of 2, 3-bisphosphoglycerate, 3-phosphoglycerate, 2-phosphoglycerate and PEP. Which is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q2106409",
    "question_audio": null,
    "question_video": null,
    "map_id": 29824,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase (PK) deficiency&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">KEY POINTS:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Severe neonatal jaundice + elevated indirect bilirubin + exchange blood transfusion </strong>are suggestive of <strong>hemolysis.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Low hemoglobin and hematocrit values + reticulocytosis</strong> &ndash; indicates <strong>anemia.</strong> </span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus, <strong>hemolytic anemia</strong> is confirmed. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">levels of <strong>2,3-BPG, 3-PG, 2-PG, </strong>and <strong>PEP</strong> (all are <strong>distal glycolysis intermediates</strong>) are seen in <strong>blocks in glycolysis below phosphoenolpyruvate.</strong> </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic anemia</strong> is associated with<strong> deficiencies </strong>of most of the <strong>enzymes of glycolysis, </strong>among which <strong>PK deficiency is the most common. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only<strong> hemolytic anemia</strong> induced by a <strong>PK deficiency</strong> <strong>meets all these criteria</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:16px\"><strong><u>Other Options:</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">G6PD deficiency:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is the<strong> most </strong>common cause of<strong> hemolytic anemia. </strong>Patients may have <strong>hemolytic crises</strong> when <strong>stressed by</strong> certain <strong>oxidizing drugs, infections and by fava beans</strong>. Here glycolytic intermediates don&#39;t accumulate.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sickle cell anemia HbS:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is the <strong>most </strong>common<strong> hemoglobinopathy </strong>with <strong>molecular defect in substitution of glutamate </strong>by <strong>valine at 6th position</strong> of the <strong>beta-chain</strong> &rarr; <strong>sickling of RBCs</strong> &rarr; <strong>block small vessels</strong> &rarr; clinical manifestations. But glycolytic intermediates do not accumulate here. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-Thalassemia: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Results from <strong>reduced synthesis of the hemoglobin B-chain </strong>&rarr; leads to an<strong> excess of x-globin chains</strong> &rarr; <strong>precipitate RBCs</strong> and prevent <strong>nascent red cells </strong>from<strong> maturing</strong>. <strong>Symptoms of anemia</strong> are<strong> delayed </strong>because of<strong> fetal haemoglobin.</strong> Here also<strong> no accumulation of glycolytic intermediates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase deficiency</strong> is a cause of <strong>congenital non-spherocytic hemolytic anemia</strong>, characterized by <strong>elevated levels of certain</strong> <strong>glycolytic intermediates</strong> due to<strong> impaired ATP production</strong> in red blood cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 168, 693-694.</span></span></strong></p>",
    "correct_choice_id": 30729,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 6122,
    "choices": [
      {
        "id": 24457,
        "text": "<p><span style=\"font-size:12pt;\">Glucokinase</span></p>"
      },
      {
        "id": 24458,
        "text": "<p><span style=\"font-size:12pt;\">Hexokinase</span></p>"
      },
      {
        "id": 24459,
        "text": "<p><span style=\"font-size:12pt;\">PFK</span></p>"
      },
      {
        "id": 24460,
        "text": "<p><span style=\"font-size:12pt;\">Enolase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">During a review of laboratory practices, a medical student is presented with a case study. A 55-year-old woman underwent routine blood work at 8 am in plain Vacutainer, but her blood glucose level was not processed until 11 am, with results reported at noon showing a blood glucose level of 48 mg/dl, despite all other tests being normal. Sample for blood glucose should be taken in Vacutainer containing NaF because it inhibit the following enzyme:</span></p>",
    "unique_key": "Q4552782",
    "question_audio": null,
    "question_video": null,
    "map_id": 29823,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Enolase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In blood samples collected for glucose estimation, it\u2019s crucial to prevent glycolysis (the breakdown of glucose by blood cells), which continues even after blood is drawn. If left unchecked, this can artificially lower blood glucose levels over time, as in the case described where the delay led to a falsely low glucose reading (48 mg/dL).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">To prevent this:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Blood for glucose estimation is collected in gray-top Vacutainers containing:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Sodium fluoride (NaF): an inhibitor of glycolysis,</span></li><li><span style=\"font-size:12.0pt;\">Often combined with potassium oxalate (an anticoagulant).</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sodium fluoride inhibits the enzyme:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Enolase, which catalyzes the conversion of 2-phosphoglycerate to phosphoenolpyruvate (PEP) in the glycolytic pathway.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Although NaF acts late in glycolysis, it is effective because it eventually halts the entire pathway, preserving glucose levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Glucokinase</strong>:</span><br><span style=\"font-size:12.0pt;\">Enzyme in the liver and pancreas (not in RBCs), catalyzes glucose to glucose-6-phosphate. Not inhibited by NaF.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Hexokinase</strong>:</span><br><span style=\"font-size:12.0pt;\">Catalyzes the first step of glycolysis in most tissues, converting glucose to glucose-6-phosphate. Not the target of NaF.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. PFK (Phosphofructokinase</strong>):</span><br><span style=\"font-size:12.0pt;\">A key rate-limiting enzyme of glycolysis, but again, NaF does not inhibit PFK.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This question highlights the importance of proper pre-analytical handling of blood samples for glucose testing. Blood samples should either be processed immediately or collected in tubes containing glycolysis inhibitors (such as sodium fluoride) to prevent falsely lowered glucose results due to continued cellular metabolism. The case demonstrates how delayed processing can lead to clinically significant errors in laboratory results, potentially misleading diagnosis and treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/e: 111.</span></p>",
    "correct_choice_id": 24460,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6139,
    "choices": [
      {
        "id": 24525,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexokinase</span></span></span></p>"
      },
      {
        "id": 24526,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></span></p>"
      },
      {
        "id": 24527,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphofructokinase&nbsp;&nbsp; </span></span></span></p>"
      },
      {
        "id": 24528,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate kinase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a research project focusing on glucose metabolism, a group of medical students observe that ATP is produced in the cytosol before the breakdown products of glucose enter the mitochondria. This finding highlights an important step in the glycolytic pathway. Which enzyme involved in glucose metabolism is responsible for this early ATP generation in the cytosol?</span></span></span></p>",
    "unique_key": "Q2446294",
    "question_audio": null,
    "question_video": null,
    "map_id": 29822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pyruvate kinase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase</strong> <strong>catalyzes</strong> <strong>last </strong>and an<strong> irreversible step of glycolysis</strong> and is a <strong>regulatory enzyme</strong> of glycolysis. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When<strong> energy is in plenty </strong>in the cell, <strong>glycolysis is inhibited. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin</strong> <strong>increases</strong> its<strong> activity </strong>whereas<strong> glucagon inhibits it. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase</strong> is<strong> inactive</strong> in the <strong>phosphorylated state. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hemolytic anaemia</strong>, because of <strong>destruction of energy</strong> <strong>depleted RBCs.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture19_T9tgs1j.jpg\" style=\"height:351px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hexokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Catalyzes the <strong>first step</strong> of <strong>glycolysis, phosphorylating glucose to glucose-6-phosphate</strong>, but does<strong> not </strong>directly result in <strong>ATP generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Functions similarly to hexokinase but is<strong> specific to the liver and pancreatic &beta;-cells, </strong>also<strong> not </strong>directly involved in <strong>ATP generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Phosphofructokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A key <strong>regulatory enzyme</strong> in glycolysis that <strong>catalyzes</strong> the conversion of <strong>fructose-6-phosphate to</strong> <strong>fructose-1,6-bisphosphate,</strong> <strong>not </strong>directly involved in<strong> ATP generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate kinase</strong> is involved in the <strong>last step </strong>of the <strong>glycolytic pathway, </strong>where it catalyzes the <strong>conversion of phosphoenolpyruvate</strong> (PEP) <strong>to pyruvate</strong>, generating<strong> ATP </strong>in the process. This <strong>occurs</strong> in the<strong> cytosol</strong> and is <strong>one </strong>of the<strong> steps in glycolysis</strong> that produces<strong> ATP</strong> <strong>before the metabolites</strong> <strong>enter</strong> the<strong> mitochondria </strong>for further <strong>energy</strong> <strong>production</strong> processes like the <strong>citric acid cycle</strong> and <strong>oxidative</strong> <strong>phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 168-172.</span></strong></span></span></p>",
    "correct_choice_id": 24528,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6146,
    "choices": [
      {
        "id": 24553,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDH complex is analogous to &alpha;-ketoglutarate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24554,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fat can be converted to glucose, because PDH cycle is reversible </span></span></span></p>"
      },
      {
        "id": 24555,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TPP, lipoic acid, coenzyme A, FAD, NAD are the coenzymes involved</span></span></span></p>"
      },
      {
        "id": 24556,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDH defect leads to lactic acidosis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about the oxidative decarboxylation of pyruvate to acetyl CoA is incorrect?</span></span></span></p>",
    "unique_key": "Q4389468",
    "question_audio": null,
    "question_video": null,
    "map_id": 29880,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Fat can be converted to glucose, because PDH cycle is reversible </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDH COMPLEX: </span></strong></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate</strong> is <strong>oxidatively decarboxylated</strong> to <strong>Acetyl CoA</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The oxidation of <strong>Pyruvate to Acetyl-CoA</strong> is the<strong> irreversible route </strong>from<strong> glycolysis to the citric Acid Cycle. No alternate</strong> pathway to<strong> circumvent </strong>this step</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate dehydrogenase complex</strong> is <strong>analogous</strong> to the <strong>&alpha;-ketoglutarate dehydrogenase</strong> </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(option A)</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Multienzyme complex </strong>associated with the<strong> inner mitochondrial membrane</strong></span></span></span></li>\r\n</ul>\r\n\r\n<ol start=\"2\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDH complex consists of 3 Enzymes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Pyruvate Dehydrogenase</strong>, <strong>Dihydrolipoyl Transacetylase</strong> and <strong>Dihydrolipoyl</strong> <strong>Dehydrogenase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5 Coenzymes (option C):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Thiamine pyrophosphate</strong> (TPP),<strong> Lipoamide</strong>, <strong>Coenzyme A,</strong> <strong>FAD and NAD+</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PDH defect</span></span></span></strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> leads to</span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> lactic acidosis (option D)</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Completely <strong>irreversible</strong> process: </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(option B)</span></strong></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is<strong> no pathway </strong>available in the <strong>body to circumvent</strong> this step and <strong>glucose</strong> through this step is<strong> converted to acetyl CoA</strong> <strong>from</strong> which <strong>fatty acid</strong>s can be <strong>synthesized</strong>. But the <strong>backward reaction </strong>is <strong>not</strong> possible, and </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">there is no net synthesis of glucose from fat.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, the<strong> PDH complex</strong> is <strong>analogous</strong> to the <strong>&alpha;-ketoglutarate dehydrogenase complex </strong>in terms of <strong>function and coenzyme</strong> requirements.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, these <strong>coenzymes</strong> are all involved in the<strong> function </strong>of the <strong>PDH complex.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> True,</strong> a defect in the <strong>PDH complex</strong> can lead to <strong>lactic acidosis</strong> because <strong>pyruvate </strong>is then preferentially<strong> converted to lactate</strong> by <strong>lactate dehydrogenase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>conversion of pyruvate to acetyl CoA</strong> via the <strong>PDH complex</strong> is an <strong>irreversible </strong>step in metabolism. This means that <strong>fat, </strong>which is <strong>broken down into acetyl CoA,</strong> <strong>cannot</strong> be converted<strong> back</strong> to<strong> glucose</strong> through this pathway. This is a<strong> fundamental</strong> concept in metabolism, as it explains why<strong> fatty acids cannot </strong>undergo <strong>gluconeogenesis to form glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 173, Vasudevan 9/ ed: p 115</span></strong></span></span></p>",
    "correct_choice_id": 24554,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 6144,
    "choices": [
      {
        "id": 24545,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate dehydrogenase </span></span></span></p>"
      },
      {
        "id": 24546,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dihydrolipoyl Transacetylase</span></span></span></p>"
      },
      {
        "id": 24547,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lipoamide </span></span></span></p>"
      },
      {
        "id": 24548,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dihydrolipoyl dehydrogenase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Examines the following diagram, illustrating the PDH complex and its enzymatic </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture21_2waVOtU.jpg\" style=\"height:433px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">components, labelled A, B, and C</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the name of enzyme component &#39;C&#39; within the PDH complex?</span></span></span></p>",
    "unique_key": "Q9265710",
    "question_audio": null,
    "question_video": null,
    "map_id": 29879,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Dihydrolipoyl dehydrogenase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dihydrolipoyl dehydrogenase (E3) </strong>is the<strong> third</strong> enzyme in the<strong> PDH complex </strong>and is responsible for the <strong>reoxidation of the lipoamide</strong> <strong>groups </strong>in the complex. It <strong>transfers</strong> the <strong>electrons to NAD+,</strong> <strong>reducing</strong> it to<strong> NADH,</strong> which is then <strong>used </strong>in other metabolic processes such as the<strong> electron transport chain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pyruvate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the<strong> first enzyme</strong> in the<strong> complex </strong>and is responsible for the <strong>decarboxylation of pyruvate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Dihydrolipoyl transacetylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> second enzyme</strong> in the <strong>complex, </strong>responsible for<strong> transferring the acetyl group to CoA</strong> to <strong>form acetyl-CoA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lipoamide:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Not</strong> an enzyme but rather a <strong>cofactor bound </strong>to the enzymes in the <strong>PDH complex.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The enzyme part of the <strong>PDH complex</strong> is made up of <strong>three component enzymes.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PYRUVATE DEHYDROGENASE (ENZYME 1):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Catalyses oxidative decarboxylation; Coenzyme: TPP; Enzyme bound hydroxyethyl TPP is formed</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DIHYDRO LIPOYL TRANSACETYLASE (ENZYME 2):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hydroxyethyl group is oxidized to form acetyl group &rarr; transferred from TPP to lipoamide &rarr; acetyl lipoamide.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DIHYDROLIPOYL DEHYDROGENASE (ENZYME 3):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oxidation of lipoamide; cofactors: TPP, lipoamide and FAD are regenerated</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 173, Vasudevan 9/ ed: p 115</span></strong></span></span></p>",
    "correct_choice_id": 24548,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 6332,
    "choices": [
      {
        "id": 25297,
        "text": "<p>B</p>"
      },
      {
        "id": 25298,
        "text": "<p>C</p>"
      },
      {
        "id": 25299,
        "text": "<p>D</p>"
      },
      {
        "id": 25300,
        "text": "<p>A</p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagram below represents the various fates of pyruvate. Which letter on the diagram shows the reaction requiring biotin as a cofactor and is activated by acetylcoenzyme A?&nbsp;&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture9.jpg\" style=\"height:243px; width:500px\" /></span></span></span></p>",
    "unique_key": "Q8471861",
    "question_audio": null,
    "question_video": null,
    "map_id": 29888,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) C&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate carboxylase</strong>, a <strong>mitochondrial </strong>enzyme of<strong> gluconeogenesis,</strong> requires <strong>biotin and ATP </strong>for its essential function</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate enters the<strong> mitochondrion </strong>and is <strong>carboxylated to oxaloacetate. </strong>This reaction is important in maintaining an <strong>adequate level of oxaloacetate</strong> for the <strong>condensation</strong> reaction with <strong>acetylCoA .</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If <strong>acetyl-CoA accumulates</strong>, it acts as<strong> both an allosteric activator</strong> of<strong> pyruvate carboxylase </strong>and an <strong>inhibitor of pyruvate</strong> <strong>dehydrogenase</strong>, thus ensuring a <strong>supply of oxaloacetate.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Denotes<strong> PDH present in mitochondria,</strong> which<strong> oxidatively decarboxylates pyruvate to acetyl CoA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Denotes<strong> ALT. </strong>Alanine is formed by <strong>transamination of pyruvate</strong> by the enzyme <strong>alanine aminotransferase (ALT),</strong> which requires<strong> PLP. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate + Glutamate &rarr; Alanine + alpha ketoglutarate</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Pyruvate kinase dephosphorylates phosphoenolpyruvate to pyruvate,</strong> which is a <strong>substrate </strong>level key <strong>glycolytic enzyme.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The role of<strong> biotin is a cofactor </strong>in the <strong>carboxylation </strong>reaction catalyzed by<strong> pyruvate carboxylase</strong> and how <strong>acetyl-CoA </strong>serves as an <strong>allosteric activator</strong> of the enzyme, linking the <strong>state of cellular energy to gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 165,166.</span></strong></span></span></p>",
    "correct_choice_id": 25298,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 6057,
    "choices": [
      {
        "id": 24198,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;Cahill&rsquo;s cycle </span></span></span></span></p>"
      },
      {
        "id": 24199,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;Location: not seen in RBCs</span></span></span></span></p>"
      },
      {
        "id": 24200,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;No re-utilization of lactate for gluconeogenesis </span></span></span></span></p>"
      },
      {
        "id": 24201,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">&nbsp;Energy need explains the oxygen debt after exercise</span></span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">A 42-year-old marathon runner experiences muscle fatigue and laboured breathing post-race. Upon evaluation, a metabolic cycle is considered in understanding her physiological state, as shown below. Which statement is correct regarding the metabolic cycle illustrated?</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/01/picture1_XU5jYM8.jpg\" style=\"height:206px; width:300px\" /></span></span></span></span></span></p>",
    "unique_key": "Q1578186",
    "question_audio": null,
    "question_video": null,
    "map_id": 29885,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D) Energy need explains the oxygen debt after exercise&nbsp; </span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option D:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Cori&#39;s Cycle or Lactic Acid Cycle:</span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">It is a process in which <strong>glucose </strong>is<strong> converted to lactate</strong> in the <strong>muscle</strong>; and in the<strong> liver</strong> this <strong>lactate </strong>is <strong>re-converted </strong>into <strong>glucose.</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">It <strong>prevents lactate accumulation</strong><strong> </strong>&amp; <strong>muscle cramps</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Significance:<strong> During exercise,</strong> <strong>lactate</strong> production is<strong> high,</strong> which is <strong>utilized by liver </strong>to produce<strong> glucose </strong>and the process needs <strong>ATP.</strong></span></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The resultant<strong> increased oxygen consumption </strong>is the explanation for the <strong>oxygen debt </strong>after<strong> vigorous exercise</strong></span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"color:black\">Explanation:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option A. Cahill&rsquo;s cycle</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">: It is also know</span></span><span style=\"font-size:12.0pt\">n<span style=\"color:black\"> as<strong> </strong></span><strong>glucose-alanine cycle</strong> and occurs in <strong>fasting muscles<span style=\"color:black\">.</span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option B. Location not seen in RBCs</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">:</span></span> <span style=\"font-size:12.0pt\"><strong>Lactate</strong> is released by <strong>exercising skeletal muscle </strong>and by cells that<strong> lack mitochondria</strong> such as <strong>RBCs </strong>into the <strong>blood.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option C. No re-utilization of lactate for gluconeogenesis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">:<strong> Glucose</strong> is converted to <strong>lactate in the muscle </strong>and in the <strong>liver this lactate</strong> is<strong> re-converted into glucose.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective:</span></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The<strong> Cori cycle</strong> is <strong>energy-intensive,</strong> costing<strong> 6 ATPs </strong>in the <strong>liver</strong> to <strong>resynthesize glucose</strong> from<strong> 2 lactate molecules</strong>. During <strong>exercise</strong>, the body incurs an &quot;<strong>oxygen debt</strong>,&quot; as it uses<strong> more oxygen to replenish ATP stores </strong>and <strong>clear </strong>the <strong>lactate</strong> produced, explaining the<strong> labored</strong> <strong>breathing post-exercise.</strong></span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ref</span></span></u></strong><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">: Harper30/e: p 556, Vasudevan 9/ed: p 114</span></span></strong></span></span></p>",
    "correct_choice_id": 24201,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 6147,
    "choices": [
      {
        "id": 24557,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alanine aminotransferase</span></span></span></p>"
      },
      {
        "id": 24558,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24559,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate carboxylase</span></span></span></p>"
      },
      {
        "id": 24560,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate dehydrogenase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatric team is evaluating a 6-month-old full-term baby girl who presents with failure to thrive, hypotonia, decreased muscle mass, head lag, and metabolic acidosis. Her blood work shows elevated levels of lactate, pyruvate, and alanine. These clinical findings suggest a deficiency in a key metabolic enzyme. Which enzyme is most likely to be deficient in this infant, given her clinical and laboratory presentation?</span></span></span></p>",
    "unique_key": "Q9986462",
    "question_audio": null,
    "question_video": null,
    "map_id": 29881,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Pyruvate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>increased concentrations of pyruvate, lactate, and alanine </strong>indicates there is a <strong>block </strong>in the<strong> pathway </strong>from<strong> pyruvate</strong> towards <strong>TCA cycle. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>deficiency in pyruvate dehydrogenas</strong>e &rarr; <strong>build-up of pyruvate. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate</strong> has <strong>three fates</strong> other than getting converted to Acetyl-CoA by </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pyruvate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> conversion to oxaloacetate by </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">pyruvate carboxylase (option C),</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> reduction to </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">lactate by lactate dehydrogenase (option B),</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> and transamination to the amino acid alanine by </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">alanine aminotransferase (option A).</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As<strong> pyruvate builds up</strong>, an<strong> increase in lactate</strong> and<strong> alanine</strong> would be expected if <strong>pyruvate dehydrogenase </strong>was<strong> deficient.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Alanine aminotransferase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is involved in the<strong> transamination of alanine to pyruvate</strong>. A<strong> deficiency</strong> would <strong>not</strong> likely result in<strong> elevated levels of pyruvate or lactate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lactate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A<strong> deficiency </strong>in this enzyme would typically lead to<strong> lower levels of lactate</strong>, not higher.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pyruvate carboxylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While this enzyme is involved in<strong> gluconeogenesis</strong>, its <strong>deficiency</strong> usually leads to<strong> hypoglycemia </strong>and <strong>does not</strong> typically cause<strong> elevated lactate levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate dehydrogenase deficiency</strong> is characterized by the<strong> accumulation of pyruvate</strong> that <strong>cannot </strong>be effectively converted into <strong>acetyl CoA,</strong> leading to its <strong>reduction to lactate</strong>&nbsp;resulting in<strong> lactic acidosis </strong>and<strong> transamination to alanine</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p115-116,253-254.</span></strong></span></span></p>",
    "correct_choice_id": 24560,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6148,
    "choices": [
      {
        "id": 24561,
        "text": "<p><span style=\"font-size:12.0pt;\">Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms.</span></p>"
      },
      {
        "id": 24562,
        "text": "<p><span style=\"font-size:12.0pt;\">A high carbohydrate diet would be expected to be beneficial for this patient.</span></p>"
      },
      {
        "id": 24563,
        "text": "<p><span style=\"font-size:12.0pt;\">Citrate production from aerobic glycolysis is expected to be increased.</span></p>"
      },
      {
        "id": 24564,
        "text": "<p><span style=\"font-size:12.0pt;\">PDH kinase, a regulatory enzyme of the PDH complex, is expected to be active.</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A neurology team is managing a 2-month-old boy with neurological symptoms and lactic acidosis. To determine the underlying metabolic issue, they perform an enzyme assay on extracts from the patient's cultured skin fibroblasts, assessing the activity of the pyruvate dehydrogenase (PDH) complex. They find that the complex operates at only 5% of the normal activity with a standard amount of thiamine pyrophosphate (TPP) but achieves 80% of normal activity with a much higher TPP concentration. What is the correct interpretation concerning the patient's condition and potential interventions?</span></p>",
    "unique_key": "Q6455077",
    "question_audio": null,
    "question_video": null,
    "map_id": 29882,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Administration of thiamine is expected to reduce his serum lactate level and improve his clinical symptoms</strong>.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This child exhibits classic signs of <strong>pyruvate dehydrogenase (PDH) complex deficiency</strong>, specifically a <strong>thiamine-responsive form</strong>:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The <strong>PDH complex</strong> catalyzes the <strong>conversion of pyruvate to acetyl-CoA</strong>, feeding into the <strong>TCA cycle</strong>.</span></li><li><span style=\"font-size:12.0pt;\">A deficiency in PDH activity leads to <strong>accumulation of pyruvate</strong>, which is instead converted to <strong>lactate</strong> \u2192 <strong>lactic acidosis</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The enzyme assay suggests a <strong>mutation affecting the enzyme's affinity (Km)</strong> for <strong>TPP</strong>, the <strong>coenzyme derived from thiamine</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High doses of thiamine</strong> increase intracellular TPP and <strong>improve PDH activity</strong>, thereby <strong>reducing lactate buildup</strong> and <strong>improving clinical outcomes</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option B. High carbohydrate diet would be beneficial</strong></span><br><span style=\"font-size:12.0pt;\">\u2192 False. In PDH deficiency, increasing carbohydrate intake leads to <strong>more pyruvate accumulation</strong> and <strong>worsened lactic acidosis</strong>.&nbsp;</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Citrate production from aerobic glycolysis is expected to be increased</strong></span><br><span style=\"font-size:12.0pt;\">\u2192 Incorrect. Impaired PDH activity limits <strong>acetyl-CoA formation</strong>, the precursor for <strong>citrate synthesis</strong>, thus <strong>citrate production is decreased</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. PDH kinase is expected to be active</strong></span><br><span style=\"font-size:12.0pt;\">\u2192 Incorrect. PDH kinase <strong>inhibits the PDH complex</strong>. However, <strong>high pyruvate levels inhibit PDH kinase</strong>, making it <strong>inactive</strong> under these conditions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Thiamine (Vitamin B1)</strong> is the precursor for <strong>TPP</strong>, a coenzyme for <strong>PDH complex, \u03b1-ketoglutarate dehydrogenase, and transketolase</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Some <strong>PDH deficiencies are thiamine-responsive</strong>, especially those with a <strong>mutated E1 subunit</strong> that has a <strong>high Km for TPP</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thiamine therapy</strong> can significantly reduce <strong>serum lactate</strong> and improve <strong>neurological symptoms</strong> in responsive cases</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e: p 165-167, 174.</span></p>",
    "correct_choice_id": 24561,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6151,
    "choices": [
      {
        "id": 24573,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True</span></span></span></p>"
      },
      {
        "id": 24574,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False</span></span></span></p>"
      },
      {
        "id": 24575,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Information Insufficient</span></span></span></p>"
      },
      {
        "id": 24576,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A genetic counselor is discussing the potential impact of enzyme deficiencies on metabolic pathways with a couple awaiting the birth of their child. The counselor explains that certain genetic conditions can disrupt normal metabolic processes. She asks the couple to consider the statement: &quot;A defect in the pyruvate dehydrogenase (PDH) complex can lead to lactic acidosis.&quot; Is this statement true or false?</span></span></span></p>",
    "unique_key": "Q8739460",
    "question_audio": null,
    "question_video": null,
    "map_id": 29884,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) True</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A <strong>PDH defect</strong> can indeed lead to <strong>lactic acidosis.</strong> The <strong>PDH complex </strong>is responsible for <strong>converting pyruvate to acetyl CoA, </strong>a step that <strong>links glycolysis to the citric acid cycle</strong>. If <strong>PDH is deficient or defective</strong>,<strong> pyruvate cannot</strong> effectively <strong>enter </strong>the <strong>citric acid cycle</strong> and is instead<strong> converted to lactate by lactate dehydrogenase.</strong> This can lead to an <strong>accumulation of lactate </strong>in the blood, resulting in <strong>lactic</strong> <strong>acidosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Significance of PDH Complex</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thiamine deficiency </strong>affect<strong> PDH </strong>and thereby the <strong>complete oxidation of Glucose</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>PDH defect</strong> can lead to<strong> Lactic Acidosis</strong> due to<strong> excess of pyruvate </strong>and<strong> conversion to lactate</strong> instead of acetyl CoA</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fat</strong> <strong>cannot</strong> be converted to<strong> glucose</strong> because of the <strong>irreversible nature of PDH</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p:115-117.</span></strong></span></span></p>",
    "correct_choice_id": 24573,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6157,
    "choices": [
      {
        "id": 24597,
        "text": "<p><span style=\"font-size:12pt;\">To Glucose</span></p>"
      },
      {
        "id": 24598,
        "text": "<p><span style=\"font-size:12pt;\">To Lactate</span></p>"
      },
      {
        "id": 24599,
        "text": "<p><span style=\"font-size:12pt;\">To Oxaloacetate</span></p>"
      },
      {
        "id": 24600,
        "text": "<p><span style=\"font-size:12pt;\">All the above</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">PG Junior Residents of Biochemistry department are discussing a complex case of metabolic disorder; a debate arises regarding the metabolic flexibility of pyruvate under various physiological conditions. A senior consultant poses a question to the team to clarify the understanding of pyruvate metabolism. Which of the following is a fate of pyruvate in human metabolism?</span></p>",
    "unique_key": "Q4150484",
    "question_audio": null,
    "question_video": null,
    "map_id": 29886,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) All the above</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pyruvate is a critical metabolic intermediate that sits at the crossroads of several important pathways in human metabolism. All three of the listed conversions are physiologically significant fates of pyruvate:</span></p><ol><li><span style=\"font-size:12.0pt;\">Conversion to Glucose (option A):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Pyruvate can be converted to glucose through the process of gluconeogenesis, which occurs primarily in the liver and kidneys</span></li><li><span style=\"font-size:12.0pt;\">This process begins with the carboxylation of pyruvate to oxaloacetate by pyruvate carboxylase (requires biotin as a cofactor)</span></li><li><span style=\"font-size:12.0pt;\">This conversion is particularly important during fasting states or when glucose is needed by tissues like the brain</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Conversion to Lactate (option B):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Under anaerobic conditions or during intense exercise, pyruvate is reduced to lactate by lactate dehydrogenase (LDH)</span></li><li><span style=\"font-size:12.0pt;\">This reaction regenerates NAD+ from NADH, allowing glycolysis to continue</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Conversion to Oxaloacetate (option C):</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Pyruvate can be directly carboxylated to form oxaloacetate by the enzyme pyruvate carboxylase</span></li><li><span style=\"font-size:12.0pt;\">This reaction is crucial for both gluconeogenesis and anaplerotic reactions that replenish TCA cycle intermediates</span></li><li><span style=\"font-size:12.0pt;\">The reaction requires ATP and the cofactor biotin</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It's worth noting that pyruvate has additional important metabolic fates not mentioned in the options:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Conversion to acetyl-CoA by pyruvate dehydrogenase complex (requires thiamine, lipoic acid, NAD+, FAD, and CoA)</span></li><li><span style=\"font-size:12.0pt;\">Transamination to form the amino acid alanine via alanine aminotransferase (ALT)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The major fates of pyruvate in human metabolism include:</span></p><ol><li><span style=\"font-size:12.0pt;\">Conversion to glucose through gluconeogenesis (pyruvate carboxylase)</span></li><li><span style=\"font-size:12.0pt;\">Reduction to lactate under anaerobic conditions (lactate dehydrogenase)</span></li><li><span style=\"font-size:12.0pt;\">Carboxylation to oxaloacetate for the TCA cycle or gluconeogenesis (pyruvate carboxylase)</span></li><li><span style=\"font-size:12.0pt;\">Oxidative decarboxylation to acetyl-CoA (pyruvate dehydrogenase complex)</span></li><li><span style=\"font-size:12.0pt;\">Transamination to form alanine (alanine aminotransferase)</span></li></ol><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture23.jpg\" alt=\"\" width=\"500\" height=\"310\"></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/e p:117.</span></p>",
    "correct_choice_id": 24600,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6149,
    "choices": [
      {
        "id": 24565,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True</span></span></span></p>"
      },
      {
        "id": 24566,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False</span></span></span></p>"
      },
      {
        "id": 24567,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Information Insufficient</span></span></span></p>"
      },
      {
        "id": 24568,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Can the acetyl CoA, derived from fatty acid oxidation, be converted back into glucose to maintain blood glucose levels? What is the correct response based on human metabolic pathways?</span></span></span></p>",
    "unique_key": "Q9469335",
    "question_audio": null,
    "question_video": null,
    "map_id": 29883,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) False</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA</strong> <strong>cannot </strong>be converted into <strong>glucose</strong> in humans because the reactions of the <strong>citric acid cycle are not reversible</strong>, and there is <strong>no pathway</strong> that can <strong>convert acetyl CoA back to pyruvate</strong> or any other<strong> gluconeogenic precursors.</strong> This <strong>underscores</strong> the importance of the concept that while<strong> glucose can be converted into acetyl CoA, </strong>the<strong> reverse is not true</strong>, marking a<strong> one-way route</strong> towards <strong>energy production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fate of Acetyl CoA</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty Acid Synthesis</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketone Body Synthesis</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol Synthesis</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TCA Cycle</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA cannot be converted to glucose as the link reaction is irreversible.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p: 141.</span></strong></span></span></p>",
    "correct_choice_id": 24566,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9168,
    "choices": [
      {
        "id": 36639,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl-CoA</span></span></span></p>"
      },
      {
        "id": 36640,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetoacetyl-CoA</span></span></span></p>"
      },
      {
        "id": 36641,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D-Methylmalonyl CoA</span></span></span></p>"
      },
      {
        "id": 36642,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Butyryl CoA</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 42-year-old biochemist working on a project related to metabolic diseases encounters a patient&rsquo;s chart with a rare metabolic disorder affecting the metabolism of certain fatty acids. The patient has an abnormal accumulation of fatty acids with an odd number of carbon atoms. Intrigued, the biochemist considers the metabolic fate of such fatty acids, specifically the conversion of propionyl-CoA, a product of their &beta;-oxidation. He reflects on the pathway this metabolite takes in the process leading towards the citric acid cycle:</span></span></span></p>",
    "unique_key": "Q1082638",
    "question_audio": null,
    "question_video": null,
    "map_id": 29887,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D-Methylmalonyl CoA</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propionyl CoA </strong>is first carboxylated to <strong>D-methyl malonyl CoA</strong> by a <strong>biotin </strong>dependent carboxylase. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>One molecule of ATP </strong>is utilized to <strong>supply energy.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/8.jpg\" style=\"height:467px; width:602px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Acetyl-CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Acetyl-CoA is a product of <strong>even-numbered fatty acid oxidation</strong>, <strong>not</strong> directly from <strong>propionyl-CoA </strong>derived from <strong>odd-numbered fatty acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Acetoacetyl-CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Acetoacetyl-CoA is an intermediate in<strong> ketone body synthesis</strong> and is <strong>not </strong>directly related to the metabolism of<strong> propionyl-CoA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Butyryl CoA</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Butyryl CoA is a <strong>four-carbon acyl-CoA</strong> molecule that is <strong>not </strong>a direct product of <strong>propionyl-CoA metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Propionyl-CoA,</strong> which is derived from the <strong>oxidation of fatty acids</strong> with an <strong>odd number of carbon atoms</strong>, is converted into<strong> D-Methylmalonyl CoA. </strong>This conversion involves a <strong>carboxylation reaction,</strong> which is <strong>catalyzed </strong>by the enzyme <strong>propionyl-CoA carboxylase, </strong>with <strong>biotin </strong>as a cofactor. <strong>D-Methylmalonyl CoA </strong>is then converted into <strong>succinyl-CoA</strong>, which can <strong>enter </strong>the <strong>citric acid cycle</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 205</span></strong></span></span></p>",
    "correct_choice_id": 36641,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6195,
    "choices": [
      {
        "id": 24749,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspartate</span></span></span></p>"
      },
      {
        "id": 24750,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malate </span></span></span></p>"
      },
      {
        "id": 24751,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;-ketoglutarate</span></span></span></p>"
      },
      {
        "id": 24752,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fumarate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A teenager is brought to the ER with symptoms of increased confusion and lethargy. Lab tests reveal abnormal liver function and significantly elevated serum ammonia levels. His parents note his recent high protein intake, attributed to his athletic activities. Hyperammonemia can disrupt the TCA cycle by depleting a specific intermediate, leading to impaired energy metabolism. Which TCA cycle intermediate is most likely depleted in this scenario, contributing to the cycle&#39;s inhibition?</span></span></span></p>",
    "unique_key": "Q2658231",
    "question_audio": null,
    "question_video": null,
    "map_id": 29841,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) &alpha;-ketoglutarate&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture27.jpg\" style=\"height:400px; width:700px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Since<strong> ammonia</strong> is <strong>toxic to CNS,</strong> it is important to <strong>maintain</strong> only <strong>traces</strong> (<strong>10-20 &mu;g/dL</strong>) in <strong>peripheral blood </strong>and it should be<strong> effectively detoxified</strong> and <strong>eliminated from the body. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In severely<strong> impaired hepatic function</strong> or the development of <strong>collateral links</strong> between the <strong>portal and systemic veins in cirrhosis</strong>, <strong>portal blood bypasses the liver</strong>, <strong>systemic blood ammonia </strong>may <strong>attain toxic levels. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Symptoms</strong> of ammonia intoxication include<strong> tremor, slurred speech, blurred vision, coma,</strong> and <strong>ultimately death. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ammonia</strong> may be<strong> toxic</strong> to the <strong>brain</strong> in part because it reacts with<strong> &alpha;-ketoglutarate</strong> to form <strong>glutamate. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>resulting depletion</strong> of levels of<strong> &alpha;-ketoglutarate</strong> then<strong> impairs </strong>function of the<strong> tricarboxylic</strong> <strong>acid (TCA) cycle</strong> in <strong>neurons. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Aspartate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Although <strong>aspartate is involved </strong>in the<strong> urea cycle</strong>, its<strong> depletion</strong> <strong>does not</strong> directly <strong>inhibit the TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Malate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Malate is a <strong>TCA cycle intermediate</strong>, but it is <strong>not directly</strong> <strong>depleted</strong> by <strong>hyperammonemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fumarate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Fumarate is also part of the <strong>TCA cycle</strong> but is <strong>not</strong> the <strong>intermediate depleted</strong> by <strong>hyperammonemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperammonemia</strong> can i<strong>nhibit</strong> the <strong>TCA cycle</strong> by <strong>depleting &alpha;-ketoglutarate</strong>. <strong>Ammonia</strong> is <strong>detoxified</strong> in the <strong>liver </strong>by the <strong>urea cycle,</strong> which consumes <strong>&alpha;-ketoglutarate </strong>as it combines with<strong> ammonia to form glutamate.</strong> This process <strong>depletes &alpha;-ketoglutarate</strong>, a critical <strong>intermediate</strong> in the<strong> TCA cycle</strong>, leading to <strong>impaired energy metabolism </strong>and contributing to the<strong> symptoms observed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Harper 30/e:&nbsp; p 291, 292, Lippincott: P 253.</span></strong></span></span></p>",
    "correct_choice_id": 24751,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6165,
    "choices": [
      {
        "id": 24629,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ETC</span></span></span></p>"
      },
      {
        "id": 24630,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 24631,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMP shunt</span></span></span></p>"
      },
      {
        "id": 24632,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TCA Cycle </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 1-year-old child, while playing, accidentally ingests a small amount of rat poison containing fluoroacetate, found in the cupboard. This substance reacts with oxaloacetate to produce fluorocitrate. Which major metabolic pathway is most likely to be inhibited by this poison?</span></span></span></p>",
    "unique_key": "Q9979676",
    "question_audio": null,
    "question_video": null,
    "map_id": 29839,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) TCA Cycle</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>TCA Cycle </strong>is<strong> inhibited by Fluoroacetate,</strong> is an e.g., of<strong> suicidal inhibition.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fluoroacetate</strong> <strong>first </strong>gets <strong>converted to Fluoroacetyl coA</strong> &rarr; condenses with <strong>Oxaloacetate</strong> &rarr; converted to <strong>Fluoro citrate </strong>&rarr;<strong> inhibit Aconitase enzyme</strong> of TCA cycle. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. ETC:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Inhibitors</strong> includes <strong>Alkylguanides, hypotensive drug, Rotenone, insecticide</strong> and <strong>fish</strong> <strong>poison, Barbiturates, Carboxin, BAL, Naphthoquinone</strong> etc. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glycolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Key </strong>enzymes such as HK, GK, PFK are<strong> inhibited by G-6-P, Glucagon,</strong> <strong>ATP, cyclic AMP,</strong> <strong>citrate, low pH, cAMP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. HMP shunt:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> G6PD</strong> is the <strong>rate-limiting step</strong>, <strong>inhibited</strong> by <strong>NADPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fluorocitrate</strong>, formed from the reaction of<strong> fluoroacetate with oxaloacetate, </strong>is a <strong>potent inhibitor</strong> of the <strong>TCA cycle</strong>. It specifically <strong>inhibits aconitase</strong>, an enzyme in the<strong> TCA cycle</strong>, thereby<strong> blocking</strong> the conversion of<strong> citrate to isocitrate </strong>and <strong>disrupting </strong>cellular <strong>energy production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 161-163.</span></strong></span></span></p>",
    "correct_choice_id": 24632,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6221,
    "choices": [
      {
        "id": 24853,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pantothenic Acid as a part of CoA</span></span></span></p>"
      },
      {
        "id": 24854,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Riboflavin as FAD</span></span></span></p>"
      },
      {
        "id": 24855,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine</span></span></span></p>"
      },
      {
        "id": 24856,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There are one specific vitamins, which is involved in the TCA cycle as key for comprehending its biochemical intricacies and the nutritional requirements that support this fundamental metabolic pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following vitamins are involved in the TCA cycle?</span></span></span></p>",
    "unique_key": "Q6634750",
    "question_audio": null,
    "question_video": null,
    "map_id": 29832,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All </strong>the listed<strong> vitamins</strong> are involved in the <strong>TCA cycle:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pantothenic Acid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; It is a component of <strong>Coenzyme A (CoA)</strong>, essential for the formation of Acetyl-<strong>CoA, </strong>a<strong> substrate</strong> entering the <strong>TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Riboflavin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is<strong> converted into Flavin Adenine Dinucleotide (FAD), </strong>a <strong>coenzyme</strong> used by <strong>succinate</strong> <strong>dehydrogenase</strong> in the TCA cycle.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Thiamine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; As <strong>thiamine pyrophosphate (TPP)</strong>, it is a <strong>coenzyme</strong> for the<strong> pyruvate dehydrogenase</strong> <strong>complex</strong> that converts <strong>pyruvate into Acetyl-CoA,</strong> linking<strong> glycolysis with the TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamins in TCA Cycle:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pantothenic Acid </strong>as a part of CoA</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Riboflavin</strong> as FAD</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Niacin </strong>as NAD+</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: 251.</span></strong></span></span></p>",
    "correct_choice_id": 24856,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6163,
    "choices": [
      {
        "id": 24621,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isocitrate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24622,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;- ketoglutarate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24623,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinyl CoA synthetase</span></span></span></p>"
      },
      {
        "id": 24624,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinate dehydrogenase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which enzyme catalyzes the substrate-level phosphorylation step in the TCA cycle?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q6101501",
    "question_audio": null,
    "question_video": null,
    "map_id": 29837,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Succinyl CoA synthetase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Formation of succinate:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The enzyme is<strong> succinate thiokinase / Succinyl-CoA Synthetase</strong> (<strong>step 5 of TCA cycle</strong>). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A molecule of<strong> GDP is phosphorylated to GTP </strong>and <strong>succinate is formed. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> GTP </strong>can be converted to <strong>ATP by reacting with an ADP molecule:</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; GTP + ADP &rarr; GDP + ATP</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">I<strong>socitrate dehydrogenase</strong>- Catalyzes<strong> step 3 </strong>of <strong>TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>&alpha;- ketoglutarate dehydrogenase</strong> - Catalyzes <strong>step 4</strong> of <strong>TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Succinate dehydrogenase</strong>- Catalyzes<strong> step 6</strong> of <strong>TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Succinyl CoA synthetase catalyzes</strong> the only <strong>substrate-level phosphorylation</strong> step within the <strong>TCA cycle, </strong>where<strong> GDP</strong> (guanosine diphosphate) is <strong>phosphorylated to GTP</strong> (guanosine triphosphate), which can then be <strong>converted to ATP. </strong>This step involves the <strong>conversion</strong> of <strong>succinyl CoA to succinate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: 247-249.</span></strong></span></span></p>",
    "correct_choice_id": 24623,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6193,
    "choices": [
      {
        "id": 24741,
        "text": "<p><span style=\"font-size:12pt;\">1.5</span></p>"
      },
      {
        "id": 24742,
        "text": "<p><span style=\"font-size:12.0pt;\">2.5</span></p>"
      },
      {
        "id": 24743,
        "text": "<p><span style=\"font-size:12.0pt;\">3.5</span></p>"
      },
      {
        "id": 24744,
        "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">During the conversion of \u03b1-ketoglutarate to succinate in the TCA cycle, several reactions occur, leading to the production of energy-rich molecules. This conversion involves the decarboxylation of \u03b1-ketoglutarate, the generation of Succinyl CoA, and the subsequent formation of succinate. how many ATP molecules are typically produced through this series of reactions?</span></p>",
    "unique_key": "Q2544552",
    "question_audio": null,
    "question_video": null,
    "map_id": 29835,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. 3.5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The conversion of \u03b1-ketoglutarate to succinate in the TCA cycle involves two key steps:</span></p><ol><li><span style=\"font-size:12.0pt;\">First, \u03b1-ketoglutarate dehydrogenase complex catalyzes the oxidative decarboxylation of \u03b1-ketoglutarate to form succinyl-CoA, CO\u2082, and NADH.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">The NADH produced in this step will yield approximately 2.5 ATP molecules when oxidized through the electron transport chain.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Second, succinyl-CoA synthetase (also called succinate thiokinase) catalyzes the conversion of succinyl-CoA to succinate with the generation of GTP (which is energetically equivalent to ATP.</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">This substrate-level phosphorylation directly produces 1 GTP/ATP molecule.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the total ATP yield from converting \u03b1-ketoglutarate to succinate is:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">2.5 ATP from NADH oxidation in the electron transport chain</span></li><li><span style=\"font-size:12.0pt;\">1 ATP from substrate-level phosphorylation (GTP formation)</span></li><li><span style=\"font-size:12.0pt;\">Total: 3.5 ATP molecules&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This makes option C (3.5) the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understanding the energetics of the TCA cycle reactions, specifically:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The \u03b1-ketoglutarate dehydrogenase complex reaction produces NADH</span></li><li><span style=\"font-size:12.0pt;\">The succinyl-CoA synthetase reaction produces GTP/ATP via substrate-level phosphorylation</span></li><li><span style=\"font-size:12.0pt;\">NADH yields approximately 2.5 ATP when oxidized through the electron transport chain</span></li><li><span style=\"font-size:12.0pt;\">Together, these reactions yield 3.5 ATP molecules from the conversion of \u03b1-ketoglutarate to succinate</span></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture1.jpg\" alt=\"\" width=\"1000\" height=\"309\"></strong></span></p>",
    "correct_choice_id": 24743,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 6035,
    "choices": [
      {
        "id": 24110,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></span></p>"
      },
      {
        "id": 24111,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acids</span></span></span></p>"
      },
      {
        "id": 24112,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cholesterol</span></span></span></p>"
      },
      {
        "id": 24113,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketone bodies</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA plays a central role in energy metabolism, acting as a substrate for several biosynthetic pathways. Which of the following is NOT a product of Acetyl CoA conversion? </span></span></p>",
    "unique_key": "Q9852999",
    "question_audio": null,
    "question_video": null,
    "map_id": 29836,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA cannot be converted into glucose </strong>because the <strong>pyruvate dehydrogenase reaction </strong>that <strong>produces Acetyl CoA from pyruvate </strong>is <strong>irreversible</strong>. This means that <strong>organisms </strong>that <strong>rely solely on acetyl CoA </strong>as a <strong>substrate for gluconeogenesis</strong> cannot <strong>convert fatty acids into glucose.</strong> This process is known as the <strong>irreversibility of fatty acid to glucose conversion</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options B:</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fatty acids</strong> can be <strong>synthesized from acetyl CoA</strong> in a process known as <strong>lipogenesis,</strong> primarily in the liver and adipose tissue.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options C:</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Cholesterol </strong>is also <strong>synthesized from acetyl CoA </strong>via the <strong>mevalonate pathway</strong>, which is critical for cell membrane integrity and as a precursor for steroid hormones.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Options D:</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Ketone bodies </strong>are <strong>produced from acetyl CoA </strong>during <strong>periods of low carbohydrate availability</strong>, such as <strong>fasting</strong>, <strong>prolonged exercise</strong>, or <strong>low-carbohydrate diets</strong>, primarily in the liver.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA </strong>is <strong>not </strong>a <strong>substrate for gluconeogenesis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the <strong>starting material </strong>for <strong>Fatty acid </strong>and <strong>Cholesterol synthesis</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an <strong>intermediate in Ketone body synthesis</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Ref</u>:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harper 30/e p188, 189</span></strong></span></span></p>",
    "correct_choice_id": 24110,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6160,
    "choices": [
      {
        "id": 24609,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citrate</span></span></p>"
      },
      {
        "id": 24610,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxaloacetate</span></span></span></p>"
      },
      {
        "id": 24611,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl-CoA</span></span></span></p>"
      },
      {
        "id": 24612,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a fitness center, a personal trainer discusses with a client the metabolic changes that occur during intense aerobic workouts. The trainer explains how the body metabolizes glucose to meet the increased energy demands of vigorous exercise. The conversation leads to a question about the form in which carbon atoms from glucose enter the tricarboxylic acid (TCA) cycle during such high-energy activities. What is the correct form in which these carbons enter the TCA cycle?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q5504167",
    "question_audio": null,
    "question_video": null,
    "map_id": 29833,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Acetyl-CoA&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During <strong>aerobic glycolysis</strong>, the<strong> end product,</strong> <strong>pyruvate</strong>, is converted into <strong>acetyl-CoA </strong>before entering the <strong>TCA cycle</strong>. Acetyl-CoA then combines with<strong> oxaloacetate to form citrate,</strong> which is the<strong> first compound</strong> formed in the <strong>cycle. </strong>Thus, the <strong>carbons</strong> derived from <strong>glucose </strong>primarily<strong> enter the TCA cycle</strong> in the form of<strong> acetyl-CoA.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Citrate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Oxaloacetate</strong> condenses with <strong>acetyl CoA entering TCA cycle</strong> to form <strong>citrate</strong> (a<strong> tricarboxylic molecule</strong>) (inside <strong>TCA</strong> <strong>cycle</strong>) with the help of the<strong> enzyme citrate synthase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Oxaloacetate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Pyruvate</strong> is<strong> carboxylated</strong> to <strong>oxaloacetate</strong> which is then <strong>used for gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pyruvate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucose</strong> is<strong> converted </strong>to <strong>pyruvate </strong>which is then <strong>converted to acetyl-CoA </strong>&rarr; <strong>enter TCA cycle</strong> and <strong>Pyruvate </strong>as such <strong>cannot enter TCA cycle. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>aerobic glycolysis</strong>, <strong>glucose</strong> is converted into<strong> pyruvate</strong> &rarr; then c<strong>onverted to Acetyl-CoA</strong>, which actually <strong>enters the citric</strong> <strong>acid cycle.</strong>&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two Acetyl-CoA</strong>, each containing<strong> two of the glucose&rsquo;s carbons</strong>, are formed from <strong>each</strong> <strong>glucose molecule. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Lippincott 7/e: P 96-98.</span></strong></span></span></p>",
    "correct_choice_id": 24611,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6198,
    "choices": [
      {
        "id": 24761,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate condenses with Oxaloacetate to form Citrate</span></span></span></p>"
      },
      {
        "id": 24762,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha ketoglutarate is a five Carbon compound</span></span></span></p>"
      },
      {
        "id": 24763,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidative Phosphorylation occurs in the cytoplasm only</span></span></span></p>"
      },
      {
        "id": 24764,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Krebs cycle can operate in anaerobic condition</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is true about Krebs Cycle?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q2951630",
    "question_audio": null,
    "question_video": null,
    "map_id": 29842,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Alpha ketoglutarate is a five Carbon compound.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha-ketoglutarate,</strong> indeed, is a <strong>five-carbon compound </strong>that is part of the<strong> Krebs Cycle</strong>. It is formed from <strong>isocitrate</strong> through a <strong>decarboxylation reaction </strong>catalyzed by <strong>isocitrate dehydrogenase</strong> and is further converted into<strong> succinyl-CoA, </strong>a <strong>four-carbon</strong> compound, in a <strong>subsequent step of the cycle</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pyruvate <strong>does not</strong> directly condense with <strong>oxaloacetate to form citrate</strong>. Instead,<strong> pyruvate </strong>is first <strong>converted into acetyl-CoA</strong>, which then <strong>condenses with oxaloacetate. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Oxidative phosphorylation</strong> occurs in the <strong>mitochondria</strong>, not in the cytoplasm. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>Krebs cycle</strong> is an<strong> aerobic process</strong> and <strong>does not </strong>operate under<strong> anaerobic conditions</strong>, as it <strong>relies on oxygen indirectly</strong> through the<strong> electron transport</strong> chain for the <strong>regeneration of NAD+</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;-Ketoglutarate Dehydrogenase: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>&alpha;-ketoglutarate (5C) oxidised </strong>and <strong>decarboxylated</strong> to<strong> Succinyl CoA</strong> <strong>(4C)</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Second</strong> <strong>Oxidative Decarboxylation </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>1 NADH</strong> is formed</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physiologically <strong>Unidirectional </strong>step</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Multienzyme Complex</strong> similar to <strong>Pyruvate Dehydrogenase</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p161-167.</span></strong></span></span></p>",
    "correct_choice_id": 24762,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6200,
    "choices": [
      {
        "id": 24769,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malonate</span></span></span></p>"
      },
      {
        "id": 24770,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arsenite</span></span></span></p>"
      },
      {
        "id": 24771,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluoroacetate</span></span></span></p>"
      },
      {
        "id": 24772,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following substances is known to bind to CoA and condense with oxaloacetate, thereby inhibiting the TCA cycle?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q6335588",
    "question_audio": null,
    "question_video": null,
    "map_id": 29843,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Fluoroacetate. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> poison fluoroacetate</strong> is found in some of<strong> plants.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some<strong> fluorinated compounds</strong> are used as<strong> anticancer agents</strong> and<strong> industrial chemicals </strong>(including <strong>pesticides</strong>) are <strong>metabolized to fluoroacetate</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is<strong> toxic</strong> because<strong> Fluoroacetyl-CoA </strong>condenses with <strong>oxaloacetate</strong> to form <strong>fluorocitrate</strong>, which in turn <strong>inhibits aconitase</strong>, causing<strong> citrate to accumulate.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Malonate -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Malonate is a<strong> competitive inhibitor</strong> of<strong> succinate dehydrogenase,</strong> another enzyme in the <strong>TCA cycle</strong>, but it<strong> does not </strong>condense with <strong>oxaloacetate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Arsenite -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Arsenite <strong>inhibits</strong> the<strong> pyruvate dehydrogenase complex</strong> and <strong>alpha-ketoglutarate</strong> <strong>dehydrogenase complex</strong>, but it <strong>does not</strong> directly bind to <strong>CoA </strong>and <strong>condense with oxaloacetate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fluorocitrate</strong> is a potent<strong> inhibitor of aconitase</strong>, an enzyme in the <strong>TCA cycle, </strong>leading to the <strong>inhibition of the</strong> <strong>cycle</strong> and <strong>disruption</strong> of<strong> cellular energy metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p161-167</span></strong></span></span></p>",
    "correct_choice_id": 24771,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6201,
    "choices": [
      {
        "id": 24773,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O</span></span></span></p>"
      },
      {
        "id": 24774,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2</span></span></span></p>"
      },
      {
        "id": 24775,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O2</span></span></span></p>"
      },
      {
        "id": 24776,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CO2</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During the Tricarboxylic Acid (TCA) cycle, citrate undergoes a series of transformations to facilitate cellular energy production. One of the initial steps involves the conversion of citrate to cis-aconitate. This reaction is catalyzed by the enzyme aconitase. Understanding the specific changes that occur during this conversion is essential for comprehending the intricate details of the TCA cycle. What is liberated during the conversion of citrate to cis-aconitate?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q1641590",
    "question_audio": null,
    "question_video": null,
    "map_id": 29846,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) H2O. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>conversion of citrate to cis-aconitate, </strong>catalyzed by<strong> aconitase</strong>, involves the <strong>removal of a water molecule</strong> (<strong>dehydration</strong>). This is an <strong>intermediary step </strong>before<strong> cis-aconitate</strong> is <strong>hydrated </strong>back to <strong>form</strong> <strong>isocitrate,</strong> another compound in the <strong>TCA cycle.</strong> Therefore,<strong> H2O </strong>is <strong>liberated</strong> during this <strong>conversion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. H2 -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Hydrogen gas </strong>is <strong>not</strong> a product of this specific reaction in the <strong>TCA cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. H2O2 -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Hydrogen peroxide </strong>is<strong> not </strong>produced during the conversion of <strong>citrate to cis-aconitate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. CO2 -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Carbon dioxide</strong> is <strong>not</strong> liberated in this step; it is produced in <strong>later steps of the TCA cycle</strong> when<strong> isocitrate </strong>and then<strong> alpha-ketoglutarate are decarboxylated.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Citrate isomerized to Isocitrate</strong> by<strong> Aconitase</strong> which is a<strong> reversible reaction.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>reaction</strong> occurs in<strong> two steps</strong>: <strong>dehydration to cis aconitate </strong>and <strong>rehydration to isocitrate.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p163</span></strong></span></span></p>",
    "correct_choice_id": 24773,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 7618,
    "choices": [
      {
        "id": 30440,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alanine</span></span></span></p>"
      },
      {
        "id": 30441,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutamine</span></span></span></p>"
      },
      {
        "id": 30442,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leucine</span></span></span></p>"
      },
      {
        "id": 30443,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 2-months-old male infant presents with seizures, hypotonia, retardation of psychomotor functions and poor head control. Blood investigations show lactic acidosis and highly elevated plasma pyruvate levels, which are several times higher than the normal level. When the Pyruvate carboxylase activity was measured using the fibroblasts extracts, it is less than 1 percent of the normal level. Administration of which of the following amino acids would be the best therapy for this patient?</span></span></span></p>",
    "unique_key": "Q8089834",
    "question_audio": null,
    "question_video": null,
    "map_id": 29831,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glutamine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glutamine administration </strong>is beneficial in conditions with <strong>pyruvate carboxylase deficiency</strong>. <strong>Glutamine </strong>can contribute to <strong>anaplerosis, </strong>replenishing the<strong> TCA cycle intermediates, </strong>thus helping to <strong>mitigate </strong>the <strong>effects </strong>of the<strong> enzyme deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><u>Other Options:</u></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: Alanine </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- <strong>Not </strong>directly useful in replenishing <strong>TCA cycle </strong>intermediates in the context of <strong>pyruvate carboxylase deficiency</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C: Leucine</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> - An<strong> essential amino acid </strong>but <strong>not </strong>specifically <strong>beneficial for treating pyruvate carboxylase deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D: Lysine </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">- <strong>Essential </strong>but <strong>does not </strong>have a direct role in <strong>ameliorating </strong>the <strong>effects </strong>of <strong>pyruvate carboxylase deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency in pyruvate carboxylase </strong>leads to <strong>diminution </strong>of <strong>oxaloacetate</strong>, a<strong> C4 acid </strong>which acts as an <strong>acceptor </strong>for the <strong>acetyl group from acetyl-CoA</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the <strong>TCA cycle </strong>to <strong>function efficiently,</strong> <strong>C4 acids </strong>must be <strong>replenished by </strong>feeding the <strong>TCA with carbon skeletons </strong>of <strong>amino acids.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glutamine </strong>&rarr; converted to <strong>alpha-ketoglutarate </strong>&rarr; <strong>increase </strong>in all of <strong>C4</strong> <strong>acids </strong>(<strong>succinate, fumarate, malate, and oxaloacetate</strong>). </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 164,165,188.</span></span></strong></p>",
    "correct_choice_id": 30441,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6142,
    "choices": [
      {
        "id": 24537,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytosol</span></span></span></p>"
      },
      {
        "id": 24538,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondria</span></span></span></p>"
      },
      {
        "id": 24539,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lysosomes</span></span></span></p>"
      },
      {
        "id": 24540,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoplasmic reticulum</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A third-year medical student is shadowing in the metabolic diseases unit and encounters a patient being evaluated for a disorder affecting energy production. The patient&#39;s symptoms are suggestive of a defect in the complete oxidation of glucose. Intrigued, the student reviews biochemistry notes to understand where in the cell this process might be impaired. To aid in diagnosing and managing the patient&#39;s condition, the student seeks to identify the cellular compartment responsible for the full catabolism of glucose into carbon dioxide and water. Where are the enzymes located that facilitate this complete metabolic breakdown?</span></span></span></p>",
    "unique_key": "Q8735967",
    "question_audio": null,
    "question_video": null,
    "map_id": 29845,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Mitochondria </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mitochondria</strong> are the <strong>organelles </strong>where <strong>complete oxidation of glucose </strong>occurs.<strong> Glycolysis</strong> happens in the<strong> cytosol,</strong> breaking <strong>glucose</strong> <strong>down into pyruvate,</strong> which then <strong>enters the mitochondria</strong>. Here, <strong>pyruvate undergoes further oxidation</strong> in the<strong> citric acid cycle </strong>and <strong>oxidative phosphorylation,</strong> resulting in the<strong> production of CO2, water, and ATP, the cell&#39;s energy currency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Cytosol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Only hosts<strong> glycolysis</strong>, the<strong> first</strong> stage of<strong> glucose metabolism, not </strong>its complete <strong>oxidation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lysosomes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Involved in <strong>degrading and recycling cellular waste</strong>, <strong>not </strong>in<strong> energy metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Endoplasmic reticulum:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Plays a key role in<strong> protein and lipid synthesis</strong>, but <strong>not</strong> in the <strong>oxidation of glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Under<strong> aerobic conditions</strong>, <strong>pyruvate</strong> is taken up into <strong>mitochondria and after oxidative decarboxylation</strong> to<strong> Acetyl-CoA</strong> is oxidized to<strong> CO2</strong> by the <strong>citric acid cycle</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Under<strong> anaerobic conditions</strong>, <strong>pyruvate</strong> is reduced by the <strong>NADH to lactate, </strong>catalyzed by<strong> lactate dehydrogenase.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p: 172</span></strong></span></span></p>",
    "correct_choice_id": 24538,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6164,
    "choices": [
      {
        "id": 24625,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isocitrate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24626,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fumarase</span></span></span></p>"
      },
      {
        "id": 24627,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24628,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinate dehydrogenase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A post-operative patient develops angular stomatitis and shows low riboflavin excretion, indicative of a deficiency. Riboflavin is essential for FAD, a coenzyme in the TCA cycle. Which TCA cycle enzyme, dependent on FAD, would be affected by this deficiency?</span></span></span></p>",
    "unique_key": "Q7239461",
    "question_audio": null,
    "question_video": null,
    "map_id": 29838,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Succinate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient has demonstrated a <strong>deficiency in riboflavin</strong> (<strong>urinary excretion &lt;&lt; 30 &micro;g/mg creatinine</strong> is considered as <strong>clinically deficient</strong>). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Riboflavin</strong> is a component of the<strong> cofactor FAD</strong> (<strong>flavin adenine dinucleotide</strong>) and is required for the conversion of <strong>succinate to fumarate</strong> by <strong>succinate dehydrogenase.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FAD-DEPENDENT ENZYMES:</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Succinate to fumarate</strong> by <strong>succinate dehydrogenase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acyl CoA </strong>to <strong>alpha-beta </strong>unsaturated <strong>acyl CoA </strong>by <strong>acyl CoA dehydrogenase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Xanthine </strong>to<strong> uric acid </strong>by<strong>&nbsp;xanthine oxidase</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate </strong>to<strong> acetyl CoA</strong> by <strong>pyruvate dehydrogenase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alpha ketoglutarate </strong>to <strong>succinyl CoA</strong> by <strong>alpha ketoglutarate dehydrogenase </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Isocitrate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Forms <strong>Alpha Keto Glutarate </strong>in TCA cycle with <strong>NADH</strong> <strong>generation, </strong>which is<strong> later oxidized</strong> in<strong> ETC</strong> to generate<strong> ATPs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Fumarase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In TCA cycle, it helps in formation of <strong>malate from fumarate </strong>and the reaction involves<strong> addition of a water molecule.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Malate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In <strong>TCA cycle</strong>, <strong>malate</strong> is <strong>oxidized to oxaloacetate</strong> by this <strong>enzyme </strong>and the<strong> coenzyme is NAD+.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - <strong>None of the above 3 enzymes</strong> are <strong>dependent on FAD. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Succinate dehydrogenase</strong> is the<strong> TCA cycle</strong> enzyme directly impacted by <strong>riboflavin deficiency,</strong> as it uses<strong> FAD,</strong> derived from<strong> riboflavin, as a coenzyme. </strong>This enzyme catalyzes the <strong>oxidation of</strong> <strong>succinate to fumarate, </strong>with<strong> FAD</strong> being <strong>reduced to FADH2 </strong>in the process. A <strong>deficiency</strong> in <strong>riboflavin</strong> would <strong>impair the function of succinate dehydrogenase, </strong>affecting the <strong>efficiency</strong> of the<strong> TCA cycle</strong> and overall <strong>energy production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 556; Vasudevan 9/e: 479.</span></strong></span></span></p>",
    "correct_choice_id": 24628,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6225,
    "choices": [
      {
        "id": 24869,
        "text": "<p><span style=\"font-size:12.0pt;\">Complete oxidation of acetyl CoA</span></p>"
      },
      {
        "id": 24870,
        "text": "<p><span style=\"font-size:12.0pt;\">ATP generation</span></p>"
      },
      {
        "id": 24871,
        "text": "<p><span style=\"font-size:12.0pt;\">Synthesis of NADPH</span></p>"
      },
      {
        "id": 24872,
        "text": "<p><span style=\"font-size:12.0pt;\">Amphibolic pathway</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Among the following, which is NOT a function or significance of the TCA cycle?</span></p>",
    "unique_key": "Q4317797",
    "question_audio": null,
    "question_video": null,
    "map_id": 29844,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: C. Synthesis of NADPH</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The synthesis of NADPH is NOT a function of the TCA cycle. The TCA cycle (tricarboxylic acid cycle, also known as the Krebs cycle or citric acid cycle) produces NADH, not NADPH. This is a key distinction because NADH and NADPH have different roles in metabolism:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">NADH primarily serves as an electron carrier for energy production in the electron transport chain</span></li><li><span style=\"font-size:12.0pt;\">NADPH serves as a reducing agent for biosynthetic reactions and antioxidant defense</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The TCA cycle specifically generates reduced electron carriers in the form of NADH (three molecules per acetyl-CoA) and FADH\u2082 (one molecule per acetyl-CoA), but not NADPH. NADPH is primarily produced by other pathways such as:</span></p><ol><li><span style=\"font-size:12.0pt;\">The pentose phosphate pathway</span></li><li><span style=\"font-size:12.0pt;\">The malic enzyme reaction</span></li><li><span style=\"font-size:12.0pt;\">Isocitrate dehydrogenase in the cytosol (not the mitochondrial form involved in the TCA cycle)</span></li><li><span style=\"font-size:12.0pt;\">NADP\u207a-dependent glutamate dehydrogenase</span></li><li><span style=\"font-size:12.0pt;\">NADP\u207a-dependent malate dehydrogenase (malic enzyme)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Complete oxidation of acetyl CoA</strong> - This IS a function of the TCA cycle. The cycle completely oxidizes the two-carbon acetyl group of acetyl-CoA to two molecules of CO\u2082. This oxidation is coupled with the reduction of electron carriers (NAD\u207a to NADH and FAD to FADH\u2082).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. ATP generation</strong> - This IS a function of the TCA cycle. The cycle directly generates one GTP (equivalent to one ATP) per turn through substrate-level phosphorylation catalyzed by succinyl-CoA synthetase. More importantly, it indirectly enables substantial ATP production by providing NADH and FADH\u2082 to the electron transport chain for oxidative phosphorylation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amphibolic pathway</strong> - This IS a characteristic of the TCA cycle. The term \"amphibolic\" means the pathway serves both catabolic (breakdown) and anabolic (biosynthetic) functions. While the TCA cycle primarily functions in catabolism to generate energy, several of its intermediates serve as precursors for biosynthetic pathways, including:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Oxaloacetate and \u03b1-ketoglutarate for amino acid synthesis</span></li><li><span style=\"font-size:12.0pt;\">Succinyl-CoA for heme synthesis</span></li><li><span style=\"font-size:12.0pt;\">Citrate for fatty acid synthesis (after transport to the cytosol)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key functions and significance of the TCA cycle include:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Complete oxidation of acetyl-CoA to CO\u2082</span></li><li><span style=\"font-size:12.0pt;\">Energy production through substrate-level phosphorylation (GTP) and generation of reducing equivalents (NADH, FADH\u2082)</span></li><li><span style=\"font-size:12.0pt;\">Serving as a final common oxidative pathway for carbohydrates, proteins, and fats</span></li><li><span style=\"font-size:12.0pt;\">Acting as an amphibolic pathway (both catabolic and anabolic functions)</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p161-167.</span></p>",
    "correct_choice_id": 24871,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6161,
    "choices": [
      {
        "id": 24613,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">9 ATP</span></span></span></p>"
      },
      {
        "id": 24614,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">10 ATP</span></span></span></p>"
      },
      {
        "id": 24615,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">13 ATP</span></span></span></p>"
      },
      {
        "id": 24616,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">12 ATP</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While conducting a research study on the efficiency of various diets on long-distance runners, a team of exercise physiologists focuses on the metabolic pathways that are most active during extended periods of physical activity. They are particularly interested in quantifying the energy output from different substrates. The team debates the number of ATP molecules generated from the complete oxidation of one molecule of acetyl CoA through the TCA cycle. What is the correct ATP yield from this process?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q7762072",
    "question_audio": null,
    "question_video": null,
    "map_id": 29834,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp; 10 ATP</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> oxidation of one molecule of acetyl CoA</strong> in the TCA cycle produces<strong> 3 NADH, 1 FADH2, and 1 GTP.</strong> With the assumption that<strong> 1</strong> <strong>NADH generates 2.5 ATP</strong> and <strong>1 FADH2 yields 1.5 ATP</strong> through <strong>oxidative phosphorylation,</strong> the<strong> total ATP</strong> produced is calculated as follows:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>3 NADH x 2.5 ATP/NADH</strong> = <strong>7.5 ATP</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 FADH2 x 1.5 ATP/FADH2 = 1.5 ATP</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 GTP = 1 ATP</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The sum of these yields a total of <strong>10 ATP</strong> per molecule of <strong>acetyl CoA</strong> oxidized through the<strong> TCA cycle, </strong>making<strong> option B </strong>the most <strong>accurate answer.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note -<strong> Three molecules of NADH </strong>and <strong>one of FADH2 </strong>are produced for <strong>each molecule of acetyl-CoA</strong> catabolized in <strong>one</strong> turn of the <strong>cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective :</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture24.jpg\" style=\"height:420px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: 253.</span></strong></span></span></p>",
    "correct_choice_id": 24614,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6166,
    "choices": [
      {
        "id": 24633,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphofructokinase</span></span></span></p>"
      },
      {
        "id": 24634,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></span></p>"
      },
      {
        "id": 24635,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 24636,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate dehydrogenase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In conditions of low oxygen levels (low pO2), the body must adapt its metabolic pathways to ensure energy production continues. One such adaptation involves an enzyme that compensates for reduced Tricarboxylic Acid (TCA) cycle activity under hypoxic conditions. This enzyme facilitates a key step in an alternative pathway, allowing cells to generate ATP anaerobically. Which enzyme is responsible for this compensatory mechanism?</span></span></span></p>",
    "unique_key": "Q2243082",
    "question_audio": null,
    "question_video": null,
    "map_id": 29840,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Lactate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lactate dehydrogenase (LDH) </strong>catalyzes the conversion of <strong>pyruvate to lactate </strong>in the <strong>anaerobic glycolysis</strong> <strong>pathway</strong>, compensating for <strong>low TCA cycle activity</strong> under conditions of <strong>low oxygen.</strong> This reaction allows for the <strong>continued</strong> production of<strong> ATP anaerobically</strong> and the<strong> regeneration of NAD+,</strong> essential for<strong> glycolysis</strong> to <strong>proceed.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture25.jpg\" style=\"height:488px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Phosphofructokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme<strong> catalyzes </strong>an <strong>early step in glycolysis</strong> and is <strong>not</strong> directly involved in compensating for <strong>low TCA cycle activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This <strong>enzyme </strong>acts in the <strong>initial step of glycolysis </strong>in <strong>liver cells, </strong>converting <strong>glucose</strong> <strong>to glucose-6-phosphate</strong>, and is<strong> not</strong> a <strong>compensatory</strong> mechanism for <strong>low TCA activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pyruvate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme converts <strong>pyruvate to acetyl-CoA</strong> for <strong>entry into the TCA</strong> <strong>cycle</strong>; its activity is <strong>reduced</strong>, <strong>not</strong> <strong>compensated</strong> for, under <strong>low oxygen conditions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the<strong> absence of mitochondria (Eg: RBC) </strong>and in <strong>hypoxic conditions</strong>, <strong>anaerobic glycolysis</strong> will be turned on where <strong>lactate dehydrogenase (LDH) </strong>will convert <strong>pyruvate to lactate. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 168-169.</span></strong></span></span></p>",
    "correct_choice_id": 24635,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6073,
    "choices": [
      {
        "id": 24262,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis </span></span></span></p>"
      },
      {
        "id": 24263,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidative phosphorylation</span></span></span></p>"
      },
      {
        "id": 24264,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TCA in mitochondria</span></span></span></p>"
      },
      {
        "id": 91481,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">From beta-oxidation </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A research team is exploring the metabolic adaptations of cancer cells and how these cells meet their increased energy demands. In most cancer cells, the predominant metabolic pathway for generating the necessary energy is distinct from that of normal, non-cancerous cells. Which metabolic process do cancer cells primarily exploit to derive the energy needed for their rapid growth and proliferation?</span></span></span></p>",
    "unique_key": "Q7330441",
    "question_audio": null,
    "question_video": null,
    "map_id": 29889,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Glycolysis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>1924, </strong>the biochemist <strong>Otto Warburg</strong> and<strong> his colleagues</strong> discovered that <strong>cancer cells</strong> <strong>take up large</strong> amounts of<strong> glucose</strong> and<strong> metabolize</strong> it to <strong>lactic acid,</strong> even in the<strong> presence of oxygen. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This<strong> observation</strong> is known as the&nbsp;</span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warburg effect</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Based on these data, <strong>Warburg</strong> made <strong>two hypotheses: </strong></span></span></span></li>\r\n</ul>\r\n\r\n<ol style=\"margin-left:40px\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">increased ratio of glycolysis&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">to <strong>aerobic respiration</strong> was due to<strong> defects </strong>in the <strong>mitochondrial respiratory chain</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This<strong> enhanced glycolysis&nbsp;</strong>enabled<strong> cancer cells to proliferate</strong> in the <strong>reduced oxygen</strong> tension often<strong> seen in tumours.</strong></span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thus, the <strong>switching from aerobic to anaerobic glucose metabolism</strong> was the<strong> driver</strong> of <strong>tumorigenesis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Oxidative phosphorylation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While important in many tissues, <strong>cancer cells</strong> rely <strong>less</strong> on <strong>oxidative phosphorylation </strong>compared to<strong> normal cells</strong>, partially because it is<strong> less efficient under hypoxic conditions,</strong> which are <strong>common in tumors.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. TCA cycle in mitochondria</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The<strong> TCA cycle</strong> is used by <strong>all cells</strong>, but <strong>cancer cells </strong>often have <strong>mitochondrial defects</strong> that <strong>reduce</strong> their <strong>reliance </strong>on this <strong>pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Beta-oxidation</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This pathway <strong>oxidizes fatty acids </strong>to generate<strong> acetyl-CoA for energy</strong>; however, <strong>cancer cells</strong> typically<strong> rely on</strong> this<strong> less </strong>than on <strong>glycolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cancer cells</strong> predominantly use<strong> glycolysis for energy production,</strong> even in the<strong> presence of oxygen,</strong> a phenomenon known as the <strong>Warburg effect. </strong>This metabolic <strong>adaptation allows cancer cells to thrive</strong> even under <strong>hypoxic conditions</strong> and contributes to the <strong>acidic</strong> <strong>microenvironment</strong> often seen in<strong> tumors </strong>due to <strong>lactate production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p738.</span></strong></span></span></p>",
    "correct_choice_id": 24262,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6137,
    "choices": [
      {
        "id": 24517,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crabtree Effect</span></span></p>"
      },
      {
        "id": 24518,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pasteur Effect</span></span></span></p>"
      },
      {
        "id": 24519,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chemiosmotic effect</span></span></p>"
      },
      {
        "id": 24520,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Feedback inhibition</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with chronic obstructive pulmonary disease (COPD) has been receiving supplemental oxygen therapy for several years, leading to an improvement in symptoms. However, concerns arise regarding potential lung injury from prolonged oxygen exposure, known as oxygen toxicity. This condition can lead to a decrease in the rate of glycolysis due to high oxygen levels. What is the phenomenon called where elevated oxygen levels decrease the glycolysis rate?</span></span></span></p>",
    "unique_key": "Q9399875",
    "question_audio": null,
    "question_video": null,
    "map_id": 29890,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Pasteur Effect.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pasteur Effect:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Inhibition of Glycolysis </strong>by <strong>excessive oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:&nbsp;</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Crabtree Effect:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">With the <strong>constant supply of O<sub>2</sub>,</strong> if the<strong> glucose concentration is increased,</strong> it will create a<strong> comparative</strong> <strong>anaerobiosis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chemiosmotic effect:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Explains the<strong> oxidative phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Feedback inhibition:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> or <strong>end-product inhibition</strong> means that the <strong>activity of the enzyme</strong> is <strong>inhibited </strong>by the<strong> final product of</strong> the<strong> biosynthetic pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Pasteur effect</strong> describes the <strong>inhibition of glycolysis </strong>by <strong>high concentrations of oxygen.</strong> In the<strong> presence of oxygen,</strong> <strong>cells</strong> preferentially<strong> utilize aerobic metabolism</strong>, which is<strong> more</strong> efficient in terms of<strong> ATP production,</strong> <strong>leading</strong> to a <strong>reduced</strong> need for <strong>glycolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 285-287.</span></strong></span></span></p>",
    "correct_choice_id": 24518,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6283,
    "choices": [
      {
        "id": 25101,
        "text": "<p><span style=\"font-size:12.0pt;\">It is used to transport NADH from Cytosol to Mitochondria.</span></p>"
      },
      {
        "id": 25102,
        "text": "<p><span style=\"font-size:12.0pt;\">It is used to transport NADPH from Cytoplasm to Mitochondria.</span></p>"
      },
      {
        "id": 25103,
        "text": "<p><span style=\"font-size:12.0pt;\">Malate get converted to Oxaloacetate and release NADH</span></p>"
      },
      {
        "id": 25104,
        "text": "<p><span style=\"font-size:12.0pt;\">Oxaloacetate is reconstituted from Aspartate and \u03b1 Ketoglutarate</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">Which of the following statements about the malate-aspartate shuttle is FALSE?</span></p>",
    "unique_key": "Q3784205",
    "question_audio": null,
    "question_video": null,
    "map_id": 29985,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: B. It is used to transport NADPH from Cytoplasm to Mitochondria.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The malate-aspartate shuttle is a key biochemical system that allows the transfer of reducing equivalents (NADH) from the cytosol into the mitochondrial matrix, because the inner mitochondrial membrane is impermeable to NADH itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>How it works:</strong></span></p><ol><li><span style=\"font-size:12.0pt;\">In the cytosol:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Oxaloacetate (OAA) is reduced to malate by cytosolic malate dehydrogenase, using NADH.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Malate is transported into the mitochondria.</span></li><li><span style=\"font-size:12.0pt;\">In the mitochondria:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Malate is oxidized back to OAA by mitochondrial malate dehydrogenase, regenerating NADH inside the mitochondria.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">OAA is transaminated to aspartate, which can travel back to the cytosol to complete the cycle.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. It is used to transport NADH from Cytosol to Mitochondria</strong>:</span><br><span style=\"font-size:12.0pt;\">True.</span><br><span style=\"font-size:12.0pt;\">This is the core purpose of the shuttle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. It is used to transport NADPH from Cytoplasm to Mitochondria</strong>:</span><br><span style=\"font-size:12.0pt;\">False.</span><br><span style=\"font-size:12.0pt;\">The shuttle transports NADH equivalents, not NADPH. NADPH is involved mainly in biosynthesis and antioxidant defenses, not in this shuttle system.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Malate gets converted to Oxaloacetate and releases NADH</strong>:</span><br><span style=\"font-size:12.0pt;\">True.</span><br><span style=\"font-size:12.0pt;\">Inside mitochondria, malate \u2192 OAA + NADH (via malate dehydrogenase).</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Oxaloacetate is reconstituted from Aspartate and \u03b1-Ketoglutarate</strong>:</span><br><span style=\"font-size:12.0pt;\">True.</span><br><span style=\"font-size:12.0pt;\">Aspartate + \u03b1-KG \u2194 OAA + glutamate (via transamination).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The <strong>malate-aspartate shuttle</strong> transfers <strong>cytosolic NADH equivalents</strong> into the mitochondria for <strong>oxidative phosphorylation</strong>.</span></li><li><span style=\"font-size:12.0pt;\">It operates via a <strong>series of reversible reactions</strong>, involving:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Oxaloacetate \u2192 Malate</strong> (reduced by cytosolic NADH)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Malate transport</strong> into mitochondria</span></li><li><span style=\"font-size:12.0pt;\"><strong>Malate \u2192 Oxaloacetate</strong> (regenerates NADH in matrix)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Transamination</strong> of oxaloacetate+ Glutamate&nbsp; \u2194 aspartate + \u03b1-ketoglutarate</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 219.</span></p>",
    "correct_choice_id": 25102,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6263,
    "choices": [
      {
        "id": 25021,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidation step between cytochrome and coenzyme Q and distal cytochromes</span></span></span></p>"
      },
      {
        "id": 25022,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidation step involving direct reduction of oxygen</span></span></span></p>"
      },
      {
        "id": 25023,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncoupling of oxidation from phosphorylation</span></span></span></p>"
      },
      {
        "id": 25024,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidation step between cytochromes c and b</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Many compounds poison the respiratory chain by inhibiting various steps of oxidation or phosphorylation. Which of the following steps is inhibited by carbon monoxide and cyanide?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q3020722",
    "question_audio": null,
    "question_video": null,
    "map_id": 29973,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Oxidation step involving direct reduction of oxygen)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbon monoxide (CO) and cyanide (CN-) inhibit </strong>the respiratory chain by binding to <strong>cytochrome c oxidase (Complex IV),</strong> which is responsible for the <strong>direct reduction</strong> of<strong> oxygen to water </strong>in the final step of the <strong>electron transport chain.</strong> This binding <strong>prevents</strong> <strong>oxygen</strong> from being <strong>reduced,</strong> effectively<strong> halting the electron transport chain</strong> and disrupting ATP production, leading to <strong>cellular energy</strong> <strong>failure.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The step involving <strong>coenzyme Q </strong>and <strong>distal cytochromes</strong> is <strong>not</strong> the specific target of<strong> CO and CN-</strong>; these compounds specifically<strong> inhibit Complex IV.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> CO and CN</strong>- <strong>do not</strong> uncouple oxidation from phosphorylation;<strong> </strong>they <strong>directly inhibit electron transfer to oxygen</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The step between <strong>cytochromes c and b</strong> is<strong> not</strong> directly <strong>inhibited </strong>by these compounds; their <strong>inhibitory effect</strong> is on the terminal step involving <strong>oxygen reduction</strong> by<strong> cytochrome c oxidase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbon monoxide</strong> and<strong> cyanide</strong> inhibit <strong>cytochrome oxidase</strong>, the terminal step of the<strong> respiratory chain</strong> that is driven by <strong>oxygen reduction to water</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Barbiturates block</strong> transfer from <strong>cytochrome to coenzyme Q, antimycin A, and dimercaprol,</strong> the step between <strong>cytochromes c and b,</strong> and <strong>dinitrophenol </strong>is an <strong>uncoupler </strong>that releases the<strong> respiratory chain </strong>from regulation by<strong> energy</strong> (phosphorylation) needs. <strong>Oligomycin blocks phosphorylation </strong>by <strong>inhibiting ATP synthase</strong>, thus<strong> shutting down </strong>its <strong>coupled oxidation</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper Illustrated Biochemistry 31/e p 321-22.</span></strong></span></span></p>",
    "correct_choice_id": 25022,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6266,
    "choices": [
      {
        "id": 25033,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">True</span></span></span></p>"
      },
      {
        "id": 25034,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">False</span></span></span></p>"
      },
      {
        "id": 25035,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
      },
      {
        "id": 25036,
        "text": "<p>Not sure</p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome c, typically associated with the electron transport chain, also plays a role in mediating apoptosis. Is this statement true or false?.</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q6397855",
    "question_audio": null,
    "question_video": null,
    "map_id": 29976,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) True </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytochrome c</strong> indeed mediates<strong> apoptosis. </strong>Upon release from the<strong> mitochondria into the cytosol</strong> in response to<strong> apoptotic stimuli,</strong> <strong>cytochrome c</strong> interacts with<strong> Apaf-1 (apoptotic protease activating factor-1) and procaspase-9 </strong>to form the <strong>apoptosome</strong>. This <strong>complex</strong> initiates the <strong>caspase cascade,</strong> leading to the <strong>execution phase of apoptosis, </strong>characterized by<strong> cell shrinkage, chromatin</strong> <strong>condensation, and DNA fragmentation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytochrome C</strong> is a <strong>mobile electron carrier</strong> between <strong>Complex III and Complex IV.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It plays an important role in<strong> programmed cell death.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Harper 30/e p127-130.</span></strong></span></span></p>",
    "correct_choice_id": 25033,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6259,
    "choices": [
      {
        "id": 25005,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,4-dinitrophenol is an allosteric activator of ATP synthase and thus increases the rate of H+ translocation and oxidation of fats and other fuels.</span></span></span></p>"
      },
      {
        "id": 25006,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,4-dinitrophenol inhibits transport of pyruvate into the mitochondria. Fats are therefore metabolized to glycerol and subsequently to pyruvate, depleting fat stores.</span></span></span></p>"
      },
      {
        "id": 25007,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,4-dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.</span></span></span></p>"
      },
      {
        "id": 25008,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,4-dinitrophenol causes ATP to be produced at a higher rate than normal, thus causing weight loss.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the past, the uncoupler 2,4-dinitrophenol was used as a weight- reducing drug until side effects such as fatigue and breathlessness precluded its use. How could the use of this drug result in weight loss?</span></span></span></p>",
    "unique_key": "Q2187899",
    "question_audio": null,
    "question_video": null,
    "map_id": 29972,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) 2,4 dinitrophenol allows oxidation of fats in adipose tissue without production of ATP. Fat oxidation can thus proceed continuously and fat stores will be used up.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2,4-Dinitrophenol </strong>functions as an <strong>uncoupling agent </strong>in the <strong>mitochondrial electron transport chain. </strong>By <strong>disrupting</strong> the <strong>proton gradient</strong> across the <strong>mitochondrial inner membrane</strong>, it separates the processes of <strong>substrate oxidation</strong> from <strong>ATP synthesis.</strong> This <strong>decoupling</strong> leads to <strong>increased metabolic rate</strong> as <strong>energy</strong> from <strong>fat oxidation</strong> is released as<strong> heat</strong> instead of being used for <strong>ATP</strong> production. Consequently, <strong>fat stores</strong> are consumed at a<strong> higher rate</strong> to <strong>meet energy demands,</strong> leading to <strong>weight loss.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2,4-Dinitrophenol does not </strong>activate<strong> ATP synthase</strong>; it <strong>disrupts</strong> its function by <strong>preventing</strong> the establishment of a <strong>proton</strong> <strong>gradient </strong>necessary for <strong>ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>compound</strong> <strong>does not</strong> specifically <strong>inhibit pyruvate</strong> transport into <strong>mitochondria;</strong> its primary action is on the <strong>proton</strong> <strong>gradient </strong>used in <strong>oxidative phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D:</strong> <strong>2,4-Dinitrophenol</strong> actually <strong>reduces the efficiency of ATP </strong>production by <strong>uncoupling oxidation</strong> from <strong>phosphorylation,</strong> leading to<strong> increased energy </strong>expenditure as<strong> heat </strong>rather than<strong> increased ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uncouplers </strong>such as <strong>2,4-dinitrophenol</strong> dissociate <strong>oxidation from phosphorylation </strong>&rarr;<strong> ADP</strong> is <strong>not</strong> <strong>phosphorylated</strong> to produce<strong> ATP </strong>and<strong> respiration</strong> becomes<strong> uncontrolled </strong>as it tries to<strong> replenish ATP supplies</strong> &rarr; leads to <strong>increased metabolic</strong> <strong>turnover</strong> in the attempt to<strong> generate ATP</strong>. (<strong>Incorrect option A , B, D</strong>).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Less ADP </strong>will be converted to <strong>ATP &rarr; increased ADP</strong> and <strong>decreased</strong> rates of <strong>oxidative phosphorylation. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolonged <strong>energy deficits</strong> will lead to <strong>fatigue</strong> in <strong>energy-dependent tissues</strong> such as muscle or heart <strong>(cardiomyopathy),</strong> which is potentially <strong>lethal.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper Illustrated Biochemistry 31/e p 323-24.</span></strong></span></span></p>",
    "correct_choice_id": 25007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6241,
    "choices": [
      {
        "id": 24933,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2; 4; 4</span></span></span></p>"
      },
      {
        "id": 24934,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4; 4; 2</span></span></p>"
      },
      {
        "id": 24935,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3; 3; 4</span></span></p>"
      },
      {
        "id": 24936,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">4; 2; 4</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the net change in the number of protons across the mitochondrial membrane for each set of two electrons transferred through Complexes I, III, and IV, respectively?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q6882642",
    "question_audio": null,
    "question_video": null,
    "map_id": 29965,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 4; 4; 2</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex I</strong>, also known as <strong>NADH</strong>: <strong>ubiquinone oxidoreductase, </strong>transfers <strong>two electrons from NADH </strong>to <strong>ubiquinone and pumps four</strong> <strong>protons</strong> across the<strong> mitochondrial membrane</strong>, resulting in a <strong>net </strong>change of <strong>4 protons</strong>.<strong> Complex III</strong>, or <strong>cytochrome bc1 complex,</strong> transfers electrons from <strong>ubiquinol to cytochrome c</strong>, moving <strong>four protons</strong> across the membrane for each set of<strong> two electrons,</strong> <strong>totaling</strong> a net change of <strong>4 protons. Complex IV</strong>, known as <strong>cytochrome c oxidase</strong>, transfers <strong>electrons to oxygen</strong>, the <strong>final electron</strong> acceptor, pumping only <strong>two protons</strong> across the membrane for <strong>each</strong> set of <strong>two electrons,</strong> leading to a <strong>net change of 2 protons.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ETC</strong>: <strong>Complex-I /NADH-CoQ reductase or NADH dehydrogenase complex</strong>- It is<strong> tightly </strong>bound to the <strong>inner membrane</strong> of <strong>mitochondria</strong> &rarr; <strong>large negative</strong> free energy change occurs which is utilized to<strong> drive 4 protons out of the mitochondrial</strong> <strong>matrix</strong> into<strong> intermembrane space.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex III or Cytochrome Reductase</strong> -the<strong> free energy</strong> change through this <strong>complex</strong> due to<strong> electron transfer </strong>causes<strong> 4</strong> <strong>protons</strong> to be pumped out.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex IV or Cytochrome Oxidase</strong> &ndash; It is<strong> tightly</strong> bound to the <strong>mitochondrial membrane,</strong> and <strong>pumps out 2 protons</strong> to the <strong>intermembrane space.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 131.</span></strong></span></span></p>",
    "correct_choice_id": 24934,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6231,
    "choices": [
      {
        "id": 24893,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the Correct explanation of A</span></span></span></p>"
      },
      {
        "id": 24894,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A</span></span></span></p>"
      },
      {
        "id": 24895,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      },
      {
        "id": 24896,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is true but R is false</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A): Piericidin and rotenone are inhibitors of (ETC) electron transport chain.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning &reg;: Piericidin and rotenone inhibits the flow of electron between the complex II and ubiquinone (coenzyme Q)</span></span></span></p>",
    "unique_key": "Q3911093",
    "question_audio": null,
    "question_video": null,
    "map_id": 29963,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) A is right statement but R is not a correct explanation of statement A.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Piericidin </strong>and <strong>rotenone</strong> are indeed <strong>inhibitors</strong> of the <strong>electron transport chain (ETC),</strong> specifically affecting the function of <strong>Complex I</strong> (<strong>NADH dehydrogenase</strong>). They<strong> block</strong> the transfer of <strong>electrons</strong> from <strong>NADH to ubiquinone</strong> (<strong>coenzyme Q</strong>), <strong>no</strong>t from <strong>Complex II</strong>. This action<strong> inhibits the electron transport chain </strong>early in its sequence,<strong> preventing</strong> the establishment of the <strong>proton gradient </strong>necessary for <strong>ATP synthesis</strong> via <strong>oxidative phosphorylation</strong>. The <strong>assertion is correct</strong> in stating that these compounds are<strong> inhibitors of the ETC</strong>, but the<strong> reasoning is incorrect </strong>as it <strong>misidentifies the site of inhibition</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture2.jpg\" style=\"height:625px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 129-134.</span></strong></span></span></p>",
    "correct_choice_id": 24896,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6299,
    "choices": [
      {
        "id": 25165,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amyotrophic lateral sclerosis</span></span></span></p>"
      },
      {
        "id": 25166,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leber&rsquo;s optic myopathy</span></span></span></p>"
      },
      {
        "id": 25167,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ragged red fibre disease</span></span></span></p>"
      },
      {
        "id": 25168,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duchenne muscular dystrophy </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old man presents to the neurology clinic with a history of progressive vision loss and a family history of similar symptoms. Genetic testing reveals a mutation affecting the electron transport chain, specifically in the NADH-Q reductase (Complex I). Which of the following conditions is most likely associated with this mutation?</span></span></span></p>",
    "unique_key": "Q4972088",
    "question_audio": null,
    "question_video": null,
    "map_id": 29949,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Leber&rsquo;s optic myopathy</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Leber&#39;s optic myopathy </strong>is associated with <strong>mutations</strong> affecting <strong>mitochondrial function,</strong> particularly in<strong> components </strong>of the <strong>electron</strong> <strong>transport</strong> chain like <strong>NADH-Q reductase (Complex I)</strong>. These<strong> mutations</strong> lead to <strong>reduced ATP production</strong> and <strong>increased oxidative stress,</strong> contributing to the<strong> degeneration of retinal ganglion cells and optic nerve fibers</strong>, resulting in <strong>vision loss.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Amyotrophic lateral sclerosis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>progressive neurodegenerative disorder</strong> affecting <strong>motor neurons</strong> but is <strong>not</strong> typically associated with <strong>mutations in NADH-Q reductase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Ragged red fibre disease:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Also known as <strong>mitochondrial myopathy</strong>, this condition is characterized by<strong> muscle weakness</strong> and the p<strong>resence of ragged red fibers </strong>in<strong> muscle biopsies</strong>. It can be associated with <strong>various mitochondrial defects </strong>but is <strong>not</strong> specifically <strong>linked</strong> to <strong>mutations in NADH-Q reductase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Duchenne muscular dystrophy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a<strong> genetic disorder</strong> characterized by<strong> progressive muscle degeneration and weakness</strong> due to <strong>mutations in the dystrophin gene, not </strong>directly related to<strong> mitochondrial function or NADH-Q reductase mutations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mutations in mitochondrial DNA causes:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lethal infantile mitochondrial ophthalmoplegia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leber&rsquo;s hereditary optic neuropathy (LHON)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Myoclonic epilepsy</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mitochondrial encephalomyopathy lactic acidosis stroke like episodes (MELAS)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MERRF</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Kearns-Sayre syndrome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pearson syndrome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leigh syndrome</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NARP</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Mitochondrial DNA Mutations</strong> are <strong>inherited maternally</strong> (<strong>mother to all children</strong>)<br />\r\n<br />\r\n<strong>Leber&rsquo;s hereditary optic myopathy</strong> is characterized by <strong>blindness in young males</strong> and caused by a<strong> single base mutation</strong> in <strong>NADH</strong> <strong>Coenzyme Q reductase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 358</span></strong></span></span></p>",
    "correct_choice_id": 25166,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6272,
    "choices": [
      {
        "id": 25057,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-b, 4-a</span></span></span></p>"
      },
      {
        "id": 25058,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-b, 3-c, 4-a</span></span></span></p>"
      },
      {
        "id": 25059,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-b, 3-c, 4-d</span></span></span></p>"
      },
      {
        "id": 25060,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-d, 3-b, 4-c</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">How should the following inhibitors be matched with their corresponding complexes or sites?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture4_784r4vb.jpg\" style=\"height:163px; width:700px\" /></p>",
    "unique_key": "Q5769552",
    "question_audio": null,
    "question_video": null,
    "map_id": 29942,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) 1-d, 2-c, 3-b, 4-a</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyanide </strong>is known to<strong> inhibit Complex IV </strong>of the electron transport chain by binding to the <strong>cytochrome c oxidase</strong>, <strong>preventing</strong> the transfer of<strong> electrons to oxygen</strong> and thereby<strong> halting ATP synthesis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Malonate</strong> is a<strong> competitive</strong> inhibitor of <strong>succinate dehydrogenase (Complex II),</strong> specifically <strong>inhibiting</strong> the site between <strong>succinate dehydrogenase and Co-Q (coenzyme Q).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>BAL (British Anti-Lewisite) does not </strong>directly<strong> inhibit</strong> any specific<strong> complex </strong>within the<strong> electron transport chain;</strong> thus, its <strong>inclusion </strong>might be <strong>misleading</strong>. However, in the context of this question and the available options, <strong>it is matched with b,</strong> but this is<strong> not reflective</strong> of its<strong> actual function.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Chlorpromazine</strong> is <strong>not</strong> a <strong>classical inhibitor</strong> of the<strong> electron transport chain</strong>, and its inclusion in this list<strong> might not</strong> be accurate for <strong>educational purposes</strong>. However, based on the available options, it is <strong>matched with a, Complex I to Co-Q.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture5.jpg\" style=\"height:224px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 266.</span></strong></span></span></p>",
    "correct_choice_id": 25057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6269,
    "choices": [
      {
        "id": 25045,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal gland</span></span></span></p>"
      },
      {
        "id": 25046,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal music</span></span></span></p>"
      },
      {
        "id": 25047,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brown adipose tissue</span></span></span></p>"
      },
      {
        "id": 25048,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One specialized organ in mammals has a unique adaptation that allows it to utilize fuel oxidation not primarily for ATP production but for the generation of heat, aiding in thermoregulation. Which of the following is this specialized organ?</span></span></span></p>",
    "unique_key": "Q1362491",
    "question_audio": null,
    "question_video": null,
    "map_id": 29977,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Brown adipose tissue</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Brown adipose tissue </strong>gets its colour due to the<strong> high density of mitochondria </strong>in the individual<strong> adipose cells</strong> and <strong>new-born babies</strong> have it in <strong>their neck and upper back</strong> which serves the function of <strong>non-shivering thermogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Brown adipose tissue </strong>contains <strong>thermogenin,</strong> which is a physiological<strong> uncoupler of oxidative phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> muscle contractions </strong>take place in the process of shivering<strong> not only generate ATP</strong> but also <strong>produce heat. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Non-shivering thermogenesis</strong> is a<strong> hormonal stimulus</strong> for <strong>heat generation without </strong>the associated<strong> muscle contractions of shivering.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This process in<strong> brown fat</strong> is initiated by the <strong>release of free fatty acids </strong>from the<strong> triglycerides stored</strong> in the <strong>adipose cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>adrenal gland</strong> is involved in <strong>hormone production,</strong> including<strong> stress and metabolic hormones</strong>, but it is <strong>not</strong> primarily associated with<strong> heat generation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Skeletal muscle</strong> can <strong>produce heat</strong> through <strong>shivering thermogenesis, </strong>where<strong> muscle contractions </strong>generate <strong>heat,</strong> but this is <strong>not its primary function.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>heart&#39;s primary function</strong> is to<strong> pump blood throughout the body,</strong> and while it <strong>does produce heat</strong> as a byproduct of its <strong>metabolic activities</strong>, it is<strong> not</strong> specialized for <strong>heat production like brown adipose tissue.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Brown adipose tissue</strong> is the specialized organ in <strong>mammals designed</strong> for <strong>heat production</strong> through<strong> non-shivering thermogenesis,</strong> emphasizing its role in<strong> thermoregulation and energy metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 162, 267.</span></strong></span></span></p>",
    "correct_choice_id": 25047,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 6322,
    "choices": [
      {
        "id": 25257,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolytic enzymes are in mitochondrial matrix</span></span></span></p>"
      },
      {
        "id": 25258,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inner mitochondrial membrane contains enzymes of electron transport chain</span></span></span></p>"
      },
      {
        "id": 25259,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluid matrix contains enzymes of TCA cycle</span></span></span></p>"
      },
      {
        "id": 25260,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA synthetase in localized in the outer mitochondrial membrane </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about mitochondria is NOT true?</span></span></span></p>",
    "unique_key": "Q1461357",
    "question_audio": null,
    "question_video": null,
    "map_id": 29957,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Glycolytic enzymes are in mitochondrial matrix</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycolytic enzymes</strong> are primarily located in the<strong> cytosol,</strong> not the mitochondrial matrix. <strong>Glycolysis,</strong> the process of <strong>breaking down</strong> <strong>glucose to pyruvate</strong>, occurs in the<strong> cytosol</strong>. The<strong> products of glycolysis</strong>,<strong> pyruvate, and NADH</strong>, are then <strong>transported </strong>into <strong>mitochondria</strong> for further processing in the<strong> TCA cycle and oxidative phosphorylation</strong>, respectively.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note -</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> electron transport chain </strong>is functioning<strong> inside the mitochondria.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> inner membrane</strong> contains the <strong>respiratory chain and translocating systems</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> knob</strong> like<strong> protrusions </strong>represent the <strong>ATP synthase system.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The inner mitochondrial membrane contains enzymes of the electron transport chain: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is <strong>true</strong>. The <strong>inner mitochondrial membrane </strong>is the site of the <strong>electron transport chain</strong>, where <strong>ATP is synthesized.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>: The fluid matrix contains enzymes of the TCA cycle:</strong> This is also <strong>true</strong>. The <strong>mitochondrial matrix</strong> houses enzymes of the <strong>TCA cycle,</strong> which is involved in <strong>energy production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acyl-CoA synthetase is localized in the outer mitochondrial membrane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True, acyl-CoA synthetase</strong>, involved in<strong> fatty acid</strong> <strong>metabolism,</strong> is found on the<strong> outer mitochondrial membrane. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LOCATION OF ENZYMES IN MITOCHONDRIA</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture7.jpg\" style=\"height:404px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 259.</span></strong></span></span></p>",
    "correct_choice_id": 25257,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6228,
    "choices": [
      {
        "id": 24881,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are right but R is not the correct explanation of A</span></span></span></p>"
      },
      {
        "id": 24882,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is right but R is a wrong statement</span></span></span></p>"
      },
      {
        "id": 24883,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A </span></span></span></p>"
      },
      {
        "id": 24884,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The assertion and reasoning provided require analysis to understand the action of atractyloside and its effects on mitochondrial function.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A): Atractyloside prevents ATP synthesis in the matrix of mitochondria. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R): Atractyloside blocks complex V, the F0 component of inner mitochondrial membrane and stops the inflow of H+ into the matrix.</span></span></span></p>",
    "unique_key": "Q2639035",
    "question_audio": null,
    "question_video": null,
    "map_id": 29960,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) A is right but R is a wrong statement&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atractyloside</strong> is known to<strong> inhibit ATP synthesis,</strong> but<strong> not </strong>by<strong> blocking complex V</strong> (ATP synthase) or the <strong>F0</strong> component. Instead,<strong> atractyloside inhibits the ADP/ATP carrier </strong>(also known as the <strong>adenine nucleotide</strong> <strong>translocase</strong>) in the <strong>inner mitochondrial membrane</strong>, which is responsible for <strong>exchanging ADP and ATP</strong> between the <strong>mitochondrial matrix and the cytosol</strong>. This <strong>inhibition</strong> prevents the <strong>export of ATP </strong>from the <strong>mitochondria to the cytosol </strong>and the import of <strong>ADP from the cytosol to the matrix,</strong> thus<strong> inhibiting ATP</strong> <strong>synthesis indirectly.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atractyloside blocks ATP/ADP transporter</strong> and prevents <strong>ADP transport into the matrix. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> absence of ADP </strong>in the matrix, <strong>ATP</strong> synthesis <strong>does not </strong>occur.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin</strong> blocks <strong>complex V</strong> (F0) and prevents <strong>transportation of H+</strong> within the matrix.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 130-133.</span></strong></span></span></p>",
    "correct_choice_id": 24882,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6229,
    "choices": [
      {
        "id": 24885,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fo Sub complex</span></span></span></p>"
      },
      {
        "id": 24886,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">subunit of F1</span></span></span></p>"
      },
      {
        "id": 24887,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta; subunit of F1 sub complex </span></span></span></p>"
      },
      {
        "id": 24888,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C disc of Fo sub complex</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which subunit within ATP synthase is directly responsible for ATP formation?&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>",
    "unique_key": "Q4087563",
    "question_audio": null,
    "question_video": null,
    "map_id": 29961,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) &beta; subunit of F1 sub complex </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ATP synthesis</strong> occurs in the <strong>&beta; subunit</strong> of the<strong> F1 sub complex of ATP synthase</strong>. This<strong> subunit</strong> undergoes conformational<strong> changes</strong> that facilitate the <strong>binding of ADP </strong>and <strong>inorganic phosphate</strong>, <strong>catalyzing</strong> their <strong>conversion to ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fo Subcomplex:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fo <strong>unit spans </strong>the<strong> inner mitochondrial membrane</strong> and serves as a <strong>proton</strong> channel, through which<strong> protons enter into mitochondria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. subunit of F1:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It <strong>projects into the matrix </strong>and catalyzes <strong>ATP</strong> synthesis. <strong>F1 unit</strong> has <strong>9 polypeptide</strong> chains (<strong>3&alpha;, 3&beta;, 1&gamma;,1&xi;, 1&sigma;</strong>), in which the <strong>&alpha; chains</strong> have <strong>binding sites</strong> for <strong>ATP and ADP </strong>and<strong> &beta; chains</strong> have <strong>catalytic sites.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. C disc of Fo sub complex:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Translocation</strong> of <strong>protons</strong> carried out by the<strong> Fo catalyzes</strong> the formation of <strong>phospho-anhydride </strong>bond of<strong> ATP</strong> by<strong> F1</strong>. Coupling of the <strong>dissipation of proton gradient</strong> with <strong>ATP synthesis</strong> is due to the <strong>interaction of F1 and Fo.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATP SYNTHASE / COMPLEX V OF ELECTRON TRANSPORT CHAIN: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>enzyme complex </strong>consists of an <strong>F0 sub complex</strong> which acts as a disk of <strong>&ldquo;C&rdquo; </strong>protein subunits. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A<strong> &gamma; subunit</strong> is attached as a <strong>&ldquo;bent axle.&rdquo; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Protons</strong> passing through the<strong> disk of &ldquo;C&rdquo; units</strong> cause it and the<strong> &gamma;-subunit </strong>attached to it to rotate. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>&gamma; subunit</strong> fits inside the <strong>F1 sub complex</strong>, consists of <strong>3 &alpha; and 3 &beta; subunits</strong>, which are<strong> fixed</strong> to the<strong> membrane</strong>, and they <strong>do not rotate. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ADP and Pi</strong> are taken up by the<strong> &beta; subunits</strong> to form<strong> ATP,</strong> which is<strong> expelled</strong> as the rotating<strong> &gamma;</strong> <strong>subunit</strong> pushes each<strong> &beta; subunit</strong> in turn and changes <strong>its conformation</strong> &rarr; <strong>3 ATP</strong> molecules are <strong>generated per revolution.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 131-133.</span></strong></span></span></p>",
    "correct_choice_id": 24887,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6232,
    "choices": [
      {
        "id": 24897,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Defined as the ratio of high energy inorganic phosphates incorporated to the atoms of O2 consumed.</span></span></span></p>"
      },
      {
        "id": 24898,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P:O for NAD linked oxidation is 2.5</span></span></span></p>"
      },
      {
        "id": 24899,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P:O for FMN&nbsp; linked oxidation is 3.5</span></span></span></p>"
      },
      {
        "id": 24900,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P:O for FAD linked oxidation is 1.5</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-year-old presents with seizures and lethargy. Diagnosed with a mitochondrial disorder affecting the electron transport chain, you recall the P:O ratios for various oxidations. Which statement about P:O ratios is false?</span></span></p>",
    "unique_key": "Q7356554",
    "question_audio": null,
    "question_video": null,
    "map_id": 29964,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Ans. C) P:O for FMN linked oxidation is 3.5</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> P:O ratio</strong> quantifies <strong>ATP synthesis efficiency</strong> during<strong> oxidative phosphorylation.</strong> For<strong> FMN-linked oxidation</strong>, part of <strong>Complex I, </strong>the stated <strong>P:O</strong> ratio of<strong> 3.5 </strong>is<strong> incorrect.</strong> <strong>FMN</strong> transfers<strong> electrons</strong> from<strong> NADH </strong>to the<strong> electron transport chain,</strong> contributing to a <strong>P:O</strong> ratio similar to<strong> NAD-linked oxidation</strong>, which is<strong> 2.5</strong>,<strong> not 3.5.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>: Correctly</strong> defines the<strong> P:O ratio.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Accurately</strong> represents the <strong>P:O ratio</strong> for<strong> NAD-linked oxidation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Correctly </strong>states the<strong> P: O ratio</strong> for<strong> FAD-linked oxidation</strong>, which is<strong> lower </strong>due to<strong> FADH2 </strong>entering the<strong> electron transport chain</strong> at<strong> Complex II,</strong> bypassing the<strong> proton-pumping action </strong>of <strong>Complex I.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>P: O Ratio</strong> is defined as the ratio of<strong> high energy inorganic phosphates</strong> incorporated to the <strong>atoms of O2 consumed. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NADH</strong> <strong>oxidation </strong>provides <strong>2.5 ATP </strong>&amp; <strong>FADH oxidation</strong> provides <strong>1.5 ATP </strong>per<strong> oxygen atom consumption.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 131.</span></strong></span></span></p>",
    "correct_choice_id": 24899,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 6230,
    "choices": [
      {
        "id": 24889,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The electrochemical potential difference across IMM due to the electron transport&nbsp; is positive on the matrix side.</span></span></span></p>"
      },
      {
        "id": 24890,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As electrons pass down the respiratory chain, it pumps protons across the IMM</span></span></span></p>"
      },
      {
        "id": 24891,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This proton gradient across the IMM generated by electron transport favours ATP synthesis.</span></span></span></p>"
      },
      {
        "id": 24892,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ATP synthesis occurs through an ATP synthase enzyme complex</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The chemiosmotic theory about the coupling of electron transport via the respiratory chain to the process of oxidative phosphorylation is proposed by Peter Mitchell. Which of the following statements does NOT accurately represent the chemiosmotic theory as proposed by Peter Mitchell?</span></span></span></p>",
    "unique_key": "Q9636282",
    "question_audio": null,
    "question_video": null,
    "map_id": 29962,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) The electrochemical potential difference across IMM due to the electron transport is positive on the matrix side.&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>chemiosmotic theory,</strong> proposed by<strong> Peter Mitchell</strong>, <strong>fundamentally changed</strong> our understanding of how <strong>ATP is synthesized </strong>in the<strong> mitochondria</strong>. According to this theory, the<strong> energy from electron transport</strong> is used to <strong>pump protons (H+)</strong> <strong>out</strong> of the <strong>mitochondrial matrix</strong> across the <strong>inner mitochondrial membrane</strong> (IMM), creating an <strong>electrochemical proton gradient</strong>. This gradient is characterized by a <strong>high concentration</strong> of <strong>protons</strong> in the<strong> intermembrane space </strong>and a <strong>lower concentration in the matrix,</strong> leading to a <strong>negative</strong> <strong>electrochemical</strong> <strong>potential difference</strong> across the IMM on the matrix side, <strong>not positive</strong> as stated in<strong> option A.</strong> The <strong>energy stored</strong> in this gradient is then <strong>used by ATP synthase</strong> to drive the <strong>synthesis of ATP </strong>from<strong> ADP </strong>and <strong>inorganic phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This is a <strong>core principle </strong>of the <strong>chemiosmotic theory.</strong> As electrons are <strong>transferred</strong> through the <strong>complexes </strong>of the <strong>respiratory chain, </strong>the <strong>energy</strong> released is used to <strong>pump protons from the mitochondrial</strong> <strong>matrix</strong> to the<strong> intermembrane space</strong>, thereby establishing the <strong>proton gradient essential for ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The generated <strong>proton gradient</strong> is indeed a<strong> driving force</strong> for <strong>ATP synthesis.</strong> The movement of <strong>protons back into the matrix </strong>through<strong> ATP synthase</strong> provides the <strong>energy </strong>needed for the <strong>synthesis of ATP</strong> <strong>from ADP </strong>and <strong>inorganic phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>ATP synthesis</strong> is mediated by the <strong>ATP synthase enzyme complex, </strong>which utilizes the<strong> proton</strong> motive<strong> </strong>force generated by the<strong> proton gradient</strong> to catalyze the <strong>formation of ATP.</strong> This is a <strong>correct</strong> and <strong>fundamental aspect</strong> of the <strong>chemiosmotic theory.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>electrochemical potential difference</strong> across <strong>IMM</strong> due to the<strong> electron transport</strong> should be <strong>negative</strong> on the matrix side, thereby<strong> protons are forced </strong>to <strong>re-enter</strong> through the <strong>ATP synthase</strong> <strong>complex </strong>to discharge the <strong>electrochemical gradient.&nbsp;&nbsp; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complexes I, III, and IV</strong> act as <strong>proton pumps </strong>&rarr; creates a <strong>proton gradient across</strong> the membrane, which is <strong>negative </strong>on the<strong> matrix side. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> proton motive force </strong>drives the synthesis of<strong> ATP </strong>as the <strong>protons flow back </strong>into the matrix through the<strong> ATP synthase enzyme complex.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;<strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 129-132.</span></strong></span></span></p>",
    "correct_choice_id": 24889,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6245,
    "choices": [
      {
        "id": 24949,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">H2O</span></span></span></p>"
      },
      {
        "id": 24950,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NAD+</span></span></span></p>"
      },
      {
        "id": 24951,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">O2</span></span></span></p>"
      },
      {
        "id": 24952,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Peroxide</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dehydrogenases such as glucose-6-phosphate dehydrogenase serve to transfer Hydride (H-) ions or H atom from one substrate to another in coupled oxidation-reduction reactions, ultimately (in the respiratory chain) generating energy by oxygen/water reduction. Dehydrogenases can use which of the following compounds as an electron acceptor?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q5162828",
    "question_audio": null,
    "question_video": null,
    "map_id": 29967,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) NAD+</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dehydrogenases</strong> are a class of enzymes that <strong>catalyze</strong> the <strong>removal of hydrogen</strong> <strong>atoms</strong> from a<strong> substrate</strong>, <strong>transferring</strong> them to an <strong>electron acceptor in oxidation-reduction reactions</strong>. <strong>NAD+</strong> (Nicotinamide Adenine Dinucleotide) is a common <strong>electron acceptor</strong> used by <strong>dehydrogenases,</strong> serving as a <strong>crucial cofactor</strong> in these<strong> enzymatic reactions</strong>. Upon <strong>accepting electrons</strong>,<strong> NAD+</strong> is <strong>reduced to NADH,</strong> which then participates in other <strong>metabolic pathways</strong>, including the<strong> electron transport chain,</strong> where it <strong>ultimately contributes </strong>to <strong>ATP</strong> <strong>synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> H2O</strong> is<strong> not</strong> an <strong>electron acceptor</strong> in enzymatic reactions; it is often a <strong>product of such reactions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>O2</strong> is the <strong>final electron acceptor</strong> in the electron transport chain but is<strong> not </strong>directly used by <strong>dehydrogenases.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Peroxide</strong> is <strong>not </strong>a typical<strong> electron acceptor in dehydrogenase-catalyzed reactions </strong>and is <strong>more</strong> often a product of<strong> oxidative</strong> <strong>stress.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dehydrogenases</strong> are <strong>specifi</strong>c for their<strong> substrates</strong>, but most use <strong>either NAD+ or NADP+ </strong>as the <strong>coenzyme. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Some dehydrogenases use<strong> Flavin coenzymes</strong> similar to<strong> FMN and FAD</strong> used by the <strong>oxidases. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The final steps in the conversion of<strong> oxygen to water</strong> in the <strong>respiratory chain</strong> are carried out by <strong>cytochrome oxidase</strong> (cytochrome a3) as part of<strong> complex IV.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This<strong> final </strong>enzyme is an<strong> oxidase</strong>, defined by its <strong>use of oxygen </strong>to <strong>oxidize metabolites</strong> and <strong>form water </strong>or <strong>hydrogen</strong> <strong>peroxide. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>prior cytochromes of the respiratory chain</strong> (b, cl, c, a) can be described as <strong>dehydrogenases,</strong> <strong>transferring electrons</strong> (or<strong> Protons in reverse</strong>) by <strong>oscillation between ferric</strong> (Fe+++) and <strong>ferrous</strong> (Fe++) ions. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 122.</span></strong></span></span></p>",
    "correct_choice_id": 24950,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6278,
    "choices": [
      {
        "id": 25081,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADH CoQ reductase</span></span></span></p>"
      },
      {
        "id": 25082,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome C oxidase</span></span></span></p>"
      },
      {
        "id": 25083,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isocitrate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 25084,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CoQ Cytochrome C reductase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 27-year-old male is involved in a research study examining mitochondrial function. He is in excellent health and reports no significant medical history. As part of the study, he undergoes various tests to assess his cellular metabolism. One particular focus of the study is the efficiency and regulation of oxidative phosphorylation within the electron transport chain (ETC) in his mitochondria. Given this context, which of the following enzymes or complexes is LEAST likely to play a regulatory role in oxidative phosphorylation?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q4907655",
    "question_audio": null,
    "question_video": null,
    "map_id": 29943,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Isocitrate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isocitrate dehydrogenase</strong> is an enzyme in the<strong> citric acid cycle (Krebs cycle)</strong> that catalyzes the <strong>oxidative decarboxylation </strong>of<strong> isocitrate</strong> into <strong>alpha-ketoglutarate</strong>. While it plays a crucial role in <strong>energy production</strong>, it is<strong> not</strong> directly involved in the regulation of<strong> oxidative</strong> <strong>phosphorylation </strong>within the<strong> electron transport chain (ETC). </strong>The regulation of oxidative phosphorylation is primarily concerned with the <strong>ETC and the phosphorylation of ADP </strong>to form<strong> ATP,</strong> processes that occur in the <strong>inner mitochondrial membrane</strong> and are <strong>distinct</strong> from the <strong>citric acid cycle&rsquo;s reactions</strong> in the<strong> mitochondrial matrix.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. NADH CoQ reductase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the <strong>first enzyme</strong> in the <strong>electron transport chain</strong> and plays a critical role in the <strong>initiation of</strong> <strong>electron transport</strong>, directly influencing<strong> oxidative phosphorylation efficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cytochrome C oxidase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> As the<strong> last enzyme</strong> in the <strong>electron transport chain</strong>, it is pivotal in <strong>transferring electrons to oxygen,</strong> the<strong> final electron acceptor,</strong> and thus plays a significant role in <strong>regulating oxidative phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. CoQ Cytochrome C reductase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is involved in the <strong>electron transport chain</strong>, facilitating the <strong>transfer of electrons</strong> <strong>from CoQ to cytochrome c,</strong> and thereby influencing the<strong> efficiency of oxidative phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of the Electron Transport Chain are contained in four large protein complexes:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex I NADH CoQ Oxidoreductase </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex II CoQ Succinate Reductase.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex III CoQ Cytochrome C Oxidoreductase</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Complex IV Cytochrome C Oxidase </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p130, 133.</span></strong></span></span></p>",
    "correct_choice_id": 25083,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6247,
    "choices": [
      {
        "id": 24957,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Selective disruption of complex II function</span></span></span></p>"
      },
      {
        "id": 24958,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disruption of ubiquinone phosphorylation</span></span></span></p>"
      },
      {
        "id": 24959,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disruption of NADH entry into the respiratory chain</span></span></span></p>"
      },
      {
        "id": 24960,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disruption of proton flow across the inner mitochondrial membrane</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomycin is a macrolide antibiotic derived from Streptomyces, a genus of soil bacteria that has contributed over two-thirds of naturally derived antibiotics, that inhibits ATP synthase required for oxidative phosphorylation. Which of the following options best explains the consequence of this inhibition?</span></span></span></p>",
    "unique_key": "Q1349814",
    "question_audio": null,
    "question_video": null,
    "map_id": 29968,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Disruption of proton flow across the inner mitochondrial membrane</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin</strong> <strong>inhibits mitochondrial ATP synthase</strong> that is powered by the<strong> proton pumps of complex I to IV. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Accumulation of protons</strong> within the mitochondrial double membrane<strong> prevents electron transport</strong> and thus <strong>ablates</strong> <strong>phosphorylation and oxidation;</strong> <strong>inhibitors </strong>of terminal <strong>heme-oxygen/complex IV oxidation</strong> like <strong>cyanide</strong> will<strong> inhibit </strong>prior <strong>electron transfer reactions</strong> and keep <strong>all components</strong> in a<strong> reduced state. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin disrupts</strong> both <strong>phosphorylation and oxidation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Selective complex inhibitors </strong>such as <strong>carboxin</strong> for <strong>complex II </strong>or<strong> barbiturates for complex I </strong>where<strong> NADH </strong>enters the chain would cause<strong> partial disruption of electron transfer.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Ubiquinone </strong>is one of <strong>three oxidation states of coenzyme Q </strong>(<strong>quinol to quinone to semiquinone</strong>) that cycle with forms of <strong>cytochrome c </strong>at the level of <strong>complex III;</strong> <strong>no coenzyme Q</strong> intermediates are <strong>phosphorylated.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Oligomycin does not</strong> interfere with <strong>NADH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin</strong> <strong>blocks ATP synthase</strong>, the enzyme responsible for<strong> synthesizing ATP from ADP </strong>and <strong>inorganic phosphate.</strong> This <strong>blockade</strong> <strong>prevents protons </strong>from <strong>flowing back</strong> into the <strong>mitochondrial matrix</strong> through<strong> ATP synthase,</strong> effectively <strong>stopping</strong> the utilization of the <strong>proton gradient </strong>generated by the <strong>electron transport chain.</strong> The <strong>gradient builds</strong> up, halting further <strong>proton pumping </strong>by the <strong>complexes </strong>of the<strong> electron transport chain,</strong> thus<strong> indirectly </strong>affecting<strong> ATP production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper Illustrated Biochemistry 31/e p 123.</span></strong></span></span></p>",
    "correct_choice_id": 24960,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6252,
    "choices": [
      {
        "id": 24977,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Availability of ADP</span></span></span></p>"
      },
      {
        "id": 24978,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Availability of oxygen</span></span></span></p>"
      },
      {
        "id": 24979,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Availability of substrate</span></span></span></p>"
      },
      {
        "id": 24980,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Availability of both ADP and substrate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the resting state, what is the primary condition that limits the rate of respiration?</span></span></span></p>",
    "unique_key": "Q3544402",
    "question_audio": null,
    "question_video": null,
    "map_id": 29970,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Availability of ADP</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>resting state</strong>, the <strong>rate</strong> of <strong>cellular respiration</strong> is primarily limited by the availability of <strong>ADP.</strong> This is <strong>because </strong>the process of <strong>oxidative phosphorylation</strong>, which <strong>occurs in the mitochondria</strong>, depends on<strong> ADP </strong>as a<strong> substrate</strong> to produce <strong>ATP.</strong> When the energy demand in a<strong> cell is low </strong>(as in the resting state), the<strong> concentration</strong> of <strong>ADP </strong>is also<strong> low, slowing down </strong>the rate of <strong>ATP synthesis </strong>and, consequently, the <strong>rate of respiration</strong>. This regulatory mechanism ensures that cells <strong>do not </strong>produce <strong>more</strong> <strong>ATP</strong> than needed, maintaining<strong> energy efficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Availability of <strong>oxygen</strong> is generally <strong>not</strong> the <strong>limiting facto</strong>r in the<strong> resting state</strong>, as oxygen is typically <strong>abundant in well-perfused tissues</strong> under normal physiological conditions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The availability of<strong> substrate</strong> (such as<strong> glucose or fatty acids</strong>) is usually <strong>not a limiting factor </strong>in the<strong> resting state, </strong>as <strong>cells</strong> have mechanisms to<strong> store or obtain </strong>these <strong>substrates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>both ADP and substrates </strong>are required for<strong> respiration,</strong> <strong>ADP</strong> is the <strong>primary limiting factor </strong>in the <strong>resting state</strong> due to its role in <strong>signaling the cell&#39;s energy needs.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the<strong> resting state,</strong> the<strong> level of ADP</strong> should be <strong>low</strong> and thus<strong> respiration </strong>will be<strong> slow </strong>(<strong>incorrect answers B-D)</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An<strong> increase in ADP</strong> indicates that the<strong> cell is in the working state</strong> and <strong>respiration will increase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During<strong> heavy workloads,</strong> such as <strong>during exercise, respiration </strong>may be regulated by the<strong> availability of oxygen</strong> or the<strong> limit</strong> of the <strong>capacity of the respiratory chain </strong>itself.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper Illustrated Biochemistry 31/e p320.</span></strong></span></span></p>",
    "correct_choice_id": 24977,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6265,
    "choices": [
      {
        "id": 25029,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyt C</span></span></span></p>"
      },
      {
        "id": 25030,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxygen</span></span></span></p>"
      },
      {
        "id": 25031,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FAD</span></span></span></p>"
      },
      {
        "id": 25032,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CoQ</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following options correctly identifies this final electron acceptor?</span></span></span></p>",
    "unique_key": "Q6112393",
    "question_audio": null,
    "question_video": null,
    "map_id": 29975,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Oxygen.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxygen</strong> (O2) serves as the<strong> final electron acceptor</strong> in the<strong> electron transport chain. </strong>It accepts <strong>electrons from cytochrome c </strong>oxidase (Complex IV) and, in the<strong> presence of protons (H+)</strong>, is reduced to <strong>water (H2O)</strong>. This step is crucial for <strong>maintaining the flow </strong>of <strong>electrons</strong> through the<strong> ETC</strong>, allowing for the <strong>continuation of oxidative phosphorylation</strong> and<strong> ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Cytochrome c</strong> (Cyt c) is an<strong> electron carrier </strong>within the<strong> ETC </strong>that transfers electrons between <strong>Complex III and Complex IV</strong> but is <strong>not</strong> the <strong>final acceptor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Flavin adenine dinucleotide</strong> (FAD) is involved <strong>earlier </strong>in the<strong> ETC</strong> as part of<strong> Complex II,</strong> <strong>not</strong> as the final electron acceptor.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Coenzyme Q</strong> (CoQ) is another <strong>electron carrier</strong> that <strong>shuttles electrons</strong> between <strong>Complex I and III</strong> and from <strong>Complex II to III,</strong> but it is <strong>not </strong>the <strong>terminal electron acceptor.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Electrons </strong>are transferred in the<strong> ascending order of redox potential, </strong>the<strong> final oxygen</strong> <strong>electron acceptor</strong> is<strong> oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p133.</span></strong></span></span></p>",
    "correct_choice_id": 25030,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6280,
    "choices": [
      {
        "id": 25089,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADH-Q Oxidoreductase </span></span></span></p>"
      },
      {
        "id": 25090,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome-C Oxidase</span></span></span></p>"
      },
      {
        "id": 25091,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isocitrate Dehydrogenase</span></span></span></p>"
      },
      {
        "id": 25092,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinate Q Reductase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In examining the electron transport chain (ETC) for ATP production, which component is responsible for transferring four protons across the mitochondrial membrane?</span></span></span></p>",
    "unique_key": "Q2695204",
    "question_audio": null,
    "question_video": null,
    "map_id": 29944,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) NADH-Q Oxidoreductase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NADH: Ubiquinone Oxidoreductase (Complex I) </strong>is responsible for transferring <strong>four protons </strong>across the <strong>mitochondrial membrane,</strong> contributing to the <strong>proton gradient essential for ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cytochrome C Oxidase (Complex IV):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While crucial in the <strong>electron transport chain </strong>for transferring <strong>electrons to oxygen, </strong>the<strong> number of protons</strong> it translocates <strong>does not </strong>precisely match<strong> four per cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Isocitrate Dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Not</strong> involved in the<strong> electron transport chain;</strong> it functions in the <strong>citric acid cycle.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Succinate:</span></strong> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ubiquinone Oxidoreductase (Complex II):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Transfers</strong> <strong>electrons</strong> <strong>without</strong> pumping protons <strong>across the membrane</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex I</strong>: NADH Coenzyme Q Oxidoreductase: 4 H+ </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex II pumps</strong>: Succinate Q Reductase: no protons</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex III pumps:</strong> Cytochrome CoQ oxidoreductase: 4 H+ </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex IV pumps</strong>: Cytochrome C Oxidase: 2 H+.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e, p 130.</span></strong></span></span></p>",
    "correct_choice_id": 25089,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6287,
    "choices": [
      {
        "id": 25117,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyanide</span></span></span></p>"
      },
      {
        "id": 25118,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkylguanides</span></span></span></p>"
      },
      {
        "id": 25119,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomycin</span></span></span></p>"
      },
      {
        "id": 25120,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxygen</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male with a history of chronic obstructive pulmonary disease presents to the emergency department with symptoms of acute poisoning. Laboratory investigations are initiated to determine the cause. The medical team suspects exposure to a substance that specifically inhibits Complex IV of the electron transport chain (ETC) in the mitochondria. Which of the following substances is most likely responsible for the inhibition of Complex IV in this patient&#39;s mitochondria?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q5426934",
    "question_audio": null,
    "question_video": null,
    "map_id": 29945,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Cyanide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cyanide</strong> is a potent<strong> inhibitor of Complex IV (cytochrome c oxidase) </strong>in the <strong>electron transport chain. Complex IV </strong>is responsible for the transfer of <strong>electrons from cytochrome c to oxygen</strong>, the <strong>final electron acceptor</strong>, where<strong> water is produced</strong>. <strong>Cyanide </strong>binds to the<strong> iron atom </strong>in the <strong>heme a3-CuB </strong>center of <strong>cytochrome c oxidase,</strong> preventing the transfer of <strong>electrons to oxygen</strong> and thus<strong> halting cellular respiration</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alkylguanides:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> These are <strong>not </strong>known to specifically <strong>inhibit Complex IV </strong>of the <strong>electron transport chain</strong>. Their mechanism of action<strong> does not </strong>involve <strong>direct inhibition of mitochondrial electron transport complexes</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Oligomycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Oligomycin is <strong>an inhibitor of ATP synthase </strong>(<strong>Complex V</strong>),<strong> not Complex IV</strong>. It <strong>blocks </strong>the <strong>proton</strong> channel of <strong>ATP synthase</strong>, <strong>preventing</strong> the <strong>synthesis of ATP from ADP </strong>and <strong>inorganic phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Oxygen:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Oxygen </strong>is actually the <strong>final electron acceptor </strong>in the <strong>electron transport chain</strong>, <strong>not an inhibitor</strong>. A <strong>lack of oxygen </strong>would <strong>inhibit </strong>the function of<strong> Complex IV</strong>, but<strong> oxygen </strong>itself is essential for <strong>its activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytochrome Oxidase [Complex IV] </strong>is <strong>inhibited </strong>by <strong>CO, HCN, H2S and Na Azide.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Harper 30/e p132, 133.</span></strong></span></span></p>",
    "correct_choice_id": 25117,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6290,
    "choices": [
      {
        "id": 25129,
        "text": "<p><span style=\"font-size:12pt;\">3 ATP molecules</span></p>"
      },
      {
        "id": 25130,
        "text": "<p><span style=\"font-size:12pt;\">1.5 ATP molecules</span></p>"
      },
      {
        "id": 25131,
        "text": "<p><span style=\"font-size:12pt;\">1 ATP molecule</span></p>"
      },
      {
        "id": 25132,
        "text": "<p><span style=\"font-size:12pt;\">No ATP at all</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 30-year-old researcher is conducting an experiment to measure ATP production through oxidative phosphorylation in isolated mitochondria. During the experiment, they specifically focus on the contribution of FADH to the electron transport chain. Considering the efficiency of ATP generation via the oxidation of FADH, how many ATP molecules are typically produced from the oxidation of one molecule of FADH?</span></p>",
    "unique_key": "Q3112728",
    "question_audio": null,
    "question_video": null,
    "map_id": 29946,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp; 1.5 ATP molecules</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">FADH donates electrons to the <strong>electron transport chain (ETC)</strong> at <strong>complex II (succinate dehydrogenase)</strong>, which is <strong>after</strong> the site where NADH enters (complex I). Because of this, <strong>FADH bypasses complex I</strong>, resulting in <strong>fewer protons being pumped</strong> across the mitochondrial inner membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key facts:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>NADH</strong> oxidation results in ~10 protons pumped \u2192 yields <strong>~2.5 ATP</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>FADH</strong> oxidation results in ~6 protons pumped \u2192 yields <strong>~1.5 ATP</strong></span></li><li><span style=\"font-size:12.0pt;\">It takes <strong>~4 protons</strong> (including cost of phosphate transport) to produce <strong>1 ATP molecule</strong> via <strong>ATP synthase</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, the oxidation of <strong>one FADH</strong> produces approximately <strong>1.5 ATP molecules</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand the <strong>bioenergetic yield</strong> of different electron donors in the ETC:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>NADH</strong> \u2192 ~2.5 ATP</span></li><li><span style=\"font-size:12.0pt;\"><strong>FADH</strong> \u2192 ~1.5 ATP</span></li></ul><p><span style=\"font-size:12.0pt;\">This knowledge is critical for calculating total <strong>ATP yield from glucose</strong>, <strong>fatty acid oxidation</strong>, or in <strong>experimental mitochondrial assays</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 263.</span></p>",
    "correct_choice_id": 25130,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6297,
    "choices": [
      {
        "id": 25157,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Located in inner mitochondrial membrane</span></span></span></p>"
      },
      {
        "id": 25158,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components are organized in decreasing order of redox potential</span></span></span></p>"
      },
      {
        "id": 25159,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Involved with ATP synthesis</span></span></span></p>"
      },
      {
        "id": 25160,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cyanide inhibits electron flow</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about the electron transport chain is FALSE?</span></span></span></p>",
    "unique_key": "Q4538699",
    "question_audio": null,
    "question_video": null,
    "map_id": 29947,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Components are organized in decreasing order of redox potential</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> false statement is B</strong> because the components of the <strong>electron transport chain (ETC) </strong>are organized in <strong>increasing order of redox</strong> <strong>potential,</strong> not decreasing. The redox potential is a measure of the <strong>tendency of a chemical species</strong> to<strong> acquire electrons</strong> and thereby be <strong>reduced</strong>. <strong>Components</strong> with <strong>higher redox potentials</strong> will <strong>accept electrons </strong>from those with <strong>lower redox potentials</strong>. This<strong> increasing</strong> order is crucial for the <strong>flow of electron</strong>s through the <strong>ETC from electron donors</strong> to the <strong>final electron acceptor, oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is located in the inner mitochondrial membrane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> True,</strong> the ETC is located in the <strong>inner mitochondrial membrane,</strong> where it plays a key role in<strong> cellular respiration.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It is involved with ATP synthesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True,</strong> the <strong>ETC</strong> is<strong> closely linked </strong>to <strong>oxidative phosphorylation,</strong> where the <strong>energy</strong> from <strong>electrons </strong>transferred along the<strong> chain</strong> is used to<strong> pump protons across the membrane</strong>, creating a <strong>proton gradient</strong> that drives <strong>ATP</strong> <strong>synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cyanide inhibits electron flow:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True,</strong> cyanide is a <strong>potent inhibitor of cytochrome c oxidase</strong> (Complex IV of the ETC), effectively <strong>blocking electron flow </strong>to<strong> oxygen </strong>and <strong>stopping cellular respiration.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ETC</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Site:</strong> In the <strong>Inner Mitochondrial Membrane</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Components </strong>of the Electron Transport Chain are contained in<strong> four large protein complexes</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Electrons</strong> are transferred in the <strong>ascending or increasing order </strong>of <strong>redox potential</strong>. <strong>NADH </strong>has <strong>lowest and Oxygen</strong> has <strong>highest redox potential.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>flow of electrons</strong> through the <strong>respiratory chain generates ATP</strong> by the process of <strong>oxidative phosphorylation.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibitors</strong> are mentioned in the image.&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 260.</span></strong></span></span></p>",
    "correct_choice_id": 25158,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6314,
    "choices": [
      {
        "id": 25225,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coenzyme Q</span></span></span></p>"
      },
      {
        "id": 25226,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome b</span></span></span></p>"
      },
      {
        "id": 25227,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome aa3</span></span></span></p>"
      },
      {
        "id": 25228,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome c</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the following components of the respiratory chain directly reacts with molecular oxygen to facilitate this reduction?</span></span></span></p>",
    "unique_key": "Q7259119",
    "question_audio": null,
    "question_video": null,
    "map_id": 29954,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Cytochrome aa3</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytochrome aa3,</strong> also known as <strong>Cytochrome c oxidase</strong> or <strong>Complex IV </strong>of the electron transport chain, is the component that<strong> directly</strong> reacts with <strong>molecular oxygen</strong>. It<strong> receives electrons from Cytochrome c</strong>, facilitating the <strong>reduction of molecular oxygen </strong>to<strong> water</strong>. This process is<strong> essential </strong>for the maintenance of the<strong> proton gradient </strong>across the mitochondrial membrane, which drives<strong> ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Coenzyme Q:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Acts as a mobile <strong>electron carrier</strong> between<strong> Complex I/II and Complex III</strong>, but it <strong>does not</strong> directly react with <strong>molecular oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cytochrome b:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Part of<strong> Complex III (Cytochrome bc1 complex) </strong>and involved in the<strong> transfer of electrons </strong>within the complex but<strong> does not</strong> directly interact with<strong> molecular oxygen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cytochrome c:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Transports <strong>electrons from Complex III to Complex IV</strong> but <strong>does not</strong> directly react with<strong> molecular oxygen</strong>; it is the<strong> electron donor to Cytochrome c oxidase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex IV </strong>contains different <strong>proteins </strong>such as<strong> cytochrome a and cytochrome a3. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Four electrons</strong> are accepted from <strong>cytochrome c</strong> and passed on to <strong>molecular oxygen&nbsp;</strong></span></span></span><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">4 H+ + O2 + 4 Cyt c-Fe++ &rarr; 2 H2O + 4 Cyt c+++</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2 protons </strong>are pumped <strong>out</strong> to the <strong>intermembrane space</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cytochrome oxidase </strong>has <strong>4 redox centres a, a3, CuA and CuB </strong>and the <strong>electron transfer </strong>in this complex is as shown</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Cyt c &rarr;CuA &rarr;Cyt a &rarr;Cyt a3 &rarr;CuB</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 262.</span></strong></span></span></p>",
    "correct_choice_id": 25227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6313,
    "choices": [
      {
        "id": 25221,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the fourth complex of ETC</span></span></span></p>"
      },
      {
        "id": 25222,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">F0 spans inner mitochondrial membrane&nbsp; &amp; F1 projects into matrix </span></span></span></p>"
      },
      {
        "id": 25223,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">F1 spans inner mitochondrial membrane&nbsp; &amp; F0&nbsp; projects into matrix</span></span></span></p>"
      },
      {
        "id": 25224,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amobarbital is an inhibitor of this complex</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements correctly describes the ATP Synthase complex?</span></span></span></p>",
    "unique_key": "Q6256541",
    "question_audio": null,
    "question_video": null,
    "map_id": 29953,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) F0 spans inner mitochondrial membrane &amp; F1 projects into matrix </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>ATP Synthase </strong>is composed of <strong>two main components: F0 and F1</strong>. The<strong> F0 unit</strong> is embedded in the <strong>inner mitochondrial membrane</strong> and functions as a<strong> proton channel, </strong>allowing <strong>protons to flow back </strong>into the <strong>mitochondrial matrix.</strong> The<strong> F1 unit,</strong> <strong>projecting into the matrix,</strong> contains the <strong>catalytic sites for ATP synthesis</strong>. This arrangement<strong> facilitates </strong>the utilization of the<strong> proton gradient </strong>generated by the <strong>electron transport chain</strong> to drive the<strong> synthesis of ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is the fourth complex of the electron transport chain (ETC):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> ATP Synthase is sometimes referred to as<strong> Complex V, not Complex IV</strong>, in the <strong>electron transport chain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. The F1 unit spans the inner mitochondrial membrane and the F0 unit projects into the matrix:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement <strong>incorrectly</strong> describes the orientation of the<strong> F0 and F1 units of ATP Synthase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Amobarbital is an inhibitor of this complex:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Amobarbital </strong>is known to <strong>inhibit Complex I </strong>(<strong>NADH:Ubiquinone</strong> <strong>Oxidoreductase</strong>) of the ETC, <strong>not ATP Synthase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the<strong> Fifth Complex of Electron transport Chain </strong>(option a)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Location</strong>- Embedded in the<strong> inner mitochondrial membrane.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Divided into<strong> two Subcomplexes: F0 Subcomplex and F1 Subcomplex.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>F0 Subcomplex: Hydrophobic in nature</strong>,<strong> F0 </strong>spans the<strong> inner mitochondrial membrane </strong>and forms a<strong> proton channel.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>F1 Subcomplex</strong>: <strong>Hydrophilic in nature, Projects</strong> into the<strong> mitochondrial matrix </strong>and is <strong>attached to F0 Subcomplex. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Inhibitors</strong> of <strong>oxidative phosphorylation:</strong></span></span></span>\r\n\t<ul>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atractyloside</strong>, inhibits <strong>translocase</strong></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin</strong>, inhibits <strong>flow of protons through Fo</strong></span></span></span></li>\r\n\t\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ionophores</strong>, e.g. <strong>Valinomycin</strong></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 264. </span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> </span></strong></span></span></p>",
    "correct_choice_id": 25222,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6311,
    "choices": [
      {
        "id": 25213,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin</span></span></span></p>"
      },
      {
        "id": 25214,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Free fatty acid</span></span></span></p>"
      },
      {
        "id": 25215,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine</span></span></span></p>"
      },
      {
        "id": 25216,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A researcher is investigating the effects of various biochemical substances on mitochondrial oxidative phosphorylation in a laboratory setting. They are particularly interested in substances that can disrupt the proton gradient across the mitochondrial membrane, thereby acting as uncouplers. Which of the following substances is capable of acting as an uncoupler in oxidative phosphorylation?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q7651619",
    "question_audio": null,
    "question_video": null,
    "map_id": 29952,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All of the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All</strong> the listed substances have been shown to have <strong>uncoupling effects on oxidative phosphorylation</strong> to varying degrees. <strong>Free fatty</strong> <strong>acids</strong> can act as<strong> uncouplers </strong>by <strong>disrupting the mitochondrial membrane potential,</strong> thereby<strong> dissipating the proton gradient.</strong> <strong>Thyroxine</strong> has been known to<strong> increase metabolic rate</strong> by <strong>uncoupling oxidative phosphorylation,</strong> thereby<strong> increasing heat production.</strong> <strong>Bilirubin</strong>, at <strong>high concentrations</strong>, can also have <strong>uncoupling effects,</strong> although its role is<strong> more </strong>commonly associated with other <strong>biochemical disruptions.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Bilirubin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>not</strong> its primary role or effect, bilirubin can <strong>act as</strong> an <strong>uncoupler</strong> under certain conditions, particularly at <strong>high concentrations.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Free fatty acid:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Free fatty acids are <strong>more </strong>commonly recognized as<strong> uncouplers</strong>, <strong>disrupting the proton gradient </strong>across the <strong>mitochondrial membrane.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Thyroxine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Thyroxine is known to <strong>increase the metabolic rate</strong> by <strong>uncoupling oxidative phosphorylation,</strong> leading to <strong>increased heat production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physiological Uncoupler</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Thermogenin </strong>[Uncoupling Protein 1] in Brown Adipose Tissue (naturally occurring uncoupler)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long Chain Free Fatty Acid</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Unconjugated Bilirubin</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 266.</span></strong></span></span></p>",
    "correct_choice_id": 25216,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6319,
    "choices": [
      {
        "id": 25245,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">LHON</span></span></span></p>"
      },
      {
        "id": 25246,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MERRF</span></span></span></p>"
      },
      {
        "id": 25247,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only A</span></span></span></p>"
      },
      {
        "id": 25248,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both A and B</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A professor is discussing mitochondrial disorders with her students, focusing on diseases associated with defects in oxidative phosphorylation (OXPHOS). She highlights several conditions that result from mutations affecting mitochondrial DNA and impairing the electron transport chain and ATP synthesis. Which of the following conditions are considered OXPHOS diseases?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q3337512",
    "question_audio": null,
    "question_video": null,
    "map_id": 29956,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp; Both A and B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Both LHON </strong>(Leber&#39;s Hereditary Optic Neuropathy) and<strong> MERRF</strong> (Myoclonic Epilepsy with Ragged Red Fibers) are examples of <strong>OXPHOS</strong> <strong>diseases</strong>. <strong>LHON</strong> is primarily associated <strong>with mutations</strong> in<strong> genes </strong>encoding<strong> mitochondrial complex I subunits</strong>, leading to <strong>optic nerve</strong> <strong>degeneration</strong> and<strong> loss of central vision. MERRF </strong>is characterized by <strong>mutations in mitochondrial tRNA genes</strong> that affect mitochondrial protein synthesis, leading to <strong>defects in the electron transport chain</strong> and<strong> muscle fiber abnormalities</strong> (ragged red fibers), along with <strong>neurological symptoms</strong>. <strong>Both diseases</strong> involve <strong>dysfunction</strong> in the <strong>oxidative phosphorylation system.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. LHON:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an <strong>OXPHOS disease</strong> affecting the <strong>optic nerves</strong>, but it is <strong>not</strong> the only one.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. MERRF:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This condition, characterized by <strong>myoclonic seizures and muscle pathology</strong>, is also an <strong>OXPHOS disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">They usually<strong> manifestations in nervous system</strong> (seizures, deafness, dementia), <strong>eyes</strong> (<strong>retinitis pigmentosa, optic atrophy, blindness,</strong> <strong>ptosis</strong>), <strong>heart</strong> (<strong>cardiomyopathy</strong>), <strong>kidneys</strong> (<strong>Fanconi&rsquo;s syndrome</strong>, with loss of metabolites in urine) and <strong>skeletal muscles</strong> (<strong>myoglobinuria</strong>). </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture6.jpg\" style=\"height:331px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 606.</span></strong></span></span></p>",
    "correct_choice_id": 25248,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6316,
    "choices": [
      {
        "id": 25233,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,4-dinitrophenol</span></span></span></p>"
      },
      {
        "id": 25234,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Valinomycin</span></span></span></p>"
      },
      {
        "id": 25235,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thermogenin</span></span></span></p>"
      },
      {
        "id": 25236,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomycin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Among the following options, which one does NOT act as an uncoupler of oxidative phosphorylation?</span></span></span></p>",
    "unique_key": "Q5053344",
    "question_audio": null,
    "question_video": null,
    "map_id": 29955,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Oligomycin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin </strong>acts as an <strong>inhibitor of ATP synthase </strong>(<strong>Complex V</strong>) in the <strong>electron transport chain</strong>, <strong>not </strong>as an <strong>uncoupler.</strong> It binds to the <strong>F0</strong> <strong>subunit of ATP synthase, </strong>preventing the flow of <strong>protons back into the mitochondrial matrix </strong>and thereby <strong>inhibiting ATP synthesis.</strong> Unlike <strong>uncouplers,</strong> which<strong> dissipate the proton gradient without </strong>affecting<strong> ATP synthase</strong> directly, <strong>oligomycin </strong>specifically <strong>blocks </strong>the <strong>enzyme&#39;s function</strong>,<strong> leading</strong> to the preservation of the <strong>proton gradient</strong> but <strong>halting ATP production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. 2,4-Dinitrophenol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a<strong> classic uncoupler</strong> that <strong>disrupts</strong> the <strong>proton gradient</strong> across the<strong> mitochondrial membrane</strong> by allowing<strong> protons to leak back into the matrix,</strong> bypassing<strong> ATP synthase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Valinomycin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although <strong>not a typical uncoupler,</strong> valinomycin acts as an<strong> ionophore for potassium ions,</strong> and in certain contexts, it can <strong>disrupt membrane potential</strong> and <strong>indirectly</strong> affect the<strong> proton gradient.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Thermogenin (UCP1):</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Thermogenin is an<strong> uncoupling protein</strong> found in the <strong>mitochondria of brown adipose tissue </strong>that allows for<strong> proton leak, </strong>generating <strong>heat</strong> instead of<strong> ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin</strong> is an <strong>antibiotic </strong>which <strong>inhibits flow of protons</strong> through<strong> Fo</strong> by binding <strong>complex V.</strong> It is <strong>not</strong> an <strong>uncoupler.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ionophores</strong> are<strong> lipid-soluble compounds</strong> which <strong>increases</strong> the permeability of <strong>lipid bilayers to certain ions.</strong> There are <strong>two types of ionophores</strong>: <strong>mobile ion carries</strong> (e.g. <strong>valinomycin</strong>) and <strong>channel formers </strong>(e.g. gramicidin). <strong>Valinomycin</strong> allows<strong> potassium to permeate mitochondria </strong>and <strong>dissipate the proton gradient. 2,4-dinitrophenol </strong>is a <strong>protonophore</strong> and acts as a<strong> synthetic uncoupler.</strong> <strong>Thermogenin</strong> is a mitochondrial membrane <strong>protein</strong> naturally present in <strong>brown</strong> <strong>adipose tissues</strong> and acts as an <strong>uncoupler.</strong> All of these <strong>inhibit oxidative phosphorylation </strong>by <strong>dissipating proton gradient.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 266.</span></strong></span></span></p>",
    "correct_choice_id": 25236,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6323,
    "choices": [
      {
        "id": 25261,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Protein assembly is seen in the inner mitochondrial membrane</span></span></span></p>"
      },
      {
        "id": 25262,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atractyloside inhibits the process</span></span></span></p>"
      },
      {
        "id": 25263,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidation is coupled to phosphorylation</span></span></span></p>"
      },
      {
        "id": 25264,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Availability of ATP regulates the process</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about ATP synthesis is NOT true?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q9210852",
    "question_audio": null,
    "question_video": null,
    "map_id": 29958,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Availability of ATP regulates the process </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>ATP synthesis</strong> is regulated by various factors, including the <strong>availability of substrates</strong> <strong>(ADP, Pi, NADH, FADH2)</strong> and the <strong>proton</strong> motive <strong>force </strong>across the <strong>mitochondrial membrane,</strong> the process is <strong>not directly</strong> regulated by the availability of <strong>ATP</strong> in a feedback <strong>inhibition manner. </strong>Instead, <strong>ATP synthesis</strong> is <strong>more </strong>directly regulated by the <strong>energy needs of the cell</strong>, where <strong>increased ADP levels </strong>(indicating<strong> high energy demand</strong>) <strong>stimulate ATP production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Protein complexes involved in ATP synthesis are located in the inner mitochondrial membrane:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>true</strong>. The protein complexes of the electron transport chain and ATP synthase are located in the inner mitochondrial membrane.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Atractyloside inhibits ATP synthesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This is <strong>true.</strong> <strong>Atractyloside inhibits</strong> the <strong>ADP/ATP carrier (translocase)</strong> in the <strong>mitochondrial membrane,</strong> thereby <strong>indirectly affecting ATP synthesis </strong>by <strong>preventing ADP from entering the mitochondria.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Oxidation processes are coupled with phosphorylation to produce ATP:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;This&nbsp; is<strong> true</strong> .This is the fundamental principle of o<strong>xidative phosphorylation,</strong> where the <strong>energy from oxidation reactions</strong> is used to drive the<strong> synthesis of ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>protein</strong> assembly in the <strong>inner mitochondrial membrane.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Also known as <strong>5th Complex</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The availability of<strong> ADP regulates</strong> the process of<strong> ATP synthesis</strong>. When <strong>ATP level is low</strong> and <strong>ADP level is high,</strong> <strong>oxidative</strong> <strong>phosphorylation</strong> happens at <strong>a rapid rate. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is known as <strong>respiratory control or acceptor control.</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibitors of oxidative phosphorylation</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Atractyloside</strong>, inhibits<strong> translocase</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oligomycin,</strong> inhibits flow of<strong> protons through Fo</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Ionophores</strong>, e.g. <strong>Valinomycin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 265.</span></strong></span></span></p>",
    "correct_choice_id": 25264,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6243,
    "choices": [
      {
        "id": 24941,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenobarbital</span></span></span></p>"
      },
      {
        "id": 24942,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carboxin</span></span></span></p>"
      },
      {
        "id": 24943,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dimercaprol</span></span></span></p>"
      },
      {
        "id": 24944,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dinitrophenol</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old female, found comatose, was rushed to the emergency department from a campus chemistry lab. She exhibits a high fever (40.5&deg;C or 105&deg;F), tachycardia, tachypnea, and her arm is stained yellow. Blood pressure readings are unsuccessful. She experienced blurred vision, headaches, and tremors following an accidental exposure to metabolic inhibitors, leading to her current state. Based on these symptoms, which toxin is most likely responsible for her condition?</span></span></span></p>",
    "unique_key": "Q1278455",
    "question_audio": null,
    "question_video": null,
    "map_id": 29966,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Dinitrophenol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The listed<strong> chemicals</strong> are <strong>inhibitors </strong>of the chain of<strong> oxidative reactions </strong>that couple oxidation of <strong>NADH to phosphorylation</strong> <strong>of ADP.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dinitrophenol </strong>is unique, which <strong>disconnects</strong> the ordinarily <strong>tight coupling</strong> of<strong> electron transport and phosphorylation</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In its <strong>presence</strong>, <strong>electron transport</strong> continues normally with <strong>no oxidative phosphorylation</strong> occurring, instead <strong>heat energy</strong> is <strong>generated</strong> (<strong>Non-shivering thermogenesis</strong>). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The same principle is utilized in a<strong> well-controlled </strong>way by<strong> brown fat</strong> to<strong> generate heat</strong> in <strong>newborn</strong> humans and <strong>cold-adapted mammals.&nbsp; </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The biological<strong> uncoupler in brown fat</strong> is a<strong> protein</strong> called<strong> thermogenin.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SITES OF BROWN FAT&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Around major vessels</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inter-scapular area</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Around adrenal cortex</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neck</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UNCOUPLERS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thermogenin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High doses of aspirin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dinitrophenol</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Barbiturates </strong>at<strong> high dosage</strong>, including the common <strong>anticonvulsant phenobarbital inhibit complex I.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Complex II</strong> connects the <strong>FADH2 </strong>derived from <strong>succinate dehydrogenase to coenzyme Q</strong> and is<strong> inhibited by carboxin.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> antimycin A </strong>and<strong> dimercaprol</strong> <strong>inhibit complex III </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical presentation of <strong>dinitrophenol poisoning</strong>, characterized by<strong> hyperthermia, rapid heart and respiratory rates, and yellow</strong> <strong>staining of the skin</strong>, highlighting the<strong> importance</strong> of understanding the <strong>effects of metabolic inhibitors</strong> in <strong>acute toxic exposures.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 123</span></strong></span></span></p>",
    "correct_choice_id": 24944,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6264,
    "choices": [
      {
        "id": 25025,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The effect of respiratory chain inhibitors cannot be characterized spectroscopically, whereas that of uncouplers can.</span></span></span></p>"
      },
      {
        "id": 25026,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.</span></span></span></p>"
      },
      {
        "id": 25027,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uncouplers are toxic substances, but respiratory chain inhibitors are not.</span></span></span></p>"
      },
      {
        "id": 25028,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory chain inhibitors allow leakage of protons across the membrane, but uncouplers do not.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements accurately highlights a key difference between respiratory chain inhibitors and uncouplers?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q7138523",
    "question_audio": null,
    "question_video": null,
    "map_id": 29974,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Uncouplers do not inhibit electron transport, but respiratory chain inhibitors do.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The primary <strong>distinction between uncouplers and respiratory chain inhibitors </strong>lies in their<strong> mechanisms of action</strong>.<strong> Uncouplers disrupt </strong>the <strong>proton gradient </strong>across the <strong>mitochondrial inner membrane </strong>by allowing <strong>protons to leak back </strong>into the <strong>mitochondrial matrix without </strong>passing through <strong>ATP synthase</strong>, thereby <strong>preventing ATP synthesis</strong>. However, they <strong>do not </strong>impede the <strong>flow of electrons </strong>through the<strong> respiratory chain</strong>. On the other hand, <strong>respiratory chain inhibitors </strong>directly <strong>block electron transport </strong>at various points in the chain,<strong> halting both electron flow </strong>and the consequent <strong>proton pumping </strong>that establishes the<strong> gradient necessary </strong>for <strong>ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Both respiratory chain inhibitors </strong>and <strong>uncouplers</strong> can be studied using<strong> spectroscopic methods</strong> to observe <strong>their effects</strong> on the <strong>electron transport chain and proton gradients.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Toxicity </strong>is <strong>not</strong> a characteristic that distinctly separates <strong>uncouplers from inhibitors</strong>; <strong>both </strong>can be<strong> toxic </strong>depending on their <strong>specific mechanism </strong>and the context of their use.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It is actually the <strong>uncouplers</strong> that <strong>increase proton</strong> leakage across the <strong>mitochondrial inner membrane,</strong> <strong>not</strong> the respiratory chain inhibitors.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uncouplers</strong> such as <strong>2, 4-dinitrophenol increase</strong> the permeability of the <strong>inner mitochondrial membrane to protons</strong>,<strong> reduce </strong>the <strong>electrochemical potential</strong>, and <strong>inhibit</strong> <strong>ATP synthase. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">UNCOUPLERS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thermogenin</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thyroxine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2,4-dinitrophenol</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High dose Aspirin</span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper Illustrated Biochemistry 31/e p 322.</span></strong></span></span></p>",
    "correct_choice_id": 25026,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6328,
    "choices": [
      {
        "id": 25281,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is a quinone derivative</span></span></span></p>"
      },
      {
        "id": 25282,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADH is the only donor of pair of electrons to CoQ</span></span></span></p>"
      },
      {
        "id": 25283,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Have long isoprenoid tail</span></span></span></p>"
      },
      {
        "id": 25284,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It reduces two molecules of cytochrome c</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A clinical researcher is investigating a rare metabolic disorder characterized by defects in the mitochondrial electron transport chain. During her research, she examines the role and characteristics of various components within the chain, including Coenzyme Q (CoQ). She comes across some common misconceptions about CoQ among her colleagues. Which of the following statements about Coenzyme Q would she identify as FALSE?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q9292296",
    "question_audio": null,
    "question_video": null,
    "map_id": 29959,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) NADH is the only donor of pair of electrons to CoQ</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement that NADH is the only donor of electrons to Coenzyme Q (CoQ) is <strong>false</strong>. While <strong>NADH, </strong>through<strong> Complex I</strong> <strong>(NADH:Ubiquinone Oxidoreductase)</strong>, is a<strong> major donor </strong>of electrons to <strong>CoQ, </strong>it is <strong>not</strong> the only one. <strong>Succinate, via Complex II</strong> <strong>(Succinate:Ubiquinone Oxidoreductase),</strong> also <strong>donates electrons to CoQ</strong>, among other <strong>potential electron donors</strong> in the <strong>electron</strong> <strong>transport chain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It is a derivative of quinone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>,<strong> CoQ</strong> has a<strong> quinone </strong>structure, which is essential for its role in<strong> electron transport.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It has a long isoprenoid tail:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, the <strong>isoprenoid tail of CoQ</strong> helps it to be <strong>soluble in the lipid bilayer </strong>of the <strong>inner</strong> <strong>mitochondrial membrane </strong>and<strong> facilitates</strong> its role as a <strong>mobile electron carrier.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It reduces two molecules of cytochrome c</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This statement is somewhat <strong>misleading.</strong> <strong>CoQ</strong> transfers <strong>electrons to Complex III</strong> <strong>(Cytochrome bc1 complex</strong>), which then eventually <strong>transfers electrons to cytochrome c</strong>. However, <strong>CoQ </strong>itself <strong>does not </strong>directly <strong>reduce</strong> <strong>cytochrome c molecules</strong>; instead, it is part of the process that leads to the <strong>reduction of cytochrome c.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>ubiquinone (Q) </strong>is reduced to <strong>semiquinone (QH) </strong>and finally to<strong> quinol (QH2).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It accepts a <strong>pair of electrons</strong> from<strong> NADH or FADH2</strong> through <strong>complex-I or complex-II </strong>respectively</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coenzyme Q </strong>is a<strong> quinone derivative</strong> having a long <strong>isoprenoid tail</strong> and the<strong> chain length of the tail</strong> is different in various species.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Two </strong>molecules of <strong>cytochrome c</strong> are <strong>reduced.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> Q cycle</strong> facilitates the<strong> switching</strong> from the <strong>two electron carrier ubiquinol </strong>to the<strong> single electron carrier cytochrome c.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 261.</span></strong></span></span></p>",
    "correct_choice_id": 25282,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6257,
    "choices": [
      {
        "id": 24997,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proton translocation</span></span></span></p>"
      },
      {
        "id": 24998,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Substrate level phosphorylation</span></span></span></p>"
      },
      {
        "id": 24999,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Electron flow through cytochromes</span></span></span></p>"
      },
      {
        "id": 25000,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduction of NADH</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxidative phosphorylation process is known for its efficiency in generating ATP by utilizing a specific gradient. Which of the following best describes what oxidative phosphorylation couples with ATP generation?</span></span></span></p>",
    "unique_key": "Q7804357",
    "question_audio": null,
    "question_video": null,
    "map_id": 29971,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Proton translocation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Oxidative phosphorylation </strong>generates<strong> ATP</strong> by <strong>coupling</strong> this process with the <strong>translocation of protons (H+) </strong>across the<strong> mitochondrial</strong> <strong>inner membrane</strong>, creating a<strong> proton gradient</strong>. This gradient, known as the <strong>proton motive force</strong>, <strong>drives protons back </strong>through<strong> ATP</strong> <strong>synthase</strong>, facilitating<strong> ATP synthesis</strong> from<strong> ADP and inorganic phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B: Substrate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> level <strong>phosphorylation </strong>is a different mechanism of <strong>ATP production</strong> that occurs in the <strong>cytoplasm and</strong> <strong>mitochondrial matrix</strong>, <strong>not </strong>directly related to the <strong>proton gradient </strong>utilized in<strong> oxidative phosphorylation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;While<strong> electron flow</strong> through <strong>cytochromes</strong> is essential for establishing the <strong>proton gradient, </strong>the<strong> direct </strong>coupling in <strong>oxidative</strong> <strong>phosphorylation</strong> involves the <strong>movement of protons</strong>,<strong> not</strong> just the <strong>electron flow.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;The <strong>reduction of NADH</strong> to <strong>NAD+</strong> occurs upstream of<strong> ATP generation</strong> in <strong>oxidative phosphorylation</strong>, contributing to the <strong>electron transport chain </strong>that establishes the<strong> proton gradient</strong> but is<strong> not </strong>the <strong>direct</strong> coupling mechanism for <strong>ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Proton </strong>translocation<strong> across </strong>the <strong>mitochondrial membrane</strong> generates an <strong>electro- chemical potential difference</strong> composed of a <strong>pH gradient </strong>and an <strong>electrical potential. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This <strong>electrochemical potential</strong> difference is used to<strong> drive ATP synthase to form ATP.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During this process <strong>NADH is oxidized</strong> not reduced, by <strong>coupling with oxygen </strong>as the <strong>ultimate electron acceptor</strong>. <strong>Substrate</strong> <strong>level phosphorylation</strong> occurs during<strong> glycolysis and TCA</strong>. <strong>Electron flow</strong> through<strong> cytochromes</strong> is<strong> indirectly </strong>causing <strong>generation of proton gradient</strong> which is directly causing <strong>ATP generation, </strong>so the best answer to<strong> choose is A</strong>&nbsp;rather than C.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper Illustrated Biochemistry 31/e p 315.</span></strong></span></span></p>",
    "correct_choice_id": 24997,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6308,
    "choices": [
      {
        "id": 25201,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Succinate to complex III </span></span></span></p>"
      },
      {
        "id": 25202,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cytochrome C to complex IV</span></span></span></p>"
      },
      {
        "id": 25203,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Coenzyme Q to complex III</span></span></span></p>"
      },
      {
        "id": 25204,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malate to coenzyme Q</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman presents to the clinic with fatigue and muscle weakness. Further investigation reveals a mitochondrial DNA mutation leading to reduced complex I activity in her cells. Given the role of complex I in the electron transport chain, which of the following electron transfers would be most directly affected by this mutation?</span></span></span></p>",
    "unique_key": "Q9389283",
    "question_audio": null,
    "question_video": null,
    "map_id": 29950,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Malate to coenzyme Q</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex I</strong> is responsible for<strong> transferring electrons from NADH to Coenzyme Q (Ubiquinone)</strong>. The <strong>malate to Coenzyme Q </strong>electron transfer involves the<strong> conversion of malate to oxaloacetate</strong> by <strong>malate dehydrogenase</strong>, where <strong>NAD+ is reduced to NADH.</strong> This <strong>NADH</strong> then <strong>donates electrons to Complex I,</strong> which subsequently <strong>transfers </strong>these<strong> electrons to Coenzyme Q.</strong> A <strong>reduction in Complex I </strong>activity would, therefore, <strong>impair the transfer of electrons</strong> from<strong> NADH</strong>, produced during the<strong> oxidation of malate,</strong> to <strong>Coenzyme Q,</strong> affecting this step in the<strong> electron transport chain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Succinate to Complex III:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This involves<strong> Complex II (Succinate Dehydrogenase),</strong> <strong>not </strong>directly affected by <strong>Complex I activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cytochrome C to Complex IV:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This step involves <strong>Complex IV (Cytochrome c Oxidase)</strong> and is downstream of <strong>Coenzyme Q,</strong> <strong>not </strong>directly affected by<strong> Complex I activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Coenzyme Q to Complex III:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This step is <strong>directly downstream of Complex I,</strong> and while it involves<strong> Coenzyme Q, </strong>the initial <strong>impairment </strong>would be in the<strong> electron transfer from NADH </strong>(<strong>produced from malate</strong>) to<strong> Coenzyme Q.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex I </strong>accepts<strong> electrons </strong>from <strong>NADH</strong> and will transfer them to<strong> coenzyme Q</strong>. <strong>Malate dehydrogenase</strong> will <strong>convert malate to</strong> <strong>oxaloacetate</strong>, generating<strong> NADH</strong> in the process. The <strong>NADH </strong>will then <strong>donate electrons</strong> to<strong> complex I </strong>to initiate <strong>electron transfer. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Succinate donates electrons</strong> at <strong>complex II </strong>(Via <strong>succinate dehydrogenase,</strong> a component of complex II), which <strong>donates to coenzyme</strong> <strong>Q</strong>, thereby <strong>bypassing complex I.</strong>&nbsp;<strong> Cytochrome c</strong> transfers<strong> electrons</strong> from <strong>complex III to complex IV.</strong> Once <strong>electrons </strong>are carried by <strong>coenzyme Q</strong>, <strong>complex I</strong> is<strong> no</strong> longer required for <strong>electron transfer to oxygen. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: DM Vasudevan 9/e: p 260.</span></strong></span></span></p>",
    "correct_choice_id": 25204,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6250,
    "choices": [
      {
        "id": 24969,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.</span></span></span></p>"
      },
      {
        "id": 24970,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It links NAD-dependent dehydrogenases to cytochrome c.</span></span></span></p>"
      },
      {
        "id": 24971,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It links each of the cytochromes in the respiratory chain to one another.</span></span></span></p>"
      },
      {
        "id": 24972,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the first step in the respiratory chain.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In managing individuals with respiratory chain disorders, supplements like riboflavin and coenzyme Q (ubiquinone) are commonly used. Understanding the role of these supplements in mitochondrial function is crucial. What is the specific function of coenzyme Q in the respiratory chain?</span></span></span></p>",
    "unique_key": "Q1564019",
    "question_audio": null,
    "question_video": null,
    "map_id": 29969,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) It links flavoproteins to cytochrome b, the cytochrome of lowest redox potential.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coenzyme Q </strong>collects reducing equivalents from <strong>flavoprotein complexes </strong>and <strong>passes</strong> them along the <strong>chain </strong>to the <strong>cytochrome b. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reducing equivalents</strong> from a<strong> number of substrates </strong>are passed through <strong>coenzyme Q</strong> in the <strong>respiratory chain, </strong>including <strong>flavin adenine dinucleotide (FADH2) </strong>and <strong>NADH </strong>that is produced from<strong> metabolic reactions.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Supplements </strong>of <strong>riboflavin</strong> (to<strong> boost flavin levels</strong>), <strong>coenzyme Q </strong>(available from <strong>health food stores</strong>) and <strong>carnitine</strong> (to facilitate <strong>entry of metabolites </strong>into<strong> mitochondria</strong>) have produced <strong>mild improvement</strong>s in patients with <strong>respiratory chain</strong> <strong>disorders. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Commercial preparations are referred to as<strong> coenzyme Q10, </strong>where the 10 refers to the <strong>number of isoprene (5-carbon)</strong> <strong>units</strong> attached to the<strong> ubiquinone ring.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>coenzyme Q </strong>does transfer<strong> electrons to components</strong> that eventually <strong>lead to cytochrome c, </strong>its <strong>direct link </strong>is with <strong>cytochrome b in Complex III,</strong> <strong>not</strong> cytochrome c.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Coenzyme Q</strong> <strong>does not</strong> directly link<strong> all cytochromes </strong>but plays a pivotal role in transferring<strong> electrons from flavoproteins</strong> to <strong>cytochrome b</strong> in<strong> Complex III.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Coenzyme Q</strong> is<strong> not</strong> the initial electron acceptor; it accepts electrons from <strong>Complex I and II,</strong> which are <strong>upstream</strong> in the <strong>electron transport chain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coenzyme Q (ubiquinone)</strong> is a critical component in the <strong>mitochondrial electron transport chain,</strong> acting as a <strong>mobile electron carrier.</strong> It <strong>primarily</strong> accepts<strong> electrons</strong> from various<strong> flavoproteins</strong>, including those in <strong>Complex I (NADH dehydrogenase) </strong>and <strong>Complex II</strong> (<strong>succinate dehydrogenase</strong>), and transfers them to <strong>cytochrome b within Complex III (cytochrome bc1 complex). </strong>This transfer is vital for maintaining the<strong> flow of electrons through </strong>the<strong> chain</strong>, essential for the <strong>generation of a proton gradient </strong>used in <strong>ATP synthesis</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 31/e p: 315.</span></strong></span></span></p>",
    "correct_choice_id": 24969,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6298,
    "choices": [
      {
        "id": 25161,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iron and copper</span></span></span></p>"
      },
      {
        "id": 25162,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iodine and zinc</span></span></span></p>"
      },
      {
        "id": 25163,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chromium and selenium</span></span></span></p>"
      },
      {
        "id": 25164,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fluoride</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following pairs of trace elements are essential for the proper functioning of the electron transport chain within the mitochondria?</span></span></span></p>",
    "unique_key": "Q2529569",
    "question_audio": null,
    "question_video": null,
    "map_id": 29948,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Iron and copper</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Iron and copper</strong> are critical <strong>trace elements </strong>in the <strong>electron transport chain.</strong> <strong>Iron</strong> is a component of various<strong> heme proteins and iron-sulfur proteins </strong>that participate in <strong>electron transfer</strong> within the<strong> ETC</strong>. <strong>Copper </strong>is found in <strong>cytochrome c oxidase</strong> (Complex IV), where it plays a vital role in<strong> electron transfer </strong>and the <strong>reduction of oxygen to water.</strong> Both these<strong> elements</strong> are <strong>essential</strong> for the efficient function of the <strong>electron transport chain</strong> and<strong> subsequent ATP synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Iodine and Zinc:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Iodine</strong> is primarily involved in <strong>thyroid hormone synthesis</strong>, and <strong>zinc</strong> serves as a<strong> cofactor </strong>for <strong>numerous</strong> <strong>enzymes</strong> but<strong> neither</strong> are directly involved in the <strong>ETC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Chromium and Selenium:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Chromium</strong> is involved in <strong>glucose metabolism,</strong> and <strong>selenium</strong> is a component of certain <strong>antioxidant enzymes</strong>. They <strong>do not</strong> have a direct role in the<strong> ETC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fluoride:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fluoride</strong> is known to <strong>inhibit </strong>certain enzymes but is <strong>not </strong>a component of the <strong>ETC.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex I NADH Coenzyme Q Oxidoreductase</strong>: Contain <strong>FMN and Fe-S (Iron- Sulfur) Complex</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Complex IV Cytochrome c Oxidase</strong>: Contain<strong> Cyt a and a3 </strong>(also known as <strong>Heme a a3</strong>) and has <strong>Copper A and Copper B</strong> <strong>centre.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 261.</span></strong></span></span></p>",
    "correct_choice_id": 25161,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6309,
    "choices": [
      {
        "id": 25205,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligomycin </span></span></span></p>"
      },
      {
        "id": 25206,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atractyloside </span></span></span></p>"
      },
      {
        "id": 25207,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotenone </span></span></span></p>"
      },
      {
        "id": 25208,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dinitrophenol </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Two farmers were applying a locally sourced pesticide to cotton crops when they began exhibiting severe symptoms, including intense breathing difficulties, high fever, and eventual unconsciousness. Given the agricultural practices, the pesticide is suspected to contain a compound that disrupts oxidative phosphorylation within the cells. Which of the following substances, known to interfere with oxidative phosphorylation, would most likely mimic the effects of the agent in the pesticide?</span></span></span></p>",
    "unique_key": "Q4934120",
    "question_audio": null,
    "question_video": null,
    "map_id": 29951,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Dinitrophenol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The key is the<strong> elevation in temperature. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Dinitrophenol</strong> is an <strong>uncoupler of oxidation and phosphorylation </strong>in that <strong>uncouplers destroy</strong> the <strong>proton gradient</strong> across the membrane (thereby<strong> inhibiting the synthesis of ATP</strong>) <strong>without blocking</strong> the transfer of <strong>electrons </strong>through the <strong>electrons</strong> <strong>transfer chain to oxygen. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>energy</strong> that should have been<strong> generated</strong> in the form of a <strong>proton gradient </strong>is<strong> lost as heat, </strong>which <strong>elevates </strong>the <strong>body</strong> <strong>temperature </strong>of the affected workers. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Electron flow </strong>is also<strong> enhanced</strong> in the<strong> presence of an uncoupler</strong>, so <strong>additional oxygen </strong>is required to allow the <strong>chain to</strong> <strong>continue</strong> (hence the<strong> heavy breathing</strong>). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>other agents</strong> added would have <strong>stopped electron transfer totally,</strong> which would<strong> not</strong> allow for an <strong>increase in</strong> <strong>temperature</strong> and would actually <strong>decrease the rate of breathing</strong> (Since <strong>oxygen is no longer </strong>required for the <strong>non-</strong>functioning<strong> electron transfer chain</strong>). </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Oligomycin </strong>works in a<strong> similar mechanism</strong> in that it <strong>blocks the ATP synthase,</strong> <strong>preventing ATP synthesis</strong> and due to <strong>coupling</strong> <strong>electron transfer</strong> through the<strong> chain.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Atractyloside</strong> <strong>inhibits the ATP/ADP </strong>exchanger and once there is<strong> no ADP </strong>in the <strong>mitochondrial matrix</strong>,<strong> electron</strong> flow will <strong>stop</strong> due to the <strong>inability to synthesize ATP</strong> (normal coupling).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Rotenone</strong> <strong>blocks complex I </strong>transfer to<strong> coenzyme Q</strong>, which significantly<strong> reduces electron flow </strong>and will <strong>not </strong>lead to an <strong>increase in temperature.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The impact of <strong>uncoupling agents </strong>like <strong>dinitrophenol </strong>on <strong>oxidative phosphorylation</strong>, particularly how they can lead to<strong> increased heat</strong> <strong>production </strong>and<strong> oxygen consumption</strong>, resulting in symptoms such as <strong>high fever, heavy breathing, and loss of consciousness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 266.</span></strong></span></span></p>",
    "correct_choice_id": 25208,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6270,
    "choices": [
      {
        "id": 25049,
        "text": "<p><span style=\"font-size:12pt;\">NADP</span></p>"
      },
      {
        "id": 25050,
        "text": "<p><span style=\"font-size:12pt;\">NAD</span></p>"
      },
      {
        "id": 25051,
        "text": "<p><span style=\"font-size:12pt;\">Coenzyme Q</span></p>"
      },
      {
        "id": 25052,
        "text": "<p><span style=\"font-size:12pt;\">FAD</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">The electron transport chain (ETC) plays a critical role in the final stages of energy production within mitochondria. This complex system involves a series of electron carriers that facilitate the transfer of electrons, culminating in ATP synthesis. Among the list below, which component is not involved in the mitochondrial electron transport chain?</span></p>",
    "unique_key": "Q8116187",
    "question_audio": null,
    "question_video": null,
    "map_id": 29978,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) NADP&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Image88667.PNG\" width=\"589\" height=\"344\"></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">NADP (Nicotinamide Adenine Dinucleotide Phosphate) is not a component of the mitochondrial electron transport chain. Instead, NADP is primarily involved in anabolic reactions, such as photosynthesis and the pentose phosphate pathway, where it acts as an electron acceptor, forming NADPH which is used in biosynthetic processes.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>: NAD (Nicotinamide Adenine Dinucleotide) is involved in the electron transport chain as it donates electrons to Complex I, initiating the chain of electron transfers.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>: Coenzyme Q, also known as ubiquinone, is a vital electron transporter within the ETC, shuttling electrons between Complex I and III, and from Complex II to III.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>: FAD (Flavin Adenine Dinucleotide) is another key component of the ETC, specifically within Complex II, where it accepts electrons from succinate, contributing to the electron transfer process.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">The main components of the ETC includes:</span></p><ul><li><span style=\"font-size:12.0pt;\">Complex I (NADH: ubiquinone oxidoreductase)</span></li><li><span style=\"font-size:12.0pt;\">Complex II (Succinate dehydrogenase)</span></li><li><span style=\"font-size:12.0pt;\">Coenzyme Q (Ubiquinone)</span></li><li><span style=\"font-size:12.0pt;\">Complex III (Cytochrome bc1 complex):&nbsp;</span></li><li><span style=\"font-size:12.0pt;\">Cytochrome C</span></li><li><span style=\"font-size:12.0pt;\">Complex IV (Cytochrome c oxidase)</span></li><li><span style=\"font-size:12.0pt;\">ATP Synthase (Complex V)</span></li></ul><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 262.&nbsp;</span></p>",
    "correct_choice_id": 25049,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6436,
    "choices": [
      {
        "id": 25713,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose from diet &gt; glycogenolysis &gt; gluconeogenesis</span></span></span></p>\r\n\r\n<p>&nbsp;</p>"
      },
      {
        "id": 25714,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose from diet &gt; gluconeogenesis &gt; glycogenolysis</span></span></span></p>"
      },
      {
        "id": 25715,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose from diet &gt; gluconeogenesis &gt; proteolysis)</span></span></span></p>"
      },
      {
        "id": 25716,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose from diet &gt; lipolysis &gt; gluconeogenesis </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During fasting, the body employs various mechanisms to maintain blood glucose levels. Which of the following sequences correctly represents the order in which these mechanisms are activated to ensure blood glucose homeostasis in the fasting state?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q5463642",
    "question_audio": null,
    "question_video": null,
    "map_id": 29918,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Glucose from diet &gt; glycogenolysis &gt; gluconeogenesis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>fasting state,</strong> after<strong> dietary glucose</strong> is <strong>depleted,</strong> the <strong>body first</strong> turns to <strong>glycogenolysis,</strong> the process of <strong>breaking down glycogen</strong> <strong>stored in the liver</strong> and<strong> muscle tissues into glucose</strong>, to maintain<strong> blood glucose levels</strong>. As<strong> fasting continues</strong> and<strong> glycogen stores</strong> become <strong>depleted</strong>, <strong>gluconeogenesis</strong>, the<strong> synthesis of glucose from non-carbohydrate substrates </strong>(such as lactate, glycerol, and amino acids), becomes the<strong> primary mechanism</strong> for maintaining<strong> blood glucose levels.</strong> This sequence ensures a <strong>continuous supply of glucose</strong> to<strong> vital organs</strong>, especially the<strong> brain</strong>, during periods of <strong>fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucose from diet &gt; gluconeogenesis &gt; glycogenolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This sequence is <strong>incorrect</strong> because<strong> glycogenolysis</strong> typically precede<strong>s gluconeogenesis </strong>in the<strong> fasting state</strong> as the <strong>body utilizes stored glycogen</strong> before <strong>synthesizing glucose</strong> from <strong>non-carbohydrate sources.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose from diet &gt; gluconeogenesis &gt; proteolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>proteolysis</strong> (the <strong>breakdown of proteins</strong>) does contribute substrates for <strong>gluconeogenesis</strong>, it is <strong>not</strong> a <strong>direct </strong>mechanism for maintaining <strong>blood glucose levels</strong> but rather provides<strong> amino acids</strong> that can be used in <strong>gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glucose from diet &gt; lipolysis &gt; gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Lipolysis,</strong> the breakdown of <strong>triglycerides into free fatty acids </strong>and <strong>glycerol</strong>, does provide<strong> substrates </strong>for<strong> gluconeogenesis (specifically glycerol),</strong> but it primarily serves as a <strong>mechanism</strong> for providing <strong>energy through fatty acid oxidation</strong> rather than <strong>directly </strong>contributing to maintaining<strong> blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During starvation: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liver </strong>produces <strong>glucose</strong> by <strong>glycogenolysis</strong> and later by <strong>gluconeogenesis </strong>so that the obligatory requirements of the <strong>brain</strong> are met.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liver</strong> also produces the<strong> ketone bodies</strong>, an <strong>alternate source of fuel. </strong>But the<strong> liver cannot </strong>use <strong>ketone bodies </strong>as its own <strong>fuel</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the<strong> fasting state</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2-2 1/2 hours</strong> &ndash;<strong> glucose</strong> from<strong> meals</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Next <strong>3 hour</strong>s &ndash; from<strong> glycogenolysis</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Later</strong> from<strong> gluconeogenesis </strong>(proteolysis &amp; lipolysis)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hyperglycemic</strong> hormones are <strong>secreted</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liver</strong> is the<strong> net</strong> producer of<strong> glucose in the fasting state</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: p 319-325.</span></span></span></strong></p>",
    "correct_choice_id": 25713,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6334,
    "choices": [
      {
        "id": 25305,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactate</span></span></span></p>"
      },
      {
        "id": 25306,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl CoA</span></span></span></p>"
      },
      {
        "id": 25307,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate</span></span></span></p>"
      },
      {
        "id": 25308,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alanine</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a clinical review session, a medical instructor is discussing the various substrates that contribute to the production of glucose through gluconeogenesis. One of the students asks which substrates can be used by the liver to synthesize glucose. The instructor provides a list but includes one substrate that does not contribute to the net synthesis of glucose in gluconeogenesis. Which of the following does not serve as a substrate for net glucose production in gluconeogenesis?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q3343385",
    "question_audio": null,
    "question_video": null,
    "map_id": 29926,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Acetyl CoA </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Acetyl CoA cannot</strong> contribute to the <strong>net synthesis of glucose in gluconeogenesis.</strong> While it is a <strong>critical molecule </strong>in metabolism that enters the<strong> citric acid cycle,</strong> it<strong> does not </strong>serve as a <strong>gluconeogenic substrate </strong>because<strong> two carbons</strong> are <strong>lost</strong> as<strong> CO2 in the cycle,</strong> which precludes the <strong>net generation of glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Lactate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Lactate can be <strong>converted to pyruvate</strong> by <strong>lactate dehydrogenase</strong> and then to <strong>glucose via gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pyruvate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pyruvate is a <strong>key gluconeogenic substrate</strong> that can be <strong>carboxylated to oxaloacetate</strong> and eventually <strong>converted to glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Alanine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Alanine</strong> can <strong>undergo transamination</strong> to form <strong>pyruvate, </strong>which can then <strong>enter the gluconeogenesis </strong>pathway to <strong>synthesize glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Substrates for Gluconeogenesis: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucogenic Amino Acid</strong> [Alanine is the major contributor]</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactate</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Propionyl CoA.</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p185, 186.</span></strong></span></span></p>",
    "correct_choice_id": 25306,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6333,
    "choices": [
      {
        "id": 25301,
        "text": "<p><span style=\"font-size:12.0pt;\">Level of fructose 1,6-biphosphate is lower than normal</span></p>"
      },
      {
        "id": 25302,
        "text": "<p><span style=\"font-size:12.0pt;\">Level of fructose 1,6-biphosphate is higher than normal</span></p>"
      },
      {
        "id": 25303,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased Glucose production</span></p>"
      },
      {
        "id": 25304,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased gluconeogenesis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 3-year-old child presents with hypoglycaemia and metabolic acidosis. Laboratory investigations reveal a genetic disorder that causes the liver enzyme fructose 1,6-bisphosphatase to be more sensitive to inhibition by fructose 2,6-bisphosphate. This enzyme is a crucial regulatory point in gluconeogenesis. Based on this enzymatic defect, which of the following metabolic changes would be expected in this child?</span></p>",
    "unique_key": "Q1618031",
    "question_audio": null,
    "question_video": null,
    "map_id": 29925,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Level of fructose 1,6-biphosphate is higher than normal</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The enzyme <strong>fructose 1,6-bisphosphatase</strong> plays a <strong>key regulatory role in gluconeogenesis.</strong></span></li><li><span style=\"font-size:12.0pt;\">It catalyzes the reaction:</span><br><span style=\"font-size:12.0pt;\"><strong>Fructose 1,6-bisphosphate \u2192 Fructose 6-phosphate + Pi.</strong></span></li><li><span style=\"font-size:12.0pt;\">This step is <strong>irreversible</strong> and crucial for glucose production in the liver, especially during fasting.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fructose 2,6-bisphosphate</strong> is a <strong>potent allosteric inhibitor</strong> of fructose 1,6-bisphosphatase and an <strong>activator of phosphofructokinase-1 (PFK-1),</strong> pushing metabolism toward <strong>glycolysis and away from gluconeogenesis.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In this case:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The child\u2019s <strong>fructose 1,6-bisphosphatase is overly sensitive to inhibition by fructose 2,6-bisphosphate.</strong></span></li><li><span style=\"font-size:12.0pt;\">This results in <strong>inhibited gluconeogenesis.</strong></span></li><li><span style=\"font-size:12.0pt;\">The blocked conversion of fructose 1,6-bisphosphate to fructose 6-phosphate causes a <strong>build-up of fructose 1,6-bisphosphate.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, you expect:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>\u2193 Glucose production (hypoglycemia),</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>\u2193 Gluconeogenesis,</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>\u2191 Fructose 1,6-bisphosphate (due to the block).</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Level of fructose 1,6-bisphosphate is lower than normal:</strong></span><br><span style=\"font-size:12.0pt;\">Incorrect. Inhibition of the enzyme leads to accumulation, <strong>not depletion,</strong> of fructose 1,6-bisphosphate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Increased glucose production:</strong></span><br><span style=\"font-size:12.0pt;\">Incorrect. Gluconeogenesis is impaired, so <strong>glucose production decreases.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Increased gluconeogenesis:</strong></span><br><span style=\"font-size:12.0pt;\">Incorrect. The mutation makes the enzyme <strong>more inhibited,</strong> so <strong>gluconeogenesis decreases.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Fructose 1,6-bisphosphatase</strong> is a <strong>key regulatory enzyme in gluconeogenesis</strong>, inhibited by <strong>fructose 2,6-bisphosphate</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Its inhibition results in <strong>accumulation of fructose 1,6-bisphosphate</strong> and impaired glucose production.</span></li><li><span style=\"font-size:12.0pt;\">This can cause <strong>fasting hypoglycemia</strong>, <strong>lactic acidosis</strong>, and <strong>failure to thrive</strong>, especially in early childhood.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p169-170.</span></p>",
    "correct_choice_id": 25302,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6365,
    "choices": [
      {
        "id": 25429,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate carboxylase</span></span></span></p>"
      },
      {
        "id": 25430,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphoenol pyruvate carboxykinase</span></span></span></p>"
      },
      {
        "id": 25431,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose-1-6-bisphosphatase</span></span></span></p>"
      },
      {
        "id": 25432,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All of the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identifying the enzymes crucial for gluconeogenesis is essential for understanding metabolic pathways that contribute to glucose homeostasis. Which of the following options lists the key enzymes responsible for this process?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q3831686",
    "question_audio": null,
    "question_video": null,
    "map_id": 29924,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All the above.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>All </strong>the listed <strong>enzymes</strong> are pivotal in the <strong>gluconeogenesis pathway.</strong> <strong>Pyruvate carboxylase </strong>catalyzes the conversion of <strong>pyruvate to</strong> <strong>oxaloacetate</strong> in the mitochondria, which is a crucial <strong>first step</strong>. <strong>Phosphoenolpyruvate carboxykinase</strong> (PEPCK) then converts <strong>oxaloacetate to phosphoenolpyruvate</strong>, continuing the <strong>gluconeogenic process. Fructose-1,6-bisphosphatase </strong>catalyzes the conversion of<strong> fructose-1,6-bisphosphate to fructose-6-phosphate,</strong> bypassing a key <strong>regulatory step</strong> of <strong>glycolysis </strong>and further <strong>advancing gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pyruvate carboxylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Initiates <strong>gluconeogenesis </strong>by converting <strong>pyruvate to oxaloacetate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Phosphoenolpyruvate carboxykinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Continues the pathway by <strong>converting oxaloacetate to phosphoenolpyruvate</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fructose-1,6-bisphosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Crucial for bypassing a key <strong>glycolytic step </strong>in the<strong> reverse direction</strong>, converting<strong> fructose-1,6-bisphosphate to fructose-6-phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Gluconeogenic Enzymes</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate carboxylase</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phosphoenol pyruvate carboxykinase</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose-1-6-bisphosphatase</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p187. </span></strong></span></span></p>",
    "correct_choice_id": 25432,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6156,
    "choices": [
      {
        "id": 24593,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carries amino group to the Liver</span></span></span></p>"
      },
      {
        "id": 24594,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alanine as a substrate for Gluconeogenesis during starvation</span></span></span></p>"
      },
      {
        "id": 24595,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both a and b</span></span></span></p>"
      },
      {
        "id": 24596,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only b</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a remote clinic, a physician is treating a mountaineer for fatigue and muscle weakness after a prolonged trek. To understand the patient&rsquo;s condition, the physician reviews metabolic processes that could be affected by long-term physical exertion and caloric deficit. Considering the body&#39;s adaptive mechanisms, which functions does the glucose-alanine cycle serve in this scenario?</span></span></span></p>",
    "unique_key": "Q3411513",
    "question_audio": null,
    "question_video": null,
    "map_id": 29920,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Both A and B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>glucose-alanine cycle</strong> is essential for <strong>transporting nitrogen</strong> in the form of <strong>amino groups </strong>to the <strong>liver </strong>and providing<strong> alanine</strong> as a <strong>substrate for gluconeogenesis</strong>. This <strong>cycle helps prevent muscle protein breakdown</strong> and supports <strong>glucose production</strong> during extended <strong>physical exertion</strong>, such as a<strong> long hike.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Carries amino group to the Liver:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>correct</strong> function of the <strong>glucose-alanine cycle </strong>but <strong>does not</strong> fully capture the <strong>cycle&#39;s roles</strong>. It transports <strong>nitrogen to the liver,</strong> where it can be <strong>safely removed</strong> from the <strong>body.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Alanine as a substrate for Gluconeogenesis during starvation: This</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is another <strong>correct</strong> function,<strong> highlighting the cycle&#39;s role</strong> in supporting <strong>glucose production</strong> from<strong> non-carbohydrate sources</strong> during periods of <strong>starvation or intense physical activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uses of glucose-alanine (Cahill) cycle</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carries amino group</strong> to the <strong>Liver.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alanine</strong> as a <strong>substrate</strong> for<strong> Gluconeogenesis</strong> during <strong>starvation.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Amino acid increased</strong> in blood during <strong>starvation is Alanine.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture22.jpg\" style=\"height:627px; width:500px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p:120.</span></strong></span></span></p>",
    "correct_choice_id": 24595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6351,
    "choices": [
      {
        "id": 25373,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 25374,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
      },
      {
        "id": 25375,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyruvate carboxylase</span></span></span></p>"
      },
      {
        "id": 25376,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose 1,6- Bisphosphatase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following enzymes is NOT directly involved in determining a cell&#39;s gluconeogenic capability?</span></span></span></p>",
    "unique_key": "Q8224131",
    "question_audio": null,
    "question_video": null,
    "map_id": 29922,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Pyruvate dehydrogenase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate dehydrogenase </strong>is an enzyme that<strong> catalyzes </strong>the conversion of<strong> pyruvate to acetyl-CoA, </strong>a key step in <strong>linking glycolysis </strong>with the <strong>citric acid cycle</strong>. This enzyme is <strong>not </strong>directly involved in <strong>gluconeogenesis</strong>, which is the process of <strong>synthesizing glucose</strong> from<strong> non-carbohydrate precursors</strong>. Instead,<strong> pyruvate dehydrogenase</strong> directs<strong> pyruvate</strong> towards <strong>energy production </strong>in the <strong>mitochondria </strong>and away from<strong> gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is crucial for the <strong>final step in gluconeogenesis,</strong> converting <strong>glucose-6-phosphate into</strong> <strong>free glucose,</strong> and is a determinant of a <strong>cell&#39;s ability to carry out gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Pyruvate carboxylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Pyruvate carboxylase <strong>catalyzes</strong> the conversion of <strong>pyruvate to oxaloacetate, </strong>an <strong>early step </strong>in <strong>gluconeogenesis</strong>, making it <strong>essential for this pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fructose 1,6-bisphosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme<strong> catalyzes</strong> a key step in <strong>gluconeogenesis </strong>by <strong>converting fructose 1,6-bisphosphate</strong> back to <strong>fructose 6-phosphate,</strong> bypassing the <strong>glycolytic enzyme phosphofructokinase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis</strong> is the process of <strong>synthesizing glucose or glycogen</strong> from <strong>non-carbohydrate precursors.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenic </strong>capacity is determined by the <strong>presence of key enzymes</strong> of <strong>Gluconeogenesis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pyruvate Dehydrogenase</strong> is<strong> not</strong> an enzyme of <strong>gluconeogenesis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p188, 189.</span></strong></span></span></p>",
    "correct_choice_id": 25373,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6349,
    "choices": [
      {
        "id": 25365,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluconeogenesis</span></span></span></p>"
      },
      {
        "id": 25366,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 25367,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogenesis</span></span></span></p>"
      },
      {
        "id": 25368,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogenolysis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a clinical rotation in endocrinology, a resident encounters a patient with a rare metabolic disorder that affects glucose production. Through discussions with the attending physician, the resident learns that the patient&#39;s condition involves a unique metabolic pathway that operates across two distinct cellular compartments, which is unusual compared to other pathways involved in glucose metabolism. Intrigued, the resident decides to research this further. Which metabolic pathway, relevant to the patient&#39;s condition, is known to occur across two different cellular compartments?</span></span></span></p>",
    "unique_key": "Q2719629",
    "question_audio": null,
    "question_video": null,
    "map_id": 29921,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Gluconeogenesis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis</strong> is a<strong> metabolic process </strong>through which <strong>glucose is synthesized </strong>from <strong>non-carbohydrate precursors.</strong> This pathway is <strong>unique </strong>because it spans<strong> two cellular compartments</strong>: the <strong>cytoplasm and the mitochondria. </strong>In the<strong> liver</strong>, which is a <strong>key site</strong> for <strong>gluconeogenesis</strong>, certain steps of this pathway occur<strong> within the mitochondria</strong>, such as the<strong> conversion of pyruvate to oxaloacetate,</strong> while other steps take place in the<strong> cytoplasm,</strong> culminating in the<strong> production of glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glycolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This process, the <strong>breakdown of glucose to pyruvate</strong>, occurs entirely <strong>within the cytoplasm </strong>and <strong>does not i</strong>nvolve multiple compartments.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glycogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glycogenesis,</strong> the process of<strong> glycogen synthesis</strong> from<strong> glucose,</strong> also occurs in the<strong> cytoplasm.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glycogenolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>breakdown of glycogen to glucose-1-phosphate </strong>(and eventually glucose) in<strong> glycogenolysis</strong> is another process confined to the <strong>cytoplasm.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis</strong> takes place in<strong> both cytosol and mitochondria</strong>. The<strong> Mitochondrial </strong>step is <strong>Pyruvate Carboxylase reaction.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathways taking place in two compartments are &ndash; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heme Synthesis</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urea Cycle</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluconeogenesis</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p188, 189</span></strong></span></span></p>",
    "correct_choice_id": 25365,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 6342,
    "choices": [
      {
        "id": 25337,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructokinase</span></span></span></p>"
      },
      {
        "id": 25338,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></span></p>"
      },
      {
        "id": 25339,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose 6 Phosphatase</span></span></span></p>"
      },
      {
        "id": 25340,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transketolase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A pediatrician evaluates a child presenting with recurrent episodes of hypoglycemia, particularly noted during fasting periods. Further investigation reveals that the child has a metabolic condition impairing both glycogenolysis and gluconeogenesis. Which enzyme deficiency is most likely responsible for these metabolic disturbances in the child?</span></span></span></p>",
    "unique_key": "Q3256563",
    "question_audio": null,
    "question_video": null,
    "map_id": 29919,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Glucose 6 Phosphatase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose 6-Phosphatase</strong> is a key enzyme in the<strong> final step of both glycogenolysis and gluconeogenesis</strong>, converting <strong>glucose 6-phosphate</strong> into <strong>free glucose</strong> for release into the<strong> bloodstream.</strong> A <strong>deficiency </strong>in this enzyme would <strong>impair the ability </strong>to maintain <strong>normal blood glucose</strong> levels by <strong>inhibiting</strong> the final steps of<strong> both pathways</strong>, leading to <strong>hypoglycemia,</strong> especially during periods of <strong>fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fructokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is involved in <strong>fructose metabolism.</strong> A<strong> deficiency </strong>would lead to <strong>fructosemia or fructosuria </strong>but <strong>not</strong> directly to<strong> impaired glycogenolysis or gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucokinase</strong> functions in the<strong> liver</strong> to p<strong>hosphorylate glucose to glucose 6-phosphate</strong>, initiating<strong> glycogen</strong> <strong>synthesis and glycolysis.</strong> A <strong>deficiency</strong> would affect <strong>glucose sensing and storage</strong> but is <strong>not directly </strong>involved in the final steps of <strong>glycogenolysis or gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Transketolase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is<strong> part of the pentose phosphate pathway, not</strong> directly involved in<strong> glycogenolysis or</strong> <strong>gluconeogenesis. </strong>Its <strong>deficiency</strong> would <strong>not</strong> lead to the described<strong> clinical presentation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose 6-phosphatase deficiency</strong> is a cause of <strong>impaired glycogenolysis and gluconeogenesis,</strong> leading to<strong> hypoglycemia</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p177.</span></strong></span></span></p>",
    "correct_choice_id": 25339,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6356,
    "choices": [
      {
        "id": 25393,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prevent hypoglycaemia during prolonged fasting</span></span></span></p>"
      },
      {
        "id": 25394,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occur in both muscle and liver</span></span></span></p>"
      },
      {
        "id": 25395,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excess of acetyl CoA stimulate it</span></span></span></p>"
      },
      {
        "id": 25396,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbon skeleton of amino acid is involved</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify which of the following statements about gluconeogenesis is incorrect: </span></span></span></p>",
    "unique_key": "Q8066863",
    "question_audio": null,
    "question_video": null,
    "map_id": 29923,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp; Occur in both muscle and liver</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis</strong> is a<strong> metabolic pathway </strong>that <strong>results</strong> in the generation of<strong> glucose</strong> from certain<strong> non-carbohydrate carbon substrates.</strong> While it <strong>predominantly</strong> occurs in the <strong>liver,</strong> it can also occur in the <strong>kidneys to a lesser extent,</strong> especially during prolonged<strong> fasting.</strong> However, it <strong>does not</strong> take place in <strong>muscle tissues </strong>because <strong>muscles lack </strong>the enzyme<strong> glucose-6-phosphatase,</strong> which is necessary for the<strong> final step</strong> of <strong>gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><strong>other options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It helps prevent hypoglycemia during prolonged fasting:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is<strong> true</strong>. <strong>Gluconeogenesis </strong>is crucial for maintaining <strong>blood glucose</strong> levels during<strong> fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It is stimulated by an excess of acetyl CoA:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> true</strong> to some extent. <strong>Acetyl CoA </strong>can <strong>activate pyruvate carboxylase</strong>, an enzyme involved in the<strong> first step of gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It involves the carbon skeletons of amino acids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> true</strong>. <strong>Amino acids</strong> can be<strong> deaminated </strong>and their <strong>carbon skeletons</strong> converted into <strong>gluconeogenic intermediates.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis</strong> occur in<strong> liver and kidney </strong>not in the muscle </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis</strong> <strong>prevents hypoglycaemia</strong> in<strong> prolonged fasting</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excess<strong> Acetyl CoA</strong> is an <strong>allosteric activator of Pyruvate Carboxylase,</strong> a key enzyme of<strong> Gluconeogenesis</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Carbon</strong> skeletons of <strong>gluconeogenic amino</strong> <strong>acids</strong> are involved in <strong>gluconeogenesis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p187</span></strong></span></span></p>",
    "correct_choice_id": 25394,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6415,
    "choices": [
      {
        "id": 25629,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It prevents lipolysis by inhibiting the activity of hormone sensitive lipase</span></span></span></p>"
      },
      {
        "id": 25630,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It stimulates glycogenolysis</span></span></span></p>"
      },
      {
        "id": 25631,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It increases proteins synthesis and prevents protein breakdown </span></span></span></p>"
      },
      {
        "id": 25632,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It decreases gluconeogenesis in cells</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding the metabolic effects of insulin, which of the following statements is INCORRECT?</span></span></span></p>",
    "unique_key": "Q6959425",
    "question_audio": null,
    "question_video": null,
    "map_id": 29930,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) It stimulates glycogenolysis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin </strong>is an <strong>anabolic hormone</strong> that promotes the <strong>storage of glucose, fatty acids, and amino acids</strong> in cells. Its actions are primarily directed towards<strong> lowering blood glucose levels</strong> and preventing the <strong>breakdown of stored energy.</strong> Specifically, <strong>insulin inhibits</strong> <strong>glycogenolysis</strong>, which is the<strong> breakdown of glycogen into glucose, not stimulates </strong>it. This is in line with <strong>insulin&#39;s overall</strong> role in <strong>reducing blood glucose levels</strong> by encouraging the <strong>storage of glucose </strong>in the form of <strong>glycogen in liver and muscle cells.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:16px\">other options:</span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. It prevents lipolysis by inhibiting the activity of hormone-sensitive lipase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>true</strong>. <strong>Insulin inhibits</strong> <strong>hormone-sensitive lipase</strong> in adipose tissue, thereby <strong>reducing the breakdown of triglycerides</strong> into<strong> free fatty acids and glycerol,</strong> which is known as<strong> lipolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. It increases protein synthesis and prevents protein breakdown:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>accurate</strong>.<strong> Insulin promotes</strong> the <strong>uptake of amino</strong> <strong>acids </strong>by <strong>cells </strong>and <strong>stimulates protein synthesis</strong> while<strong> inhibiting protein degradation</strong>, thus supporting <strong>anabolic processes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It decreases gluconeogenesis in cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>correct. Insulin</strong> <strong>inhibits gluconeogenesis</strong>, which is the generation of <strong>glucose from non-carbohydrate substrates,</strong> further contributing to the<strong> reduction of blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ol>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose Uptake</span></span></span></li>\r\n</ol>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin </strong>facilitates diffusion of<strong> glucose in muscle. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Transporter, <strong>GLUT-4 is insulin dependent</strong></span></span></span></li>\r\n</ul>\r\n\r\n<ol start=\"2\" style=\"list-style-type:decimal\">\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Utilization of Glucose</strong>: <strong>Glycolysis increased</strong> (key glycolytic enzymes: glucokinase, phosphofructokinase &amp; pyruvate kinase) </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Insulin</strong> favors<strong> storage of glucose:</strong> <strong>Glycogen synthesis increased</strong> (Glycogen synthase) (option B)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lipogenesis increased: Acetyl CoA Carboxylase and Glucose-6-Phosphate&nbsp;&nbsp; dehydrogenase</strong> (NADPH) activity is enhanced by insulin.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-lipolytic effect: Hormone sensitive lipase</strong> is <strong>decreased</strong> (option A).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Gluconeogenesis Decreased</strong> (Key gluconeogenic enzymes: Pyruvate carboxylase, Phosphoenolpyruvate carboxykinase, Fructose 1,6-bisphosphatase and Glucose 6-phosphatase are inhibited by insulin. (option D)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Anti-ketogenic Effect</strong>: <strong>HMG CoA synthase</strong> is <strong>decreased</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It<strong> increases proteins synthesis</strong> and<strong> prevents protein breakdown </strong></span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e p319-322.</span></strong></span></span></p>",
    "correct_choice_id": 25630,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6452,
    "choices": [
      {
        "id": 25777,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased skeletal muscle glucose uptake</span></span></span></p>"
      },
      {
        "id": 25778,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased adipose lipogenesis</span></span></span></p>"
      },
      {
        "id": 25779,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased adipose lipolysis</span></span></span></p>"
      },
      {
        "id": 25780,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased skeletal muscle Glycogenolysis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with an established diagnosis of diabetes mellitus reports to the clinic for a follow-up, presenting with symptoms of fatigue, weight loss, polyuria, and a burning sensation in the soles. Despite ongoing treatment, his blood glucose levels are significantly elevated. Among the following options, which is LEAST likely to contribute to the hyperglycemia seen in uncontrolled Type 1 diabetes?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q9168923",
    "question_audio": null,
    "question_video": null,
    "map_id": 29932,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Increased skeletal muscle Glycogenolysis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of<strong> uncontrolled Type 1 diabetes, </strong>the primary <strong>metabolic</strong> disturbances include<strong> decreased glucose uptake by skeletal</strong> <strong>muscles due to the lack of insulin,</strong> and <strong>increased lipolysis</strong> in adipose tissue, contributing to<strong> hyperglycemia</strong>. While <strong>increased</strong> <strong>glycogenolysis in the liver</strong> can contribute to <strong>hyperglycemia </strong>by releasing <strong>more glucose into the bloodstream</strong>, <strong>increased skeletal</strong> <strong>muscle glycogenolysis</strong> is <strong>less</strong> likely to contribute directly to <strong>hyperglycemia.</strong> This is because<strong> glucose </strong>produced from <strong>glycogen</strong> <strong>breakdown</strong> in <strong>skeletal muscles</strong> is generally used <strong>within the muscle</strong> itself and<strong> does not</strong> significantly contribute to the <strong>systemic</strong> <strong>glucose pool,</strong> especially in the context of<strong> insulin deficiency </strong>where<strong> glucose uptake</strong> by<strong> muscles</strong> is already<strong> impaired.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased skeletal muscle glucose uptake</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a significant contributor to <strong>hyperglycaemia in Type 1 diabetes</strong>, as <strong>insulin deficiency prevents glucose</strong> from<strong> entering cells,</strong> leading to <strong>elevated blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Decreased adipose lipogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>decreased formation of fat </strong>from glucose in adipose tissue could be observed in <strong>insulin deficiency,</strong> it&#39;s <strong>not</strong> a direct contributor to<strong> elevated glucose levels. Insulin </strong>promotes <strong>lipogenesis</strong>, so <strong>its deficiency</strong> would <strong>decrease </strong>this process, but this <strong>decrease does not </strong>directly cause <strong>hyperglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increased adipose lipolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Increased breakdown of fat </strong>in the <strong>absence of insulin</strong> action <strong>elevates free fatty acid levels,</strong> which can<strong> exacerbate insulin resistance </strong>and contribute to<strong> higher blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Skeletal muscle cannot </strong>export<strong> glucose</strong> into the circulation like <strong>liver</strong> due to <strong>absence</strong> of enzyme <strong>glucose-6-phosphatase. </strong>So, <strong>intramyocellular glycogen </strong>acts as a<strong> fuel source for skeletal muscle</strong> and <strong>doesn&rsquo;t </strong>contribute to the <strong>hyperglycaemia</strong> in <strong>uncontrolled</strong> <strong>type I diabetes. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasons of<strong> hyperglycemia </strong>associated with<strong> uncontrolled type I diabetes:</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There will be <strong>decreased insulin mediated glucose</strong> utilization by <strong>skeletal muscle and adipose tissues </strong>&rarr; will contribute to <strong>hyperglycaemia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There will also be<strong> decreased insulin-mediated suppression </strong>of <strong>hepatic glucose output. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased insulin-mediated suppression of lipolysis</strong> &rarr; <strong>hyperglycaemia</strong>, by<strong> activation of gluconeogenesis</strong> by<strong> fatty acid breakdown product acetyl CoA</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 149, DM Vasudevan, 9/e: p 323-326.</span></strong></span></span></p>",
    "correct_choice_id": 25780,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6407,
    "choices": [
      {
        "id": 25597,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased lipolysis</span></span></span></p>"
      },
      {
        "id": 25598,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased protein catabolism </span></span></span></p>"
      },
      {
        "id": 25599,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased hepatic Glucose output</span></span></span></p>"
      },
      {
        "id": 25600,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase glucose uptake</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 39-year-old female presents with weight loss, fatigue, nocturia, and excessive thirst. Laboratory findings reveal fasting blood sugar (FBS) &gt;140 mg/dl and postprandial blood sugar (PPBS) &gt;250 mg/dl, leading to a probable diagnosis of Type 1 diabetes mellitus. Considering the pathophysiology of Type 1 diabetes mellitus, which of the following statements is TRUE?</span></span></span></p>",
    "unique_key": "Q5085657",
    "question_audio": null,
    "question_video": null,
    "map_id": 29928,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Increased lipolysis&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> poorly controlled type 1 diabetes mellitus</strong>, the patient is<strong> hyperglycemic</strong>, due to l<strong>ack of insulin to stimulate uptake </strong>and <strong>utilization of glucose </strong>and<strong> no insulin </strong>to antagonize the actions of glucagon, there is <strong>increased gluconeogenesis </strong>from <strong>amino acids </strong>in the liver.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lack of insulin </strong>to <strong>antagonize the actions of glucagon </strong>results in <strong>increased lipolysis </strong>in adipose tissue, and the resultant <strong>NEFAs </strong>are<strong> substrates for ketogenesis </strong>in the<strong> liver. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Utilization</strong> of the <strong>ketone bodies</strong> in <strong>muscle (and other tissues) </strong>may be <strong>impaired </strong>because of the <strong>lack of oxaloacetate </strong>&rarr;&nbsp; <strong>Diabetic ketoacidosis </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Coma </strong>results from <strong>acidosis and increased osmolality </strong>of extracellular fluid </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Decreased protein catabolism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Insulin </strong>is an <strong>anabolic hormone</strong>, it promotes <strong>protein synthesis </strong>and <strong>its degradation </strong>is <strong>retarded</strong>. So, in <strong>its deficiency </strong>the effect is<strong> reversed</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Decreased hepatic Glucose output:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In<strong> muscles</strong>, the <strong>glucose transporter GLUT4 </strong>is <strong>decreased, </strong>but in <strong>liver the glucose uptake </strong>is by <strong>GLUT2 </strong>which is <strong>independent of insulin</strong>. In <strong>absence of insulin Glycolysis is inhibited, Gluconeogenesis is favoured </strong>and G<strong>lycogen synthesis and storage </strong>is <strong>not favoured. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; Increase glucose uptake:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Due to <strong>lack of insulin</strong>, <strong>no stimulation of uptake </strong>and <strong>utilization of glucose</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type 1 diabetes mellitus </strong>is characterized by an <strong>autoimmune destruction of pancreatic &beta;-cells</strong>, leading to <strong>absolute insulin deficiency</strong>. <strong>Insulin </strong>normally <strong>inhibits lipolysis</strong>, so its <strong>deficiency in Type 1 diabetes </strong>results in <strong>increased lipolysis in adipose tissue</strong>. This leads to <strong>elevated levels </strong>of <strong>free fatty acids </strong>in the bloodstream, which can contribute to the production of<strong> ketone bodies in the liver, </strong>a <strong>common complication </strong>in <strong>uncontrolled diabetes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 149 </span></strong></span></span></p>",
    "correct_choice_id": 25597,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6406,
    "choices": [
      {
        "id": 25593,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased protein synthesis</span></p>"
      },
      {
        "id": 25594,
        "text": "<p><span style=\"font-size:12.0pt;\">Glycogenesis in muscle</span></p>"
      },
      {
        "id": 25595,
        "text": "<p><span style=\"font-size:12.0pt;\">Increased conversion of fatty acid to Acetyl CoA</span></p>"
      },
      {
        "id": 25596,
        "text": "<p><span style=\"font-size:12.0pt;\">Decreased triglyceride level</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 45-year-old male with Type 1 diabetes mellitus presents with a blood glucose level greater than 300 mg/dl. In the context of his elevated blood glucose, which of the following metabolic processes continues to occur normally in this patient?</span></p>",
    "unique_key": "Q1579571",
    "question_audio": null,
    "question_video": null,
    "map_id": 29927,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Increased conversion of fatty acid to Acetyl CoA</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">In Type 1 diabetes mellitus with significantly elevated blood glucose (&gt;300 mg/dl), insulin deficiency leads to dramatic metabolic alterations. Without insulin, glucose uptake by peripheral tissues is impaired, leading to hyperglycemia. Simultaneously, the body shifts to alternative fuel sources:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Increased fatty acid mobilization from adipose tissue occurs in insulin deficiency. These fatty acids undergo \u03b2-oxidation in the liver, resulting in increased conversion to Acetyl CoA.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The excess Acetyl CoA cannot enter the TCA cycle efficiently due to low oxaloacetate availability (diverted to gluconeogenesis), and instead is shunted toward ketogenesis, producing ketone bodies (acetoacetate, \u03b2-hydroxybutyrate, and acetone). This leads to diabetic ketoacidosis in uncontrolled Type 1 diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Increased protein synthesis</strong>: Insulin promotes protein synthesis and inhibits protein breakdown. In Type 1 diabetes with insulin deficiency, protein synthesis decreases while proteolysis increases, providing amino acids for gluconeogenesis. This contributes to the catabolic state and muscle wasting seen in poorly controlled diabetes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glycogenesis in muscle</strong>: This process requires both insulin and adequate glucose transport into muscle cells via GLUT4 transporters. Insulin deficiency impairs GLUT4 translocation to the cell membrane, reducing glucose uptake and subsequent glycogen synthesis in muscle tissue.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased triglyceride level</strong> - This is incorrect. In Type 1 diabetes with insulin deficiency, triglyceride levels are not decreased but are typically increased due to impaired clearance of triglyceride-rich lipoproteins due to decreased lipoprotein lipase activity (an insulin-dependent enzyme) This often leads to hypertriglyceridemia, not decreased triglyceride levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In uncontrolled Type 1 diabetes with hyperglycemia, insulin deficiency creates a catabolic state where fat mobilization and fatty acid oxidation are accelerated, leading to increased Acetyl CoA production and ketogenesis. This represents a shift from glucose to fat metabolism. Meanwhile, anabolic processes like protein synthesis and glycogenesis are impaired, highlighting the crucial role of insulin in regulating metabolic pathways.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e:&nbsp; p 149, Lippincott: P 340&nbsp;</span></p>",
    "correct_choice_id": 25595,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6419,
    "choices": [
      {
        "id": 25645,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Has sudden onset of symptoms which is relieved after taking insulin </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> </span></span></span></p>"
      },
      {
        "id": 25646,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma glucagon level is lower than normal individuals during early disease process</span></span></span></p>"
      },
      {
        "id": 25647,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plasma insulin level is lower than normal individuals during the early disease process</span></span></span></p>"
      },
      {
        "id": 25648,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If body weight is reduced, then improvement in glucose tolerance is observed.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old obese male presents with fatigue, increased appetite, thirst, and polyuria, with a negative Rothera&#39;s test. He is diagnosed with type 2 diabetes. Regarding the characteristics of type 2 diabetes, which of the following statements is TRUE?</span></span></span></p>",
    "unique_key": "Q2974621",
    "question_audio": null,
    "question_video": null,
    "map_id": 29931,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) If body weight is reduced, then improvement in glucose tolerance is observed.&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Type 2 diabetes mellitus</strong> patients have <strong>impaired glucose tolerance. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is also called as<strong> non-insulin-dependent diabetes (NIDDM)</strong> because of <strong>impaired sensitivity or resistance </strong>of tissues to the<strong> insulin action.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of the patients appear <strong>obese</strong> and show<strong> good improvement in blood glucose (</strong>glucose tolerance) with significant <strong>weight reduction.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Has sudden onset of symptoms which is relieved after taking insulin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Gradual onset of Symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Plasma glucagon level is lower than normal individuals during early disease process:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glucagon levels are normal.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plasma insulin level is lower than normal individuals during the early disease process:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> elevated insulin levels are observed in patients and requires insulin late in the disease. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Weight reduction</strong> through <strong>lifestyle changes</strong> can significantly<strong> improve metabolic</strong> control in individuals with <strong>type 2 diabetes</strong> by <strong>enhancing insulin sensitivity </strong>and <strong>reducing insulin resistance,</strong> underscoring the importance of<strong> non-pharmacological interventions</strong> in the management of the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 185, 192-194.</span></strong></span></span></p>",
    "correct_choice_id": 25648,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6158,
    "choices": [
      {
        "id": 24601,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibition of PFK-II</span></span></span></p>"
      },
      {
        "id": 24602,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of Fructose 2,6 Bisphosphatase</span></span></span></p>"
      },
      {
        "id": 24603,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in glucagon</span></span></span></p>"
      },
      {
        "id": 24604,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increase in Fructose 2,6 Bisphosphate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During a marathon, an endurance athlete experiences a significant drop in blood glucose levels, triggering a series of metabolic adjustments. A sports medicine specialist explaining these changes to the athlete highlights how the body responds to maintain energy balance. Which of the following responses to decreased blood glucose levels is incorrect?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q2698138",
    "question_audio": null,
    "question_video": null,
    "map_id": 29929,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Increase in Fructose 2, 6 Bisphosphate</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When <strong>blood glucose levels decrease,</strong> the body <strong>does not</strong> <strong>increase</strong> <strong>fructose 2,6-bisphosphate levels.</strong> Instead, <strong>fructose 2,6-bisphosphate levels</strong> would <strong>decrease </strong>due to the activation of <strong>fructose 2,6-bisphosphatase</strong> and<strong> inhibition of PFK-II. </strong>This adjustment <strong>reduces glycolytic flux</strong> and <strong>promotes gluconeogenesis</strong>, helping to<strong> raise blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation</span></u></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Inhibition of PFK-II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>correct</strong> response to <strong>low blood glucose levels</strong>, leading to <strong>decreased fructose 2,6-bisphosphate</strong> production and <strong>reduced glycolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Activation of Fructose 2,6 Bisphosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This also accurately <strong>reflects</strong> the body&#39;s response to<strong> low blood glucose,</strong> promoting th<strong>e lowering of fructose 2,6-bisphosphate levels </strong>and encouraging<strong> gluconeogenesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increase in glucagon:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glucagon levels increase in <strong>response</strong> to <strong>low blood glucose</strong> to <strong>stimulate gluconeogenesis </strong>and <strong>glycogenolysis</strong>, <strong>raising blood glucose levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increase Blood Glucose Level</strong>:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Inhibition of Glycolysis</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By phosphorylating the key enzymes of Glycolysis (option a)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;By decreasing the level of Fructose 2, 6 Bisphosphate, the product of PFK-II </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Favour Gluconeogenesis</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By phosphorylating Key enzymes of Gluconeogenesis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">By favouring Fructose 2, 6 Bisphosphatase, which decreases the level of Fructose 2, 6 Bisphosphate, a potent activator of PFK-I.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p191</span></strong></span></span></p>",
    "correct_choice_id": 24604,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 9324,
    "choices": [
      {
        "id": 37263,
        "text": "<p><span style=\"font-size:12.0pt;\">Cystathionine synthase&nbsp;&nbsp;&nbsp;</span></p>"
      },
      {
        "id": 37264,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypoxanthine-guanine phosphoribosyl transferase&nbsp;&nbsp;&nbsp;</span></p>"
      },
      {
        "id": 37265,
        "text": "<p><span style=\"font-size:12.0pt;\">Homogentisic acid oxidase</span></p>"
      },
      {
        "id": 37266,
        "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase A&nbsp;</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 4-year-old boy with developmental delay and a behavioral history of self-injurious actions, including tongue biting and finger biting to the point of needing bandages, is brought to a pediatric neurologist. Based on the clinical presentation, which enzyme deficiency is most likely responsible for this condition?</span></p>",
    "unique_key": "Q1639108",
    "question_audio": null,
    "question_video": null,
    "map_id": 29779,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Hypoxanthine-guanine phosphoribosyl transferase.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The <strong>combination of retardation </strong>and <strong>self-mutilation</strong> helps in arriving at the diagnosis of <strong>Lesch-Nyhan disease.&nbsp;</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Hypoxanthine-guanine phosphoribosyl transferase (HGPRT) is part of the purine salvage pathway and its deficiency results in the inability to recycle purines \ud83e\udc6a overproduction of uric acid.&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>C/F-</strong> Mentally retarded, hyperuricemia, gout and engage in compulsive self-destructive behaviors.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Cystathionine synthase</strong>: Deficiency results in <strong>homocystinuria,</strong> characterized by <strong>elevated urinary homocysteine.</strong> C/F- failure to thrive and visual problems due to lens displacement.&nbsp; Also deficiency of methionine synthase, pyridoxine, folate, or vitamin B12 can cause homocystinuria.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Homogentisic acid oxidase:</strong> Deficiency results in <strong>alkaptonuria.</strong> C/F- dark urine and darkening of connective tissue (e.g., ear cartilage may appear bluish).</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Hexosaminidase A:</strong> Deficiency causes <strong>Tay-Sachs disease</strong> \ud83e\udc6a results in the accumulation of GM2 ganglioside. C/F-mental retardation, blindness with cherry-red spot on the macula and muscular weakness.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Lesch-Nyhan syndrome</strong>, a disorder caused by a<strong> deficiency </strong>in the <strong>enzyme hypoxanthine-guanine phosphoribosyl transferase </strong>(HPRT), and its deficiency leads to the <strong>overproduction of uric acid </strong>and a <strong>host of neurological </strong>and <strong>behavioral abnormalities</strong>, including <strong>self-mutilation behaviors.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Lippincott 7/e: P 296-297.</strong></span></p>",
    "correct_choice_id": 37264,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9315,
    "choices": [
      {
        "id": 37227,
        "text": "<p><span style=\"font-size:12.0pt;\">PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis</span></p>"
      },
      {
        "id": 37228,
        "text": "<p><span style=\"font-size:12.0pt;\">Sodium urate crystals can deposit in kidneys and impair renal function</span></p>"
      },
      {
        "id": 37229,
        "text": "<p><span style=\"font-size:12.0pt;\">Uric acid overproduction is seen in myeloproliferative disorders like leukemia</span></p>"
      },
      {
        "id": 37230,
        "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol used in treatment as it inhibits xanthine oxidase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female presents to the orthopedic outpatient department with joint swelling and pain, as depicted in the image. The physical examination reveals swollen, erythematous joints with tenderness. Laboratory tests show elevated serum uric acid levels. She is diagnosed with gout. Which of the following statements regarding her condition is incorrect?</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/1_MMDSPFz.jpg\" alt=\"\" width=\"255\" height=\"179\"></span></p>",
    "unique_key": "Q1654629",
    "question_audio": null,
    "question_video": null,
    "map_id": 29771,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. PRPP synthetase decreased activity can contribute to gout by increasing purine synthesis \u2013 Incorrect (Correct Answer)</strong></span><br><span style=\"font-size:12.0pt;\">This is <strong>incorrect</strong> because <strong>decreased activity</strong> of PRPP synthetase <strong>reduces</strong> purine synthesis. In contrast, <strong>increased (not decreased) activity</strong> of PRPP synthetase leads to <strong>enhanced purine synthesis</strong> and overproduction of uric acid, contributing to <strong>gout.</strong> Therefore, the statement is wrong.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option B. Sodium urate crystals can deposit in kidneys and impair renal function \u2013&nbsp; True</strong></span><br><span style=\"font-size:12.0pt;\">In <strong>chronic gout</strong>, urate crystals can deposit in the renal parenchyma and tubules, leading to <strong>urate nephropathy</strong> and potential <strong>renal failure.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Uric acid overproduction is seen in myeloproliferative disorders like leukemia \u2013 True</strong></span><br><span style=\"font-size:12.0pt;\"><strong>Leukemias and other myeloproliferative disorders</strong> involve rapid cell turnover and breakdown of nucleic acids, leading to <strong>hyperuricemia</strong> and secondary gout.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Allopurinol used in treatment as it inhibits xanthine oxidase \u2013 True</strong></span><br><span style=\"font-size:12.0pt;\"><strong>Allopurinol</strong> is a <strong>inhibitor</strong> of xanthine oxidase, reducing the conversion of hypoxanthine and xanthine to uric acid, making it effective for long-term management of gout.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Understand that <strong>gout</strong> can result from overactivity of <strong>PRPP synthetase</strong>, leading to <strong>increased de novo purine synthesis</strong> and elevated uric acid production. Treatments like <strong>allopurinol</strong> target <strong>xanthine oxidase</strong> to reduce uric acid synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30 /e: p 354.</span></p>",
    "correct_choice_id": 37227,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased"
    ]
  },
  {
    "id": 9317,
    "choices": [
      {
        "id": 37235,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Glucose 1-phosphate</span></span></span></p>"
      },
      {
        "id": 37236,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fructose 1,6-bisphosphate</span></span></span></p>"
      },
      {
        "id": 37237,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Uridine diphosphate </span></span></span></p>"
      },
      {
        "id": 37238,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cytosine diphosphate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old male presents to the clinic with the laboratory findings of reducing substances in his urine that are not glucose, signs of liver disease, and decreased liver glycogen observed in a liver biopsy. To identify the underlying cause of his symptoms, which of the following metabolite concentrations should be measured?</span></span></p>",
    "unique_key": "Q1590096",
    "question_audio": null,
    "question_video": null,
    "map_id": 29772,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C. Uridine diphosphate </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>UDP-glucose </strong>is the <strong>activated form of glucose </strong>utilized for the <strong>synthesis of glycogen </strong>and <strong>Galactose</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is <strong>formed from the reaction </strong>of <strong>glucose1-phosphate </strong>and <strong>UTP</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>conversion of galactose </strong>to <strong>glucose </strong>is at the <strong>UDP-sugar level</strong>, which is deficient in galactosemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>UDP derivatives </strong>of <strong>glucose</strong>, <strong>galactose </strong>and <strong>sugar amines </strong>are key precursors for<strong> synthesis of cerebrosides </strong>and <strong>gangliosides</strong>. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A</span></strong><span style=\"font-size:12.0pt\">. <strong>Glucose 1-phosphate </strong>and <strong>Option B</strong>. <strong>Fructose 1,6-bisphosphate</strong>: The <strong>glucose or fructose phosphates regulates glycogen </strong>stores but will not prevent synthesis of glycogen or block galactose metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Cytosine diphosphate</strong>: It is important for the <strong>synthesis of phospholipids</strong>, thus <strong>forming high-energy CDP diacylglycerol </strong>which <strong>transfers diacylglycerol </strong>to <strong>form phosphatidylinositol&rsquo;s </strong>(signal transducers) and <strong>cardiolipin </strong>(seen in mitochondrial membrane and develops antibodies in autoimmune disorders)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>presence of non-glucose reducing substances </strong>in <strong>urine </strong>and <strong>reduced liver glycogen</strong>, with <strong>elevated UDP-sugars</strong>, indicates a <strong>glycogen storage disease </strong>like <strong>GSD Type Ia</strong>. Diagnosing involves measuring UDP concentrations to reveal a block in the metabolic pathway involving glucose-6-phosphatase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30 /e: p 116,177,201, 571.</span></strong></span></span></p>",
    "correct_choice_id": 37237,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 9318,
    "choices": [
      {
        "id": 37239,
        "text": "<p><span style=\"font-size:12.0pt;\">9</span></p>"
      },
      {
        "id": 37240,
        "text": "<p><span style=\"font-size:12.0pt;\">7</span></p>"
      },
      {
        "id": 37241,
        "text": "<p>4</p>"
      },
      {
        "id": 37242,
        "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A research team is evaluating the effects of azaserine, a drug known to inhibit glutamine-dependent enzymes, on nucleotide synthesis. In considering the drug's impact on purine biosynthesis, Nitrogen atom at which position in the generic purine structure is Contributed by Glutamine?</span></p>",
    "unique_key": "Q6714458",
    "question_audio": null,
    "question_video": null,
    "map_id": 29773,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. 9</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Purine biosynthesis involves building the purine ring step by step on a ribose-5-phosphate backbone. Various atoms of the purine ring come from different precursors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Glutamine provides nitrogen atoms via its amide nitrogen (-NH2) in the purine biosynthesis pathway.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>In purine biosynthesis:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-14%20165313.png\" width=\"747\" height=\"396\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, glutamine donates nitrogen at:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">N3</span></li><li><span style=\"font-size:12.0pt;\">N9</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the context of your question (specifically asking for \u201cthe nitrogen contributed by glutamine\u201d), position 9 is one of the key sites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 7:&nbsp;</strong>N7 comes from glycine, not glutamine. Glycine contributes two carbons and one nitrogen (C4, C5, N7).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 4:&nbsp;</strong>C4 comes from glycine as well. Glycine contributes to the entire C4-C5-N7 chain.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 1:&nbsp;</strong>N1 comes from aspartate, not glutamine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Purine biosynthesis is a multi-step process that builds the purine ring atom by atom using various precursors:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Glutamine\u2019s amide nitrogen provides N3 and N9.</span></li><li><span style=\"font-size:12.0pt;\">Glycine donates C4, C5, and N7.</span></li><li><span style=\"font-size:12.0pt;\">Aspartate provides N1.</span></li><li><span style=\"font-size:12.0pt;\">Formyl-THF (N10-formyl-tetrahydrofolate) donates C2 and C8.</span></li><li><span style=\"font-size:12.0pt;\">CO2 (bicarbonate) supplies C6.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Inhibition of glutamine-dependent enzymes (like by azaserine) disrupts steps that require glutamine as an amide donor, blocking Nitrogen incorporation and thus halting purine biosynthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Harper 30/e p 348-349.</span></p>",
    "correct_choice_id": 37239,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9320,
    "choices": [
      {
        "id": 37247,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased temperature </span></span></span></p>"
      },
      {
        "id": 37248,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decreased blood flow</span></span></span></p>"
      },
      {
        "id": 37249,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exposure to sunlight</span></span></span></p>"
      },
      {
        "id": 37250,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased blood flow</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male with a history of chronic alcohol abuse presents to the clinic with pain and swelling in the joints of his hands, as shown in the picture. The condition is characterized by the formation and deposition of sodium urate crystals in peripheral joints. Which of the following factors is known to contribute to the formation of these urate crystals?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/4_8KN4vL5.jpg\" style=\"height:209px; width:280px\" /></span></span></span></p>",
    "unique_key": "Q4722488",
    "question_audio": null,
    "question_video": null,
    "map_id": 29776,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Decreased temperature</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Hyperuricemia</strong> (gout) is a clinical condition characterized by <strong>elevated levels of uric acid</strong> that <strong>lead to the formation </strong>of <strong>sodium urate crystals.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Uric acid</strong> has a <strong>pKa of 5.4 </strong>and is <strong>ionized</strong> in the <strong>body to form urate,</strong> which is not very soluble in an aqueous environment and the quantity of urate in human blood is also very close to the solubility range. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">So, any <strong>situations </strong>which <strong>leads to excessive degradation of purine </strong>bases can <strong>increase the urate concentration </strong>past the solubility point &rarr; formation of urate crystals. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>decreased body temperature </strong>seen in the <strong>joints contributes</strong> to the <strong>formation of urate crystals</strong> under these conditions.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong><span style=\"font-size:12.0pt\"> <strong>Decreased blood flow:</strong> While <strong>decreased blood flow </strong>might theoretically <strong>lead to increased concentration</strong> of <strong>uric acid,</strong> it is not typically cited as a direct contributor to crystal formation. Gout flares are not commonly associated with decreased blood flow.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Exposure to sunlight</strong>: <strong>Sunlight exposure</strong> does <strong>not affect the solubility of uric acid</strong> and is not a recognized factor in the formation of urate crystals.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Increased blood flow: </strong>Increased blood flow would generally <strong>improve the elimination of uric acid</strong> through the <strong>kidneys </strong>and is not associated with the <strong>formation of urate crystals</strong>. However, increased blood flow can lead to the inflammatory response seen with gout flares once the crystals have formed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Decreased temperature</strong> can <strong>lead to urate crystal formation in peripheral joints </strong>is important for understanding why <strong>gout</strong> commonly <strong>affects the cooler distal joints </strong>and how <strong>acute attacks</strong> may be <strong>precipitated by changes in temperature.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30/esp. 354, Lippincott 7/ed: p 301.</span></strong></span></span></p>",
    "correct_choice_id": 37247,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9325,
    "choices": [
      {
        "id": 37267,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Competitive inhibitor of xanthine oxidase &amp; decrease UA formation</span></span></span></p>"
      },
      {
        "id": 37268,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increase renal excretion of urate</span></span></span></p>"
      },
      {
        "id": 37269,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Reduce body uric acid pool</span></span></span></p>"
      },
      {
        "id": 37270,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arrest the arthritis</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old male presents with sudden onset of severe pain in his right big toe, extending up to the knee, which began in the morning. The pain developed after a night of alcohol consumption. On examination, the affected big toe is swollen, tender, and warm. Laboratory tests reveal a serum uric acid level of 9.6 mg/dl. After being prescribed allopurinol by the physician, the patient&#39;s symptoms improved within three days. What is the mechanism of action of allopurinol in the treatment of hyperuricemia?</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/6_xcRX0L4.jpg\" style=\"height:165px; width:244px\" /></span></span></span></p>",
    "unique_key": "Q1877002",
    "question_audio": null,
    "question_video": null,
    "map_id": 29780,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Competitive inhibitor of xanthine oxidase &amp; decrease UA formation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient is diagnosed to have <strong>Gout.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Allopurinol</strong> is a <strong>competitive inhibitor of xanthine oxidase </strong>&rarr; <strong>decreases the formation of uric acid.</strong> Xanthine and hypoxanthine are more soluble and are easily excreted.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Xanthine oxidase </strong>converts <strong>allopurinol to alloxanthin,</strong> which is a more effective inhibitor of xanthine oxidase. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is a good example of <strong>&lsquo;suicide inhibition&#39;.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B</span></strong><span style=\"font-size:12.0pt\">. <strong>Increase the renal excretion of urate by decreasing the reabsorption of urate from kidney tubules:</strong> Action of <strong>uricosuric drugs. </strong>e.g., probenecid.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Reduce body uric acid pool</strong>: done by <strong>PEG</strong> (polyethylene glycol) <strong>uricase </strong>and <strong>conversion of urate to allantoin</strong> (more water soluble and easily excreted).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Arrest the arthritis:</strong> Action of <strong>Colchicine</strong>, an <strong>anti-inflammatory agent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Allopurinol </strong>is a <strong>structural analog of hypoxanthine.</strong> It acts as a <strong>competitive inhibitor </strong>of <strong>xanthine oxidase</strong>, an <strong>enzyme</strong> responsible for <strong>converting hypoxanthine</strong> to <strong>xanthine</strong> and <strong>xanthine to uric acid</strong>. By <strong>inhibiting this enzyme</strong>, <strong>allopurinol reduces </strong>the <strong>production</strong> of <strong>uric acid,</strong> thereby <strong>treating hyperuricemia</strong> which is often associated with gout.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 30/e:&nbsp; p 344.</span></strong></span></span></p>",
    "correct_choice_id": 37267,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9330,
    "choices": [
      {
        "id": 37287,
        "text": "<p><span style=\"font-size:12.0pt;\">5-Methyl thymidine</span></p>"
      },
      {
        "id": 37288,
        "text": "<p><span style=\"font-size:12.0pt;\">Ara C</span></p>"
      },
      {
        "id": 37289,
        "text": "<p><span style=\"font-size:12.0pt;\">Phosphoribosylamine</span></p>"
      },
      {
        "id": 37290,
        "text": "<p><span style=\"font-size:12.0pt;\">5-Phosphoribosylpyrophosphate (PRPP)</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In the complex biochemical pathway of purine biosynthesis, certain substrates are crucial for the synthesis of the purine nucleotides. Among the following options, which compound is a necessary substrate for the initiation and progression of purine biosynthesis?</span></p>",
    "unique_key": "Q6326233",
    "question_audio": null,
    "question_video": null,
    "map_id": 29782,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. 5-Phosphoribosylpyrophosphate (PRPP)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Purine biosynthesis starts with the formation of PRPP (5-Phosphoribosyl-1-pyrophosphate), a key activated ribose sugar donor.</span></p><p><span style=\"font-size:12.0pt;\">PRPP + Glutamine \u2192 5-Phosphoribosylamine (the <i>first committed step</i> in purine biosynthesis).</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">PRPP is synthesized from ribose-5-phosphate by the enzyme PRPP synthetase.</span></li><li><span style=\"font-size:12.0pt;\">It serves as the foundation onto which the purine ring is built step-by-step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thus, PRPP is essential at both initiation and progression stages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 5</strong>-Methyl thymidine:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This is a nucleoside derivative of thymine (used in DNA), not involved in purine biosynthesis (purines = adenine &amp; guanine).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ara C (Cytarabine):</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This is a chemotherapy drug, a cytidine analog used to inhibit DNA synthesis\u2014not a substrate for purine biosynthesis.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Phosphoribosylamine:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">This compound is an intermediate (formed <i>after</i> PRPP reacts with glutamine).</span></li><li><span style=\"font-size:12.0pt;\">It's not a substrate to initiate purine biosynthesis, but a product of the first committed step.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Purine biosynthesis requires PRPP as a substrate.</span></li><li><span style=\"font-size:12.0pt;\">The first committed step is catalyzed by glutamine-PRPP amidotransferase, converting PRPP \u2192 phosphoribosylamine.</span></li><li><span style=\"font-size:12.0pt;\">This sets the stage for ring assembly to eventually produce IMP (inosine monophosphate), the precursor of AMP &amp; GMP.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: DM Vasudevan 9/e: p 583.</span></p>",
    "correct_choice_id": 37290,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "InvestigationBased"
    ]
  },
  {
    "id": 9333,
    "choices": [
      {
        "id": 37299,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenosine 5&rsquo; monophosphate (AMP)</span></span></span></p>"
      },
      {
        "id": 37300,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inosine 5&rsquo; monophosphate (IMP)</span></span></span></p>"
      },
      {
        "id": 37301,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Xanthine 5&rsquo; monophosphate (XMP)</span></span></span></p>"
      },
      {
        "id": 37302,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Guanosine 5&rsquo; monophosphate (GMP)</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which one of the nucleotide is first formed by the de novo purine biosynthesis:&nbsp;</span></span></p>",
    "unique_key": "Q7115971",
    "question_audio": null,
    "question_video": null,
    "map_id": 29783,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Inosine 5&rsquo; monophospahte (IMP)</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>regulatory enzymes</strong> of <strong>Purine Synthesis </strong>are <strong>PRPP Synthase</strong> and <strong>PRPP Glutamyl Amido transferase</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>rate limiting step</strong> of <strong>de novo Purine Synthesis</strong> is <strong>PRPP Glutamyl amidotransferase</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>PRPP level </strong>determines the <strong>de novo purine synthesis,</strong> which activates PRPP Synthase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>rate of PRPP Synthesis</strong> depends on the <strong>availability of ribose 5 Phosphate</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">AMP, ADP, GMP and GDP the end products of de novo Purine synthesis feedback regulate PRPP Synthase and PRPP Glutamyl Amidotransferase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>First Nucleotide </strong>formed in <strong>Purine Synthesis-Inosine Mono Phosphate</strong> (IMP)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/10_jBCykse.jpg\" style=\"height:412px; width:602px\" /></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Adenosine 5&rsquo; monophosphate </strong>(AMP): AMP is <strong>synthesized from IMP</strong> and not directly formed during the initial steps of de novo purine biosynthesis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Xanthine 5&rsquo; monophosphate</strong> (XMP): XMP is an <strong>intermediate in the pathway of purine metabolism</strong> but not the first nucleotide formed in the de novo synthesis of purines.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Guanosine 5&rsquo; monophosphate</strong> (GMP): Like AMP, <strong>GMP</strong> is <strong>derived from IMP </strong>and is not the initial product of the de novo purine biosynthesis pathway.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><span style=\"font-size:12.0pt\">:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Inosine 5&rsquo; monophosphate</strong> (IMP) is the <strong>first nucleotide</strong> produced in the <strong>de novo purine biosynthesis pathway.</strong> This <strong>pathway builds</strong> the <strong>purine ring molecule</strong> by <strong>molecule onto the ribose sugar.</strong> Once <strong>IMP is synthesized,</strong> it can then be further <strong>converted into other purine nucleotides,</strong> such as <strong>adenosine 5&rsquo; monophosphate</strong> (AMP) and <strong>guanosine 5&rsquo; monophosphate </strong>(GMP), through a series of specific enzymatic reactions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 7/e: p 583.</span></span></strong></p>",
    "correct_choice_id": 37300,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 9319,
    "choices": [
      {
        "id": 37243,
        "text": "<p><span style=\"font-size:12.0pt;\">Amide nitrogen of glutamine</span></p>"
      },
      {
        "id": 37244,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspartate</span></p>"
      },
      {
        "id": 37245,
        "text": "<p><span style=\"font-size:12.0pt;\">Glycine</span></p>"
      },
      {
        "id": 37246,
        "text": "<p><span style=\"font-size:12.0pt;\">N10 formyl THFA</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following correctly identifies the nitrogen sources for N3 &amp; N9 positions in Purine Ring?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/2_w4k7Xi6.jpg\" alt=\"\" width=\"400\" height=\"252\"></span></p>",
    "unique_key": "Q4008488",
    "question_audio": null,
    "question_video": null,
    "map_id": 29775,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. A. Amide nitrogen of glutamine</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>CONTRIBUTORS OF PURINE RING:&nbsp;</strong>&nbsp;&nbsp;&nbsp;</span></p><p style=\"text-align:justify;\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></p><p style=\"text-align:justify;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/3_6AxmNES.jpg\" alt=\"\" width=\"500\" height=\"318\"></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong> <strong>Aspartate </strong>\u2013 contributes N1 of PURINE ring.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Glycine </strong>- contributes N7 of PURINE ring.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>N10 formyl THFA</strong>- contributes C8 of PURINE ring.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">In the <strong>biosynthesis of purines</strong>, the <strong>nitrogen atoms at positions N3 </strong>and <strong>N9 originate</strong> from the <strong>amide nitrogen of glutamine.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Harper 30/e: p 347-348.</strong></span></p>",
    "correct_choice_id": 37243,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 6459,
    "choices": [
      {
        "id": 25805,
        "text": "<p><span style=\"font-size:12pt;\">Glycogen storage disease type I&nbsp;</span></p>"
      },
      {
        "id": 25806,
        "text": "<p><span style=\"font-size:12pt;\">Hereditary Fructose intolerance</span></p>"
      },
      {
        "id": 25807,
        "text": "<p><span style=\"font-size:12pt;\">Both a and b</span></p>"
      },
      {
        "id": 25808,
        "text": "<p><span style=\"font-size:12pt;\">Only b</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In the context of infantile conditions, hypoglycemia is observed in which of the following?</span></p>",
    "unique_key": "Q9109924",
    "question_audio": null,
    "question_video": null,
    "map_id": 29769,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Both a and b</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Both <strong>Glycogen Storage Disease Type I (GSD I)</strong> and <strong>Hereditary Fructose Intolerance (HFI)</strong> can lead to <strong>hypoglycemia</strong>, particularly in infants.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A:&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Glycogen Storage Disease Type I (Von Gierke Disease)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Caused by a <strong>deficiency of glucose-6-phosphatase</strong>.</span></li><li><span style=\"font-size:12.0pt;\">This enzyme is crucial for the <strong>final step of gluconeogenesis and glycogenolysis</strong>, converting glucose-6-phosphate to free glucose.</span></li><li><span style=\"font-size:12.0pt;\">Without it, the liver cannot release glucose into the bloodstream \u2192 <strong>severe fasting hypoglycemia</strong>, typically noticed shortly after birth.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Hereditary Fructose Intolerance (HFI)</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Caused by a <strong>deficiency of aldolase B</strong>.</span></li><li><span style=\"font-size:12.0pt;\">When <strong>fructose, sucrose, or sorbitol</strong> is introduced (e.g., via formula or weaning), <strong>fructose-1-phosphate accumulates</strong>, which:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Traps phosphate</span></li><li><span style=\"font-size:12.0pt;\">Inhibits <strong>glycogenolysis</strong></span></li></ul></li><li><span style=\"font-size:12.0pt;\">Leads to <strong>hypoglycemia</strong> and other symptoms like <strong>vomiting</strong>, <strong>hepatomegaly</strong>, and <strong>failure to thrive</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note</strong>: HFI typically manifests <strong>after exposure to fructose-containing foods</strong>, so it may not present <strong>immediately after birth</strong>, but it is a <strong>cause of hypoglycemia in infants</strong>, especially during weaning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Be aware of <strong>metabolic disorders</strong> that can cause <strong>hypoglycemia in neonates or infants</strong>, particularly:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Glycogen Storage Disease Type I (Von Gierke)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Hereditary Fructose Intolerance (HFI)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Galactosemia</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD)</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Long-Chain Acyl-CoA Dehydrogenase Deficiency (LCAD)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/e: 138.</span></p>",
    "correct_choice_id": 25807,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6412,
    "choices": [
      {
        "id": 25617,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arginase</span></span></span></p>"
      },
      {
        "id": 25618,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid synthase</span></span></span></p>"
      },
      {
        "id": 25619,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen synthase</span></span></span></p>"
      },
      {
        "id": 25620,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hormone sensitive lipase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old male presents with symptoms of excessive thirst, increased appetite, tiredness, and a thin build. He has been advised to undergo fasting blood sugar (FBS) and postprandial blood sugar (PPBS) tests and is currently 12 hours into his fast. During this period of fasting, which one of the following enzymes is likely to be phosphorylated and active?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q8738806",
    "question_audio": null,
    "question_video": null,
    "map_id": 29768,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Hormone sensitive lipase&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hormone sensitive lipase of adipocytes </strong>are <strong>phosphorylated </strong>and activated by <strong>protein kinase A </strong>in response to <strong>epinephrine</strong>.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Arginase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Arginase </strong>is an enzyme involved in the <strong>urea cycle</strong>, which converts <strong>arginine into urea and ornithine</strong>. Its activity is <strong>not </strong>directly influenced by <strong>fasting or feeding states</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fatty acid synthase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fatty acid synthase </strong>is involved in the <strong>synthesis of fatty acids</strong>, a process that is<strong> downregulated </strong>during fasting when the <strong>body is mobilizing</strong>, <strong>rather than storing, energy.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glycogen synthase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glycogen synthase is responsible for <strong>glycogen synthesis in the liver and muscle cells</strong>. This enzyme is <strong>less active </strong>during<strong> fasting</strong>, as the body is <strong>breaking down glycogen stores, not</strong> building them.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hormone-sensitive lipase (HSL)</strong> is an enzyme in <strong>adipose tissue </strong>that breaks down <strong>stored triglycerides into free fatty acids </strong>and <strong>glycerol</strong>, which can then be used for<strong> energy</strong>. HSL is <strong>activated </strong>by <strong>phosphorylation </strong>in response to <strong>low insulin and high glucagon levels</strong>, which are <strong>typical during fasting</strong>. Thus, in a <strong>fasting state</strong>, <strong>HSL</strong> would be <strong>phosphorylated and active </strong>to facilitate the <strong>mobilization of fat stores</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p 261-263</span></strong></span></span></p>",
    "correct_choice_id": 25620,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6015,
    "choices": [
      {
        "id": 24030,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as fructose</span></span></span></p>"
      },
      {
        "id": 24031,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as glyceraldehyde-3-phosphate</span></span></span></p>"
      },
      {
        "id": 24032,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enters HMP shunt via ribulose-5-phosphate</span></span></span></p>"
      },
      {
        "id": 24033,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as glycogen</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman, following a meal rich in carbohydrates, undergoes various metabolic adjustments to manage the influx of glucose. One of these adjustments involves the metabolism of glucose-6-phosphate, a key metabolite in glucose homeostasis. Considering the fed state, where glucose is abundant, what is the primary fate of glucose-6-phosphate in tissues? </span></span></span></p>",
    "unique_key": "Q2583261",
    "question_audio": null,
    "question_video": null,
    "map_id": 29787,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D)&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Storage as glycogen</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the <strong>fed state</strong>, the <strong>major fate of glucose-6-phosphate </strong>in <strong>tissues is its conversion </strong>and <strong>storage as glycogen</strong>. This <strong>process </strong>is essential for <strong>maintaining blood glucose levels </strong>within a <strong>narrow range</strong>, especially during <strong>periods of fasting</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Storage as fructose </strong>is <strong>not </strong>a <strong>primary pathway for glucose-6-phosphate metabolism </strong>in tissues during the fed state.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glyceraldehyde-3-phosphate </strong>is an <strong>intermediate in glycolysis</strong>, but the <strong>direct storage of glucose-6-phosphate</strong> as glyceraldehyde-3-phosphate is not a primary fate in the fed state.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>glucose-6-phosphate </strong>can <strong>enter the Hexose Monophosphate </strong>(HMP) <strong>shunt</strong>, this <strong>pathway is primarily active </strong>in <strong>specific tissues </strong>like the <strong>liver</strong>, and its main function is not for storage but for producing NADPH and ribose-5-phosphate for biosynthetic reactions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>uptake of glucose </strong>into the <strong>liver GLUT 2 </strong>is <strong>independent of insulin</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the well fed state &rarr; concentration of glucose entering the liver increases &rarr; increased rate of synthesis of glucose-6-phosphate.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is in excess of the liver&rsquo;s requirement for energy-yielding metabolism. So, it is used mainly for synthesis of glycogen.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In <strong>both liver</strong> and <strong>skeletal muscle,</strong> <strong>insulin acts </strong>to <strong>stimulate glycogen synthase</strong> and <strong>inhibit glycogen phosphorylase</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Harper 30/e: p148.</span></strong></span></span></p>",
    "correct_choice_id": 24033,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6378,
    "choices": [
      {
        "id": 25481,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver</span></span></span></p>"
      },
      {
        "id": 25482,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle</span></span></span></p>"
      },
      {
        "id": 25483,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Both</span></span></span></p>"
      },
      {
        "id": 25484,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following tissues is INCAPABLE of contributing directly to blood glucose levels through glycogen breakdown?</span></span></span></p>",
    "unique_key": "Q5373118",
    "question_audio": null,
    "question_video": null,
    "map_id": 29777,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Muscle</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle tissue </strong>stores <strong>glycogen</strong> for its own<strong> use </strong>and <strong>lacks</strong> the enzyme<strong> glucose-6-phosphatase, </strong>which is required to <strong>convert glucose-6-phosphate into free glucose</strong> that can be <strong>released </strong>into the <strong>bloodstream. </strong>Therefore, <strong>glycogen breakdown in muscle </strong>leads to <strong>glucose</strong>-<strong>6-phosphate </strong>being used primarily within the <strong>muscle cells themselves </strong>for <strong>energy,</strong> particularly during <strong>exercise, </strong>rather than contributing to <strong>systemic blood glucose levels</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Liver:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The liver is capable of contributing <strong>directly to blood glucose levels </strong>through <strong>glycogen breakdown. </strong>It contains the enzyme <strong>glucose-6-phosphatase, </strong>which allows for the conversion of<strong> glucose-6-phosphate into free glucose </strong>that can be released into the <strong>bloodstream, </strong>thereby maintaining <strong>blood glucose levels</strong>, especially during<strong> fasting</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Both:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is<strong> incorrect</strong> because the<strong> liver</strong> can directly contribute to <strong>blood glucose levels </strong>through <strong>glycogen</strong> <strong>breakdown</strong>, while <strong>muscle cannot.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Differences between Liver Glycogen and Muscle Glycogen.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture13.jpg\" style=\"height:270px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Muscle glycogen </strong>is<strong> not</strong> directly available as a <strong>source of blood glucose</strong> because muscle <strong>lacks glucose-6-phosphatase</strong> which releases <strong>free glucose from glucose 6-P.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p177, 178.</span></strong></span></span></p>",
    "correct_choice_id": 25482,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 6375,
    "choices": [
      {
        "id": 25469,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Only active during gluconeogenesis</span></span></p>"
      },
      {
        "id": 25470,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Requires Protein Kinase activation</span></span></p>"
      },
      {
        "id": 25471,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enzyme located in the endoplasmic reticulum</span></span></p>"
      },
      {
        "id": 25472,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibited by albumin in the cytoplasm</span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 7-year-old child with frequent hypoglycemic episodes during fasting is being evaluated. Laboratory findings indicate normal glycogen structure but impaired glycogenolysis. Given the critical role of Glucose-6-Phosphatase in this process, why isn&#39;t Glucose-6-Phosphate immediately converted to glucose in hepatocytes?</span></span></span></p>",
    "unique_key": "Q3858190",
    "question_audio": null,
    "question_video": null,
    "map_id": 29774,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Enzyme located in the endoplasmic reticulum</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-Phosphatase,</strong> which catalyzes the <strong>final step in glycogenolysis and gluconeogenesis </strong>by converting <strong>Glucose-6-Phosphate</strong> into <strong>glucose,</strong> is located in the <strong>endoplasmic reticulum (ER) of hepatocytes</strong>. This necessitates the transport of <strong>Glucose-6-Phosphate</strong> from the<strong> cytoplasm to the ER</strong>, a process mediated by <strong>specific translocases</strong>, before it can be <strong>dephosphorylated.</strong> This <strong>spatial</strong> <strong>separation </strong>serves as a<strong> regulatory </strong>mechanism to control <strong>glucose</strong> release into the <strong>bloodstream.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Only active during gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is<strong> incorrect</strong> because <strong>Glucose-6-Phosphatase</strong> is <strong>active</strong> during <strong>both</strong> <strong>gluconeogenesis and glycogenolysis</strong>, <strong>not</strong> exclusively during<strong> gluconeogenesis</strong>. Its activity is crucial for <strong>maintaining blood glucose</strong> <strong>levels</strong>, especially during<strong> fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Requires Protein Kinase activation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucose-6-Phosphatase</strong> activity is <strong>not </strong>directly regulated by <strong>protein kinases</strong>. The regulation of this enzyme is primarily through<strong> substrate availability</strong> and its <strong>subcellular localization,</strong> rather than through <strong>activation by</strong> <strong>phosphorylation</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inhibited by albumin in the cytoplasm:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> There is <strong>no</strong> direct interaction between <strong>albumin and Glucose-6-Phosphatase</strong> that would <strong>inhibit </strong>its <strong>activity.</strong> <strong>Albumin,</strong> a <strong>serum protein</strong> produced by the<strong> liver,</strong> primarily functions in maintaining <strong>oncotic pressure</strong> and <strong>transporting substances</strong>; it<strong> does not</strong> play a regulatory role in<strong> glycogenolysis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphatase</strong> is in the lumen of the<strong> smooth endoplasmic reticulum</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphate </strong>is transported to<strong> SER </strong>by a transporter known as <strong>translocase</strong> to be acted by <strong>Glucose- 6-phosphatase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Genetic defects </strong>of the <strong>Glucose-6-phosphate transporter</strong> can result in a variant of <strong>type I glycogen storage disease.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p178.</span></strong></span></span></p>",
    "correct_choice_id": 25471,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6380,
    "choices": [
      {
        "id": 25489,
        "text": "<p>9</p>"
      },
      {
        "id": 25490,
        "text": "<p>18</p>"
      },
      {
        "id": 25491,
        "text": "<p>24</p>"
      },
      {
        "id": 25492,
        "text": "<p>48</p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Approximately how many hours does it take for liver glycogen stores to become significantly depleted in an average adult under normal physiological conditions?</span></span></span></p>",
    "unique_key": "Q3730575",
    "question_audio": null,
    "question_video": null,
    "map_id": 29778,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) 18 hours</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Under <strong>normal physiological conditions</strong>,<strong> liver glycogen stores </strong>can sustain <strong>blood glucose levels </strong>for about<strong> 18 hours of fasting. </strong>After this period, the <strong>body increasingly</strong> relies on <strong>gluconeogenesis </strong>and the<strong> breakdown of fats for energy</strong>, marking a<strong> transition in the body&#39;s</strong> primary <strong>energy </strong>sources to maintain <strong>metabolic functions </strong>during <strong>prolonged fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Liver and Muscle Glycogen</strong> are generally<strong> exhausted </strong>by <strong>18 hours of fasting.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p149.</span></strong></span></span></p>",
    "correct_choice_id": 25490,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6395,
    "choices": [
      {
        "id": 25549,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acetyl-CoA carboxylase</span></span></span></p>"
      },
      {
        "id": 25550,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate dehydrogenase</span></span></span></p>"
      },
      {
        "id": 25551,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen phosphorylase</span></span></span></p>"
      },
      {
        "id": 25552,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogen synthase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old medical student, immersed in the demanding schedule of clinical rotations, often finds himself skipping lunch and dinner. To sustain his energy levels and cognitive function during these prolonged periods without food, his body must mobilize glucose from liver stores. Which enzyme plays a pivotal role in this process by facilitating the release of glucose from glycogen stored in the liver?</span></span></span></p>",
    "unique_key": "Q8246076",
    "question_audio": null,
    "question_video": null,
    "map_id": 29785,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Glycogen phosphorylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen phosphorylase</strong> is the key enzyme involved in <strong>glycogenolysis, </strong>the process of breaking down<strong> glycogen into glucose-1-phosphate,</strong> which is then converted to<strong> glucose-6-phosphate</strong>. This can be further processed to release <strong>free glucose</strong> into the <strong>bloodstream,</strong> particularly from the<strong> liver,</strong> thereby <strong>maintaining blood glucose </strong>levels during<strong> fasting states</strong> or <strong>periods of high energy</strong> <strong>demand. </strong>This enzyme is thus crucial for providing the necessary<strong> glucose to the body, </strong>especially when<strong> dietary intake </strong>is<strong> insufficient </strong>or <strong>delayed, </strong>as in the scenario described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Acetyl-CoA carboxylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is involved in<strong> fatty acid synthesis</strong>, <strong>not</strong> in the mobilization or <strong>release</strong> of <strong>glucose from</strong> <strong>glycogen stores.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucose-6-phosphate dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is part of the <strong>pentose phosphate pathway</strong> and is involved in producing <strong>NADPH</strong> and<strong> ribose-5-phosphate</strong>, <strong>rather than</strong> in the direct mobilization of <strong>glucose from stored glycogen.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glycogen synthase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This enzyme is responsible for the <strong>synthesis of glycogen from glucose</strong>, the <strong>opposite</strong> process to what is needed in this scenario, where the goal is to <strong>mobilize glucose from glycogen stores.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen </strong>is the <strong>storage form</strong> of<strong> glucose</strong>, which is an easily mobilizable <strong>fuel store</strong>. When individuals are <strong>deprived of or reduced</strong> intake of <strong>carbohydrate</strong>s, the body responds by <strong>breaking down glycogen stores </strong>in the<strong> liver</strong> in order to maintain <strong>normal blood glucose levels</strong>. The<strong> two main enzymes</strong> involved in the<strong> degradation and synthesis </strong>of </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">glycogen are glycogen phosphorylase (option c) and glycogen synthase (option d),</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> respectively.&nbsp; </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The processes of <strong>glycogen synthesis and degradation</strong> are coordinated by a <strong>hormone-triggered cascade </strong>that ensures that when one <strong>enzyme is active,</strong> the<strong> other enzyme is inactive.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 177-180.</span></strong></span></span></p>",
    "correct_choice_id": 25551,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6392,
    "choices": [
      {
        "id": 25537,
        "text": "<p><span style=\"font-size:12.0pt;\">Serum glucose levels</span></p>"
      },
      {
        "id": 25538,
        "text": "<p><span style=\"font-size:12.0pt;\">Insulin levels</span></p>"
      },
      {
        "id": 25539,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucagon Level</span></p>"
      },
      {
        "id": 25540,
        "text": "<p><span style=\"font-size:12.0pt;\">Dietary Riboflavin levels</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 1-year-old child is brought to the outpatient department by their parents due to concerns of muscle hypotonia, failure to thrive, and an enlarged abdomen. Laboratory tests reveal hypoglycemia and ultrasonography shows hepatomegaly. Following a comprehensive evaluation, the child is diagnosed with a type of glycogen storage disease (GSD). In the context of GSD, the glycogen content in the liver is not influenced by which of the following?</span></p>",
    "unique_key": "Q9209799",
    "question_audio": null,
    "question_video": null,
    "map_id": 29784,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans: D. Dietary Riboflavin levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Dietary riboflavin (vitamin B2) levels do not directly influence glycogen content in the liver in the context of glycogen storage diseases (GSDs).</span></p><p><span style=\"font-size:12.0pt;\">Riboflavin serves as a precursor for flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD), which function as cofactors for various oxidation-reduction enzymes. While riboflavin is essential for many metabolic processes, it does not play a direct regulatory role in glycogen synthesis or breakdown in the liver.</span></p><p><span style=\"font-size:12.0pt;\">Glycogen storage diseases are inherited metabolic disorders caused by enzyme deficiencies in glycogen synthesis, breakdown, or regulation pathways. The clinical presentation described in the question (muscle hypotonia, failure to thrive, enlarged abdomen, hypoglycemia, and hepatomegaly) is consistent with several types of GSD.</span></p><p><span style=\"font-size:12.0pt;\">The regulation of hepatic glycogen content primarily depends on hormonal and metabolic factors that directly control glycogen synthesis (glycogenesis) and breakdown (glycogenolysis).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Serum glucose levels</strong> - This is incorrect as a choice for factors that do NOT influence glycogen content.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Serum glucose levels directly affect hepatic glycogen metabolism. High blood glucose promotes glycogen synthesis through activation of glycogen synthase, while low blood glucose levels trigger glycogen breakdown to maintain normoglycemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Insulin levels</strong> - This is incorrect as a choice for factors that do NOT influence glycogen content. Insulin is a key hormone that promotes glycogen synthesis in the liver by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Activating glycogen synthase (via dephosphorylation)</span></li><li><span style=\"font-size:12.0pt;\">Inhibiting glycogen phosphorylase</span></li><li><span style=\"font-size:12.0pt;\">Increasing glucose uptake and its phosphorylation to glucose-6-phosphate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glucagon Level</strong> - This is incorrect as a choice for factors that do NOT influence glycogen content. Glucagon has effects opposite to insulin on hepatic glycogen. It promotes glycogenolysis (glycogen breakdown) by:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Activating glycogen phosphorylase via a cAMP-dependent protein kinase cascade</span></li><li><span style=\"font-size:12.0pt;\">Inhibiting glycogen synthase</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In glycogen storage diseases, liver glycogen content is regulated primarily by glucose levels, insulin, Glucagon and factors affecting these parameters (like dietary amino acids).&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture12.jpg\" alt=\"\" width=\"1000\" height=\"236\"></span></p>",
    "correct_choice_id": 25540,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6410,
    "choices": [
      {
        "id": 25609,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proglucagon is synthesized in &alpha; cells of islets of Langerhans</span></span></span></p>"
      },
      {
        "id": 25610,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a straight polypeptide chain with 29 amino acids</span></span></span></p>"
      },
      {
        "id": 25611,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stimulates glycogen synthesis.</span></span></span></p>"
      },
      {
        "id": 25612,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It activates the enzyme glycogen phosphorylase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about glucagon is INCORRECT?</span></span></span></p>",
    "unique_key": "Q6735042",
    "question_audio": null,
    "question_video": null,
    "map_id": 29767,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stimulates glycogen synthesis.&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is a <strong>polypeptide hormone</strong> with <strong>29 amino acids.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is secreted by the<strong> alpha cells of pancreas</strong> as proglucagon precursor.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>t&frac12;: 5 minutes</strong> and<strong> inactivated in the liver.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An<strong> increase in blood glucose level </strong>inhibits secretion of glucagon.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mainly<strong> glycogenolytic </strong>&rarr; active form of <strong>glycogen phosphorylase</strong> is formed under the <strong>influence of glucagon.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Depresses glycogen synthesis</span></span></span></strong></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Calibri, sans-serif\"><span style=\"font-size:16px\"><strong><u>other options :</u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Proglucagon is synthesized in &alpha; cells of the islets of Langerhans:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is <strong>correct</strong>. <strong>Proglucagon</strong> is indeed <strong>synthesized </strong>in the <strong>&alpha; cells, </strong>and through <strong>post-translational</strong> modifications, <strong>glucagon is produced.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. It is a straight polypeptide chain with 29 amino acids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is also <strong>correct</strong>.<strong> Glucagon</strong> is a <strong>peptide hormone</strong> composed of <strong>29 amino acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. It activates the enzyme glycogen phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>true</strong>. <strong>Glucagon</strong> activates <strong>glycogen phosphorylase</strong>, an enzyme involved in <strong>glycogenolysis,</strong> thereby <strong>promoting</strong> the <strong>breakdown of glycogen</strong> into<strong> glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucagon</strong>, a hormone produced by the <strong>&alpha; cells</strong> of the<strong> islets of Langerhans</strong> in the <strong>pancreas,</strong> plays a crucial role in <strong>glucose metabolism.</strong> Its primary function is to<strong> raise blood glucose levels</strong> by<strong> promoting glycogenolysis </strong>(the breakdown of glycogen to glucose) and <strong>gluconeogenesis</strong> (the synthesis of glucose from non-carbohydrate sources). Therefore, the statement that <strong>glucagon stimulates glycogen synthesis</strong> is <strong>incorrect</strong>, as it actually <strong>promotes glycogen breakdown.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 322</span></strong></span></span></p>",
    "correct_choice_id": 25611,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 7646,
    "choices": [
      {
        "id": 30552,
        "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TRUE</span></span></span></p>"
      },
      {
        "id": 30553,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FALSE</span></span></span></p>"
      },
      {
        "id": 30554,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the Above</span></span></span></p>"
      },
      {
        "id": 30555,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not sure</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycogenin is often discussed in the context of glycogen synthesis, but there is a common misconception about its nature. Considering the biochemical role of glycogenin, is it accurate to classify it as a polysaccharide?</span></span></span></p>",
    "unique_key": "Q1891766",
    "question_audio": null,
    "question_video": null,
    "map_id": 29770,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) FALSE</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin</strong> is <strong>not a polysaccharide</strong>; it is actually a <strong>protein that serves as a primer for glycogen synthesis</strong>. <strong>Glycogenin</strong> <strong>autocatalytically </strong>attaches <strong>glucose molecules to itself,</strong> starting the <strong>glycogen synthesis process</strong>, which is then <strong>extended by glycogen synthase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin is a 37 kDa protein (POLYPEPTIDE).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin catalyses</strong> transfer of <strong>7 glucosyl residues from UDPGlucose,</strong> in alpha 1 &rarr; 4 linkage. Thus, glucosyl residues are added on specific tyrosine residues of Glycogenin.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogenin </strong>remains at the <strong>core of the Glycogen granule</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Harper 30/e p177.</span></strong></span></span></p>",
    "correct_choice_id": 30553,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9345,
    "choices": [
      {
        "id": 37347,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6 mercaptopurine</span></span></span></p>"
      },
      {
        "id": 37348,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Actinomycin D</span></span></span></p>"
      },
      {
        "id": 37349,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Puromycin </span></span></span></p>"
      },
      {
        "id": 37350,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the management of certain leukemias, a specific drug is utilized for its ability to interfere with the synthesis of nucleic acids, crucial for the proliferation of rapidly dividing cells. This drug achieves its therapeutic effect by inhibiting a key pathway in purine metabolism, indirectly affecting DNA replication. Which of the following medications is being described?</span></span></span></p>",
    "unique_key": "Q9254961",
    "question_audio": null,
    "question_video": null,
    "map_id": 29766,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>6 mercaptopurine</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>6-Mercaptopurine</strong> is an <strong>antimetabolite</strong> that <strong>interferes with purine nucleotide synthesis</strong> and <strong>metabolism,</strong> leading to the <strong>inhibition of DNA and RNA synthesis</strong>. This effect is particularly <strong>useful in the treatment</strong> of certain <strong>types of leukemia,</strong> where it can <strong>inhibit the proliferation</strong> of <strong>rapidly dividing leukemic cells</strong> by <strong>interfering with nucleic acid synthesis,</strong> thus indirectly inhibiting DNA replication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Actinomycin D binds</strong> to <strong>DNA </strong>and <strong>inhibits RNA synthesis</strong> by <strong>preventing RNA polymerase </strong>from moving along the DNA, primarily affecting transcription rather than DNA replication directly.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Puromycin interferes</strong> with <strong>protein synthesis</strong> by causing <strong>premature chain termination</strong> during translation, which does not directly impact DNA replication.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Rifampicin inhibits bacterial RNA polymerase</strong>, thus affecting <strong>bacterial transcription.</strong> It is used primarily as an antibiotic and does not directly inhibit DNA replication in cancer cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inhibitors of DNA replication: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/picture5.jpg\" style=\"height:407px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: DM Vasudevan 9/e: p 586.</span></strong></span></span></p>",
    "correct_choice_id": 37347,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 9326,
    "choices": [
      {
        "id": 37271,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lesch-Nyhan Syndrome: Disorder of pyrimidine metabolism</span></span></span></p>"
      },
      {
        "id": 37272,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lesch-Nyhan Syndrome: Disorder of purine metabolism</span></span></span></p>"
      },
      {
        "id": 37273,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary Gout: Deficiency of Salvage Pathway</span></span></span></p>"
      },
      {
        "id": 37274,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Secondary Gout: Due to tumour lysis syndrome</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old boy is brought to the clinic by his mother, who is concerned about her son&#39;s repeated lip and finger biting and involuntary upper limb movements. She recalls noticing an orange discoloration in his diaper as an infant. Upon examination, the boy has multiple bite marks on his fingers and lips, and laboratory tests reveal a serum uric acid level of 9.5 mg/dl:</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/05/screenshot-2024-04-05-144013.png\" style=\"height:243px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Based on the clinical presentation and laboratory findings, what is the most probable diagnosis, and which metabolic pathway is affected in this disease?</span></span></span></p>",
    "unique_key": "Q2332906",
    "question_audio": null,
    "question_video": null,
    "map_id": 29781,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B. Lesch-Nyhan Syndrome: disorder of purine metabolism</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Lesch-Nyhan Syndrome</strong>: an <strong>X-linked inherited</strong> disorder of <strong>purine metabolism.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Due to <strong>deficiency of HGPRTase</strong> &rarr; the <strong>rate of salvage pathway is decreased </strong>&rarr; accumulation of PRPP and decreased inhibitory purine nucleotides. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>C/F: </strong>Self-mutilation, mental retardation, excessive uric acid, nephrolithiasis, and Gout (later life). </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Treatment:&nbsp;</strong> Allopurinol. Since the salvage pathway is deficient, it is effective only to inhibit xanthine oxidase.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Lesch-Nyhan Syndrome: </strong>Disorder of <strong>pyrimidine metabolism</strong>: This is incorrect because LNS is associated with purine, not pyrimidine, metabolism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. <strong>Primary Gout</strong>: Deficiency of <strong>Salvage Pathway</strong>: While gout involves hyperuricemia, the self-mutilating behavior and early onset are not typical of primary gout and indicate a more complex disorder like LNS.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Secondary Gout</strong>: Due to <strong>tumor lysis syndrome</strong>: Secondary gout can occur due to increased cell turnover, as seen in tumor lysis syndrome, but it does not explain the neurological and behavioral symptoms, nor is it common in children without a history of malignancy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Self-mutilating behaviors,</strong> <strong>neurological</strong> symptoms, and <strong>hyperuricemia </strong>is characteristic of <strong>Lesch-Nyhan Syndrome</strong> (LNS). <strong>LNS</strong> is a <strong>rare X-linked recessive disorder</strong> caused by a <strong>deficiency in the enzyme hypoxanthine-guanine phosphoribosyltransferase </strong>(HPRT), which is crucial in the <strong>purine salvage pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><u>Ref</u>: Harper 30/e:&nbsp; p 354-355.</span></strong></span></span></p>",
    "correct_choice_id": 37272,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased"
    ]
  },
  {
    "id": 9341,
    "choices": [
      {
        "id": 37331,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypoxanthine phosphoribosyl transferase</span></span></span></p>"
      },
      {
        "id": 37332,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenine phosphoribosyl transferase</span></span></span></p>"
      },
      {
        "id": 37333,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adenosine deaminase</span></span></span></p>"
      },
      {
        "id": 37334,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Purine nucleoside phosphorylase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 2-year-old child with a history of recurrent bacterial and viral infections, failure to thrive, developmental delays, and tremors is evaluated. Examination reveals an absence of peripheral lymphoid tissues. Laboratory findings indicate lymphopenia, with normal B-cell counts and immunoglobulin levels. Which enzyme deficiency is most likely responsible for this clinical presentation?</span></span></span></p>",
    "unique_key": "Q8711822",
    "question_audio": null,
    "question_video": null,
    "map_id": 29786,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D. Purine nucleoside phosphorylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options D</span></strong><span style=\"font-size:12.0pt\">.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>child has purine nucleoside phosphorylase deficiency</strong>, the reason is not yet fully elucidated, specially <strong>reduces T-cell counts </strong>but not B-cells. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Purine nucleoside phosphorylase</strong> is one of the <strong>salvage enzymes </strong>which <strong>converts guanosine </strong>or <strong>inosine </strong>to the <strong>free base plus ribose-1-phosphate. </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Hypoxanthine phosphoribosyl transferase</strong> deficiency leads to <strong>Lesch-Nyhan syndrome</strong>, where there is no immune deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options B.</span></strong><span style=\"font-size:12.0pt\"> <strong>Adenine phosphoribosyl transferase</strong> deficiency leads to <strong>accumulation of an insoluble metabolite</strong> (2, 8-dihydroxyadenine) that precipitates in the kidney </span><span style=\"font-size:12.0pt\">\ud83e\udc6a</span><span style=\"font-size:12.0pt\">leads to renal failures.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Options C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Adenosine deaminase deficiency </strong>leads to an <strong>immune disorder </strong>where both B and T cells are deficient.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Purine nucleoside phosphorylase</strong> (PNP) deficiency leads to a <strong>selective T-cell deficiency,</strong> part of the <strong>spectrum of SCID disorders.</strong> Despite <strong>normal B-cell counts</strong> and <strong>immunoglobulin levels,</strong> the lack of T-cell help results in functional impairment of B-cells, leading to recurrent infections.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Vasudevan 9/e: p585.</span></strong></span></span></p>",
    "correct_choice_id": 37334,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6396,
    "choices": [
      {
        "id": 25553,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase </span></span></span></p>"
      },
      {
        "id": 25554,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver phosphorylase kinase</span></span></span></p>"
      },
      {
        "id": 25555,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose 6 phosphatase</span></span></span></p>"
      },
      {
        "id": 25556,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male presents with complaints of pain in his calves during and after physical activity. Upon further evaluation, including a detailed examination and muscle biopsy, it was noted that there was an increased glycogen accumulation in the muscle tissues. Based on these findings, which of the following enzymes is most likely deficient in this patient?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q3908211",
    "question_audio": null,
    "question_video": null,
    "map_id": 29994,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Muscle phosphorylase</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical case scenario is a<strong> Glycogen storage disorder, Type V &ndash; McArdle&rsquo;s syndrome </strong>caused by <strong>defective muscle Glycogen</strong> <strong>Phosphorylase </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Liver phosphorylase kinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is a <strong>type VIII</strong> disorder with <strong>hepatomegaly,</strong> accumulation of <strong>glycogen in liver</strong> and mild <strong>hypoglycaemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose 6 phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is <strong>deficient</strong> in <strong>Von Gierke disease (Ia),&nbsp;</strong>C/F includes<strong> glycogen</strong> accumulation in <strong>liver and renal</strong> <strong>tubule cells, hypoglycaemia, lactic academia, ketosis and hyperlipemia.</strong>(No muscle weakness).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is defective in<strong> Andersen disease</strong> with <strong>Hepatosplenomegaly</strong>; accumulation of <strong>polysaccharide </strong>with<strong> few</strong> <strong>branch points</strong>; <strong>death</strong> from<strong> heart or liver failure before age 5.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture14.jpg\" style=\"height:503px; width:1000px\" /><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture15.jpg\" style=\"height:420px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: P 179.</span></strong></span></span></p>",
    "correct_choice_id": 25553,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6372,
    "choices": [
      {
        "id": 25457,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme&nbsp;&nbsp; </span></span></span></p>"
      },
      {
        "id": 25458,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Debranching enzyme&nbsp;&nbsp; </span></span></span></p>"
      },
      {
        "id": 25459,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
      },
      {
        "id": 25460,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old male with a history of short stature presents to the clinic with recurrent episodes of hypoglycemia, hepatomegaly, and bleeding tendencies. On examination, the patient also has notable hepatomegaly and enlarged kidneys. Laboratory findings include elevated levels of lactate, cholesterol, triglycerides, and uric acid. Considering the constellation of symptoms and lab findings, which enzyme deficiency is most likely responsible for this patient&#39;s clinical presentation?</span></span></span></p>",
    "unique_key": "Q2047612",
    "question_audio": null,
    "question_video": null,
    "map_id": 29988,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Glucose-6-phosphatase&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient is having classic<strong> signs and symptoms of Von Gierke disease.</strong> It is due to<strong> deficiency </strong>of the enzyme<strong> glucose-6-phosphatase.</strong> This disease usually manifests in the first 12 months of life.&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lab results reveal <strong>increased lactate, cholesterol, triglyceride and uric acid levels</strong>.&nbsp; This condition is caused by a<strong> basic</strong> <strong>enzyme.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in <strong>Anderson disease</strong>. C/F: <strong>failure to thrive, liver failure, and hypotonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Debranching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in<strong> Cori disease</strong>. C/F: <strong>hypoglycemia, hepatomegaly, short-stature, and myopathy.&nbsp; </strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Muscle phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in <strong>McArdle disease.</strong> C/F: <strong>pain, cramps and myoglobinuria on strenuous exercise.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Gierke&#39;s disease (Type I glycogen storage disease)</strong>, characterized by a<strong> deficiency in glucose-6-phosphatase. </strong>This enzyme is crucial for the <strong>final steps of gluconeogenesis and glycogenolysis,</strong> converting<strong> glucose-6-phosphate</strong> into <strong>free glucose</strong>. Its<strong> deficiency</strong> leads to <strong>impaired glucose production</strong>, resulting in <strong>hypoglycemia, </strong>and the accumulation of<strong> glycogen and fat </strong>in the<strong> liver and kidneys,</strong> causing <strong>hepatomegaly and renal enlargement</strong>. The <strong>increased </strong>levels of <strong>lactate, cholesterol, triglycerides,</strong> and<strong> uric acid </strong>are also consistent with the<strong> metabolic disturbances </strong>seen in <strong>von Gierke&#39;s disease.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 179,355</span></strong></span></span></p>",
    "correct_choice_id": 25460,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6367,
    "choices": [
      {
        "id": 25437,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Debranching enzyme</span></span></span></p>"
      },
      {
        "id": 25438,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
      },
      {
        "id": 25439,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
      },
      {
        "id": 25440,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a pediatric grand rounds presentation, a challenging case involving a 6-month-old infant with recurrent episodes of early morning hypoglycemia is discussed. The attending physician explains that administering glucagon raised the infant&#39;s blood glucose levels when fed but was ineffective during fasting periods. A liver biopsy revealed abnormal glycogen accumulation. The audience, consisting of pediatricians JRs, is then asked to determine the enzyme deficiency responsible for the infant&#39;s condition based on the clinical findings?</span></span></span></p>",
    "unique_key": "Q9145065",
    "question_audio": null,
    "question_video": null,
    "map_id": 29995,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp; Debranching enzyme</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </strong></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most probable diagnosis is<strong> Glycogen storage diseases</strong>: <strong>Cori&rsquo;s / Limit dextrinosis, Forbes disease (Type IIIa)</strong> - deficient <strong>liver and muscle</strong> <strong>debranching enzyme.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical presentation includes<strong> fasting hypoglycaemia, hepatomegaly, accumulation of branched polysaccharide (limit dextrin) &amp; muscle weakness. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> fed state</strong>, <strong>glycogen</strong> is present. So, <strong>glucagon stimulates </strong>enzyme <strong>phosphorylase</strong> to <strong>cleave glycogen</strong> there by releasing <strong>glucose to circulation.</strong> I<strong>n fasting state</strong>, there is only <strong>limit dextrin</strong> and <strong>no</strong> effect of <strong>glucagon on debranching enzyme</strong>. Hence, the<strong> glucagon </strong>will<strong> not</strong> <strong>raise</strong> the<strong> blood glucose levels. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></span></span></strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Muscle phosphorylase</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:<strong> Type V &ndash; McArdle&rsquo;s syndrome; Poor exercise tolerance</strong> with <strong>high muscle glycogen </strong>and<strong> low blood</strong> <strong>lactate</strong> after exercise.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is <strong>deficient in Von Gierke disease (Ia)</strong>,C/F includes<strong> glycogen accumulation in liver </strong>and <strong>renal</strong> t<strong>ubule cells</strong>, <strong>hypoglycaemia, lactic academia</strong>, <strong>ketosis and hyperlipidemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Is<strong> defective in Anderson disease </strong>with <strong>Hepatosplenomegaly;</strong> accumulation of<strong> polysaccharide</strong> with <strong>few</strong> <strong>branch</strong> points; <strong>death from heart or liver failure </strong>before<strong> age 5.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features of <strong>Type III Glycogen Storage Disease (Cori&#39;s or Forbes&#39; Disease)</strong> caused by a <strong>deficiency </strong>in the <strong>debranching</strong> enzyme, leading to <strong>impaired glycogenolysis</strong>,<strong> glycogen accumulation </strong>in the<strong> liver, and fasting hypoglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
    "correct_choice_id": 25437,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6369,
    "choices": [
      {
        "id": 25445,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle debranching enzyme </span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"color:black\"> </span></span></span></span></p>"
      },
      {
        "id": 25446,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase </span></span></span></p>"
      },
      {
        "id": 25447,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose 6 phosphatase</span></span></span></p>"
      },
      {
        "id": 25448,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male visits his primary care physician complaining of recurrent episodes of pain in his calves triggered by physical activity. He reports no other symptoms or significant medical history. Given the concern for a metabolic muscle disorder, a muscle biopsy is performed, revealing an accumulation of glycogen within the muscle cells. Based on the patient&#39;s symptoms and biopsy findings, which enzyme deficiency is most likely responsible for his condition?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q2735829",
    "question_audio": null,
    "question_video": null,
    "map_id": 29986,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Muscle Phosphorylase </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s presentation is indicative of<strong> McArdle&#39;s disease (Type V glycogen storage disease)</strong>, characterized by a <strong>deficiency</strong> in <strong>muscle phosphorylase</strong>. This enzyme is crucial for<strong> glycogenolysis in muscle tissue, </strong>and <strong>its deficiency</strong> leads to an<strong> inability to break</strong> <strong>down glycogen</strong> into<strong> glucose during exercise, </strong>resulting in <strong>muscle pain and cramping</strong>. The<strong> accumulation of glycogen </strong>in <strong>muscle biopsy</strong> further supports this diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Muscle debranching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Deficiency </strong>in the muscle debranching enzyme leads to <strong>Cori&#39;s disease (Type III glycogen</strong> <strong>storage disease)</strong>, which typically presents with more systemic symptoms, including<strong> hepatomegaly, </strong>in addition to<strong> muscle weakness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glucose 6 phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Deficiency</strong> of <strong>glucose-6-phosphatase </strong>characterizes <strong>von Gierke&#39;s disease (Type I glycogen storage</strong> <strong>disease</strong>), primarily affecting<strong> liver function</strong> and leading to <strong>hypoglycemia, not isolated muscle symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>deficiency</strong> in the branching enzyme results in <strong>Andersen&#39;s disease </strong>(<strong>Type IV glycogen storage disease</strong>), which is associated with<strong> liver dysfunction and progressive cirrhosis</strong>, rather than <strong>isolated muscle symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture12.jpg\" style=\"height:873px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
    "correct_choice_id": 25446,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6374,
    "choices": [
      {
        "id": 25465,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased availability of glucose to tissues </span></span></span></p>"
      },
      {
        "id": 25466,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">More formation of pentoses</span></span></span></p>"
      },
      {
        "id": 25467,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased accumulation of sorbitol</span></span></span></p>"
      },
      {
        "id": 25468,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Impaired degradation of free radicals</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old child presents to the pediatric clinic with recurrent episodes of hypoglycemia, especially noted during fasting periods. The child&#39;s growth parameters are below the normal percentile for age. Laboratory investigations reveal lactic acidosis and hyperuricemia. After further evaluation, the child is diagnosed with Glucose-6-phosphatase deficiency. The attending physician explains to the parents the association between the child&#39;s condition and the development of hyperuricemia and gout. Which of the following is the most likely cause of hyperuricemia and gout in this patient?</span></span></span></p>",
    "unique_key": "Q6724837",
    "question_audio": null,
    "question_video": null,
    "map_id": 29989,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) More formation of pentoses</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose-6-phosphatase deficiency</strong>, also known as<strong> Glycogen Storage Disease Type I (GSD I)</strong>, leads to an<strong> inability</strong> to convert <strong>glucose</strong>-<strong>6-phosphate into glucose, </strong>resulting in the <strong>trapping of glucose</strong> within <strong>cells </strong>and subsequent<strong> hypoglycemia.</strong> To compensate for the <strong>lack</strong> of available<strong> glucose,</strong> the body <strong>increases </strong>the breakdown of <strong>nucleic acids to produce more glucose </strong>through <strong>gluconeogenesis,</strong> leading to an <strong>excess</strong> production of <strong>purine bases. </strong>The <strong>increased </strong>turnover of these <strong>purine bases</strong> ultimately results in the<strong> overproduction </strong>of <strong>uric acid, </strong>a precursor to<strong> gout</strong>. This pathway also leads to an <strong>increased formation of pentoses</strong>, which are involved in the <strong>synthesis of</strong> <strong>nucleic acids,</strong> thus contributing to the<strong> cycle of purine breakdown </strong>and<strong> uric acid production.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased availability of glucose to tissues: This</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a direct consequence of <strong>Glucose-6-phosphatase deficiency</strong> leading to <strong>hypoglycemia</strong> but <strong>does not </strong>directly cause<strong> hyperuricemia and gout</strong>. The <strong>lack of glucose</strong> exacerbates the<strong> metabolic imbalance</strong> but <strong>isn&#39;t </strong>the primary cause of<strong> increased uric acid levels.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Increased accumulation of sorbitol:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Sorbitol accumulation is associated with conditions like <strong>diabetes mellitus </strong>due to <strong>increased</strong> activity of the <strong>polyol pathway</strong> when<strong> glucose levels are high.</strong> It is<strong> not </strong>directly related to <strong>Glucose-6-phosphatase deficiency</strong> or<strong> hyperuricemia and gout</strong> in this context.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Impaired degradation of free radicals:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>oxidative stress </strong>and <strong>impaired degradation of free radicals </strong>can contribute to <strong>cellular damage</strong> and various <strong>metabolic disturbances</strong>, they are<strong> not directly </strong>involved in the mechanism leading to<strong> hyperuricemia </strong>and <strong>gout </strong>in patients with<strong> Glucose-6-phosphatase deficiency.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biochemical defect in von Gierke&rsquo;s disease:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency of Glucose 6 Phosphatase</strong>&nbsp; &rarr; accumulation of<strong> Glucose 6 Phosphate</strong> &rarr; it is&nbsp; channelled to <strong>Pentose Phosphate pathway </strong>&rarr; <strong>more Pentoses</strong> are formed &rarr; enters <strong>Purine Synthesis </strong>&rarr; <strong>Uric acid</strong> accumulates (<strong>degradation product of Purine</strong>)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nelson 20/e: Defects in the metabolism of Carbohydrates</span></strong></span></span></p>",
    "correct_choice_id": 25466,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6390,
    "choices": [
      {
        "id": 25529,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
      },
      {
        "id": 25530,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acid maltase</span></span></span></p>"
      },
      {
        "id": 25531,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
      },
      {
        "id": 25532,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old infant is presented to the pediatric outpatient department by the mother, reporting symptoms of rapid heart rate, restlessness, muscle hypotonia, and abdominal distention. The infant has been diagnosed with cardiac failure and is currently being treated with diuretics and an ACE inhibitor. Radiographic evidence indicates left ventricular hypertrophy, and physical examination reveals hepatosplenomegaly. An assay performed on a dried blood spot indicates reduced activity of a specific enzyme, leading to a diagnosis of Pompe disease. Which enzyme deficiency is associated with Pompe disease?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q8718574",
    "question_audio": null,
    "question_video": null,
    "map_id": 29992,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Acid maltase&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pompe disease,</strong> also known as<strong> Glycogen Storage Disease Type II,</strong> is caused by a<strong> deficiency </strong>in the enzyme <strong>acid alpha-glucosidase,</strong> also known as<strong> acid maltase</strong>. This<strong> lysosomal</strong> enzyme is responsible for <strong>breaking down glycogen </strong>into <strong>glucose</strong> <strong>within lysosomes.</strong> Its <strong>deficiency</strong> leads to the <strong>accumulation of lysosomal glycogen</strong>, particularly affecting <strong>cardiac and skeletal muscles</strong>, as well as the<strong> liver.</strong> The <strong>hallmark </strong>features of<strong> Pompe disease</strong> include <strong>cardiomyopathy</strong> (often presenting as<strong> cardiac failure in infants</strong>), <strong>muscle weakness</strong> (hypotonia), and <strong>hepatomegaly</strong>. The <strong>diagnosis</strong> is supported by<strong> enzyme </strong>assays showing<strong> reduced acid maltase activity.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in <strong>Anderson disease</strong>. C/F: failure to<strong> thrive, liver failure, and hypotonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Muscle phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> deficiency results in<strong> McArdle disease.</strong> C/F: <strong>pain, cramps and myoglobinuria on strenuous exercise.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Deficiency results in <strong>Von Gierke disease</strong>. C/F: <strong>Hypoglycaemia; hyperketonaemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture6.jpg\" style=\"height:598px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture7.jpg\" style=\"height:332px; width:1000px\" /></span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
    "correct_choice_id": 25530,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6386,
    "choices": [
      {
        "id": 25513,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Branching enzyme</span></span></span></p>"
      },
      {
        "id": 25514,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Debranching enzyme</span></span></span></p>"
      },
      {
        "id": 25515,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle phosphorylase</span></span></span></p>"
      },
      {
        "id": 25516,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphatase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-year-old girl child is admitted with progressive abdominal distension for the past 6 months. Mother reported that the baby has difficulty in walking, gets easily tired while playing and restless and sweat in early morning hours. After giving juice or milk, she feels comfortable.&nbsp;On examination, child was found to have motor retardation and was small for age. Liver was found to be enlarged with firm consistency. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Laboratory investigations:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">FBS: 60 mg/dl (normal = 80-110 mg/dl)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">AST: 355 IU/L (normal = 15-45 IU/L)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALT: 244 IU/L (normal = 15-45 IU/L)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">ALP: 231 IU/L (normal =98-279 IU/L)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Total bilirubin: 2.0 mg/dl (normal = 0-1.0 mg/dl)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver histology: Glycogen laden vacuoles with no fibrosis or inflammatory cell infiltration. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4.jpg\" style=\"height:247px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Baby was diagnosed with GSD type III based on the results.&nbsp; What is the causative enzyme deficiency in this disease?</span></span></span></p>",
    "unique_key": "Q8585097",
    "question_audio": null,
    "question_video": null,
    "map_id": 29991,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Debranching enzyme&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen Storage Disease (GSD) Type III,</strong> also known as<strong> Cori disease or Forbes disease, </strong>is caused by a <strong>deficiency </strong>in the <strong>debranching enzyme </strong>(<strong>amylo-1,6-glucosidase, 4-alpha-glucanotransferase</strong>). This enzyme is crucial for the <strong>breakdown of glycogen</strong>, specifically in removing <strong>branch points</strong> in glycogen. A deficiency in this enzyme leads to the <strong>accumulation of abnormal glycogen</strong> with short outer branches, which is evident in the <strong>liver histology </strong>of the patient as <strong>glycogen-laden vacuoles.</strong> This <strong>accumulation disrupts</strong> normal <strong>glycogenolysis and gluconeogenesis</strong>, leading to symptoms such as<strong> hypoglycemia, hepatomegaly, and growth retardation.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Branching enzyme:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>deficiency</strong> results in <strong>Anderson disease</strong>. C/F: <strong>failure to thrive, liver failure, and hypotonia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp; Muscle phosphorylase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>deficiency</strong> results in <strong>McArdle disease.</strong> C/F: <strong>pain, cramps and myoglobinuria</strong> on strenuous exercise.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Glucose-6-phosphatase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Deficiency </strong>results in <strong>Von Gierke disease.</strong> C/F: <strong>Hypoglycemia; hyperketonaemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture10.jpg\" style=\"height:560px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture11_PgLn01X.jpg\" style=\"height:469px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 179.</span></strong></span></span></p>",
    "correct_choice_id": 25514,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 6454,
    "choices": [
      {
        "id": 25785,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the fasting plasma sugar is more than 126 mg /dl, on more than one occasion</span></span></span></p>"
      },
      {
        "id": 25786,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If 2-hr post-glucose load value of GTT is more than 200 mg /dl (even at one occasion).</span></span></span></p>"
      },
      {
        "id": 25787,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the random plasma sugar level is more than 200 mg/dl, on more than one occasion. </span></span></span></p>"
      },
      {
        "id": 25788,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the above</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following options correctly represents the diagnostic criteria for Diabetes Mellitus?</span></span></p>",
    "unique_key": "Q5443220",
    "question_audio": null,
    "question_video": null,
    "map_id": 29993,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) All the above</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The diagnostic<strong> criteria for Diabetes Mellitus</strong> include several key measurements, each of which can independently confirm the diagnosis:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fasting Plasma Glucose (FPG)</strong>: A value of <strong>126 mg/dl (7.0 mmol/l) or higher,</strong> <strong>confirmed </strong>on <strong>more than one occasion, </strong>indicates diabetes.<strong> Fasting </strong>is defined as<strong> no caloric intake for at least 8 hours.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>2-hour Plasma Glucose During an Oral Glucose Tolerance Test (OGTT)</strong>: A value of<strong> 200 mg/dl (11.1 mmol/l) or higher at the 2-hour</strong> mark during an<strong> OGTT,</strong> using a <strong>glucose load of 75 grams,</strong> confirms the diagnosis. This criterion <strong>does not </strong>necessarily require <strong>confirmation </strong>on a <strong>second occasion</strong> if the patient presents with<strong> classic symptoms of hyperglycemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Random Plasma Glucose</strong>: A value of<strong> 200 mg/dl (11.1 mmol/l) or higher, </strong>in a patient with <strong>classic symptoms of hyperglycemia</strong> (e.g., <strong>polyuria, polydipsia, unexplained weight loss</strong>), can <strong>confirm the diagnosis </strong>of<strong> diabetes</strong> without the need for fasting or an OGTT.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Given that each of these criteria can independently diagnose Diabetes Mellitus, <strong>option D) All the above is correct.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Fasting plasma sugar more than 126 mg/dl, on more than one occasion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is one of the criteria for diagnosing diabetes but not the only one.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; 2-hour post-glucose load value of GTT more than 200 mg/dl: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This too is a valid criterion for diagnosing diabetes, even if observed on just one occasion, provided there are classic symptoms of hyperglycemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Random plasma sugar level more than 200 mg/dl, on more than one occasion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While a single measurement with classic symptoms can be sufficient, additional confirmation enhances the diagnostic certainty, especially in asymptomatic individuals.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the <strong>fasting plasma sugar</strong> is <strong>more than 126 mg /dl, </strong>on <strong>more</strong> than one occasion</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If<strong> 2-hr post-glucose </strong>load value of<strong> GTT is more than 200 mg /dl</strong> (even at one occasion).</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">If the<strong> random plasma sugar level </strong>is <strong>more than 200 mg/dl</strong>, on<strong> more than one occasion. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycated haemoglobin (Glyco -Hb) </strong>or<strong> HbA1c </strong>level <strong>more than 6.5%</strong> at<strong> any occasion </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture5_cgQTuPi.jpg\" style=\"height:201px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: 314.</span></strong></span></span></p>",
    "correct_choice_id": 25788,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 9571,
    "choices": [
      {
        "id": 38251,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are often associated with deficient enzyme activity.</span></span></span></p>"
      },
      {
        "id": 38252,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Both alleles contain the same mutation.</span></span></span></p>"
      },
      {
        "id": 38253,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">They are more variable than autosomal dominant conditions.</span></span></span></p>"
      },
      {
        "id": 38254,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Most persons do not carry any abnormal recessive genes.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the context of type IV glycogen storage disease (GSD IV), an autosomal recessive condition characterized by progressive liver damage, hypoglycemia, hyperlipidemia, and hyperuricemia due to deficient glycogenolysis, which of the following statements accurately describes autosomal recessive conditions?</span></span></span></p>",
    "unique_key": "Q2685119",
    "question_audio": null,
    "question_video": null,
    "map_id": 29987,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. They are often associated with deficient enzyme activity.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Autosomal</strong> and <strong>X-linked recessive inheritance</strong> is seen in almost all <strong>metabolic diseases</strong> as seen in <strong>type IV glycogen storage disease. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Traits</strong> such as <strong>deafness </strong>can <strong>follow any of the three major mendelian inheritance mechanisms</strong> (genetic heterogeneity) tend to be <strong>more severe </strong>in <strong>recessive </strong>rather than dominant forms, and recessive conditions are less variable than dominant phenotypes. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Most mattings </strong>involve <strong>persons </strong>who have <strong>mutations at different loci</strong>, hence related persons are more likely to inherit the same mutant gene, consanguinity increases the possibility of homozygous affected offspring.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: </span></strong><span style=\"font-size:12.0pt\"><strong>Both alleles </strong>are <strong>defective </strong>but do not contain the exact same mutation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C: </span></strong><span style=\"font-size:12.0pt\">They have a <strong>horizontal pattern of affected persons </strong>in the <strong>pedigree</strong>. Males and females are affected with equal frequency and severity.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D: </span></strong><span style=\"font-size:12.0pt\">All <strong>individuals </strong>carry <strong>6 to 12 mutant recessive alleles</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>Autosomal recessive </strong>conditions, such as <strong>type IV glycogen storage disease</strong>, are frequently characterized by a <strong>deficiency in enzyme activity</strong>. This is because both copies of the gene in question (one from each parent) must be affected for the disorder to manifest, typically resulting in the absence or malfunctioning of an enzyme or protein.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Harper 31/e, p 820-821</span></strong></span></span></p>",
    "correct_choice_id": 38251,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6383,
    "choices": [
      {
        "id": 25501,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type I</span></span></span></p>"
      },
      {
        "id": 25502,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type II</span></span></span></p>"
      },
      {
        "id": 25503,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type V</span></span></span></p>"
      },
      {
        "id": 25504,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Type VII</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following glycogen storage diseases typically spares the muscles from involvement? </span></span></p>",
    "unique_key": "Q4095556",
    "question_audio": null,
    "question_video": null,
    "map_id": 29990,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Type I</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen Storage Disease Type I</strong>, also known as<strong> Von Gierke disease,</strong> primarily affects the <strong>liver and kidneys</strong> and is characterized by the <strong>deficiency </strong>of the enzyme<strong> glucose-6-phosphatase.</strong> This enzyme is crucial for the<strong> final steps of gluconeogenesis </strong>and <strong>glycogenolysis</strong>, allowing<strong> glucose </strong>to be released into the<strong> bloodstream.</strong> Due to the <strong>enzyme&#39;s absence </strong>in <strong>muscle tissue</strong>, <strong>GSD Type I</strong> <strong>does not </strong>directly <strong>involve</strong> <strong>muscle pathology.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Type II:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type II, or<strong> Pompe disease</strong>, involves <strong>lysosomal alpha-1,4-glucosidase deficiency</strong> and affects <strong>cardiac and skeletal</strong> <strong>muscles,</strong> leading to <strong>progressive muscle weakness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Type V:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type V, known as <strong>McArdle disease</strong>, specifically affects<strong> muscle phosphorylase </strong>and is characterized by<strong> muscle</strong> <strong>cramps and exercise intolerance</strong>, indicating <strong>direct muscle involvement.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Type VII:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Type VII, or<strong> Tarui disease,</strong> involves <strong>phosphofructokinase deficiency </strong>in muscle cells, leading to <strong>exercise</strong> <strong>intolerance and myopathy,</strong> hence<strong> directly affecting muscles</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Von Gierke disease (Ia) </strong>is due to<strong> Glucose 6 phosphatase deficiency</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features include <strong>glycogen </strong>accumulation in<strong> liver and renal tubule cells</strong>, <strong>hypoglycaemia, lactic acidemia, ketosis</strong> and <strong>hyperlipidemia</strong>. (<strong>No muscle weakness</strong>).</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle Glycogen Storage Disorders:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture2.jpg\" style=\"height:241px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Nelson 20/e Defects in the metabolism of Carbohydrates</span></strong></span></span></p>",
    "correct_choice_id": 25501,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual"
    ]
  },
  {
    "id": 6397,
    "choices": [
      {
        "id": 25557,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is right but R is a wrong statement</span></span></span></p>"
      },
      {
        "id": 25558,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A </span></span></span></p>"
      },
      {
        "id": 25559,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 25560,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A): Glucagon is needed for glycogenesis to occur. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R): The enzyme glycogen phosphorylase is the rate limiting enzyme for&nbsp;&nbsp; glycogenesis and it is active in phosphorylated form for which glucagon is needed.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Evaluate the accuracy of the assertion and reasoning provided.</span></span></span></p>",
    "unique_key": "Q1908592",
    "question_audio": null,
    "question_video": null,
    "map_id": 29764,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) A and R both are wrong</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>For glycogenesis,</strong> presence of <strong>insulin</strong> is must, because Insulin is required for<strong> dephosphorylation of glycogen synthase</strong> enzyme, which is the <strong>rate limiting enzyme</strong> for <strong>glycogenesis.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen synthase </strong>is<strong> active</strong> in a <strong>dephosphorylated state.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycogen phosphorylase</strong> is the key enzyme in <strong>glycogenolysis,</strong> the <strong>breakdown of glycogen </strong>into <strong>glucose-1-phosphate,</strong> <strong>not</strong> <strong>glycogenesis.</strong> This enzyme is activated in its <strong>phosphorylated </strong>form, but this <strong>activation</strong> is triggered by<strong> glucagon and adrenaline </strong>during <strong>fasting or stress, not</strong> for promoting <strong>glycogen synthesis </strong>but for <strong>breaking down glycogen into glucose </strong>to <strong>raise blood glucose levels.</strong> <strong>Glycogen synthase</strong> is the key <strong>rate-limiting enzyme in glycogenesis </strong>and is regulated by<strong> insulin and glucose levels</strong>,<strong> not glucagon.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 142,178-183.</span></strong></span></span></p>",
    "correct_choice_id": 25560,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "Factual"
    ]
  },
  {
    "id": 6014,
    "choices": [
      {
        "id": 24026,
        "text": "<p><span style=\"font-size:12.0pt;\">cAMP</span></p>"
      },
      {
        "id": 24027,
        "text": "<p><span style=\"font-size:12.0pt;\">Calmodulin</span></p>"
      },
      {
        "id": 24028,
        "text": "<p><span style=\"font-size:12.0pt;\">Protein Kinase A</span></p>"
      },
      {
        "id": 24029,
        "text": "<p><span style=\"font-size:12.0pt;\">Glycogenin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old male presents to the clinic with fatigue, muscle cramps, and a recent history of unexplained weight loss. He reports that his symptoms worsen with exercise. His medical history is unremarkable, and he is not on any medications. Laboratory investigations reveal hypoglycemia, especially after periods of fasting or strenuous activity. The physician suspects a metabolic disorder involving glycogen metabolism. Which of the following is NOT involved in the regulation of glycogen phosphorylase, an enzyme pivotal in glycogen breakdown?</span></p>",
    "unique_key": "Q8269312",
    "question_audio": null,
    "question_video": null,
    "map_id": 29765,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Glycogenin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:&nbsp;</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Glycogenin</strong> is not involved in the regulation of <strong>glycogen phosphorylase</strong>.</span></p><p><span style=\"font-size:12.0pt;\">Glycogenin serves as the core \"primer\" protein upon which glucose units are added to initiate <strong>glycogen synthesis</strong>, not glycogen breakdown. Once a short glucose chain is built on glycogenin, <strong>glycogen synthase</strong> and <strong>branching enzyme</strong> extend the glycogen molecule.</span></p><p><span style=\"font-size:12.0pt;\">In contrast, <strong>glycogen phosphorylase</strong> is the rate-limiting enzyme in <strong>glycogenolysis</strong> (glycogen breakdown), and its regulation is tightly controlled by hormonal and intracellular signaling.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A) cAMP:&nbsp;</strong>Correct \u2014 cAMP is an important <strong>second messenger</strong> in the glucagon and epinephrine pathway. It activates <strong>Protein Kinase A (PKA)</strong>, which phosphorylates <strong>phosphorylase kinase</strong>, activating it. Phosphorylase kinase then phosphorylates and activates <strong>glycogen phosphorylase</strong>, enabling glycogen breakdown.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B) Calmodulin:&nbsp;</strong>Correct \u2014 Calmodulin, when bound to calcium, directly activates <strong>phosphorylase kinase</strong>, bypassing cAMP in tissues such as muscle. This allows muscle cells to match <strong>glycogen breakdown</strong> to calcium-driven muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C) Protein Kinase A (PKA):&nbsp;</strong>Correct \u2014 PKA is a key regulator of glycogenolysis. Activated by cAMP, it phosphorylates <strong>phosphorylase kinase</strong>, which then activates <strong>glycogen phosphorylase</strong>.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Glycogen phosphorylase</strong> is the key enzyme for glycogen breakdown and is activated via phosphorylation pathways involving <strong>cAMP</strong>, <strong>Protein Kinase A</strong>, and <strong>phosphorylase kinase</strong> (which is also activated by <strong>calcium-calmodulin</strong> in muscle).</span><br><span style=\"font-size:12.0pt;\">In contrast, <strong>glycogenin</strong> functions as the core primer for glycogen synthesis, not degradation, and is not involved in the regulation of glycogen phosphorylase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>:&nbsp;Harper 30/e: p180-182</span></p>",
    "correct_choice_id": 24029,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6330,
    "choices": [
      {
        "id": 25289,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of G6PD occurs only in red blood cells.</span></span></span></p>"
      },
      {
        "id": 25290,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions.</span></span></span></p>"
      },
      {
        "id": 25291,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of G6PD &rarr; inability to keep glutathione in reduced functional form.</span></span></span></p>"
      },
      {
        "id": 25292,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The reduced NADPH formed during the shunt is utilized in fatty acid oxidation.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A child was recently diagnosed with G6PD deficiency. Glucose 6-phosphate dehydrogenase (G6PD) catalyzes the regulatory step in the HMP shunt. Which is the correct statement about G6PD and HMP shunt?</span></span></span></p>",
    "unique_key": "Q9155710",
    "question_audio": null,
    "question_video": null,
    "map_id": 29940,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp; Deficiency of G6PD &rarr; inability to keep glutathione in reduced functional form.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reduced glutathione</strong> is an important <strong>antioxidant. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>NADPH</strong> is supplied by the <strong>oxidative reactions</strong> of the<strong> pentose phosphate pathway</strong> which is <strong>regulated</strong> by the availability of<strong> NADPH at the G6PD-catalyzed step.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pathway involves<strong> two irreversible oxidative reactions, </strong>each of which generates <strong>NADPH</strong>. The NADPH is used in <strong>fatty</strong> <strong>acid synthesis, steroid hormone and cholesterol synthesis.</strong></span></span></span><br />\r\n\t&nbsp;</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture8.jpg\" style=\"height:419px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Deficiency of G6PD occurs only in red blood cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The<strong> oxidative phase </strong>of the pathway is seen in <strong>Liver, Adipose tissue,</strong> <strong>Adrenal cortex, Testes and ovaries, RBCs and Lens of eye.</strong> The <strong>non-oxidative phase</strong> is present in <strong>all tissues</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. The HMP shunt involves one reversible reductive reaction followed by a series of phosphorylated reactions and sugar inter conversions:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> involves<strong> two irreversible oxidative reactions</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; The reduced NADPH formed during the shunt is utilized in fatty acid oxidation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> used in <strong>fatty acid synthesis, steroid hormone, and cholesterol synthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>G6PD</strong> is an enzyme in the <strong>hexose monophosphate shunt</strong> that is responsible for the production of<strong> NADPH.</strong> <strong>NADPH</strong> is crucial for maintaining the <strong>reduced form of glutathione</strong>, a critical<strong> antioxidant in cells.</strong> In <strong>G6PD deficiency, </strong>the reduced production of <strong>NADPH</strong> leads to a<strong> reduced ability to maintain glutathione</strong> in its <strong>reduced form</strong>, making <strong>red blood cells </strong>more susceptible to <strong>oxidative damage</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 196-200.</span></strong></span></span></p>",
    "correct_choice_id": 25291,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6217,
    "choices": [
      {
        "id": 24837,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TCA cycle</span></span></span></p>"
      },
      {
        "id": 24838,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexose Mono Phosphate pathway</span></span></span></p>"
      },
      {
        "id": 24839,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 24840,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta Oxidation of Fatty Acid</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify which of the following pathways does not produce high-energy phosphate compounds directly helps in comprehending the energy dynamics within the cell.</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q8641538",
    "question_audio": null,
    "question_video": null,
    "map_id": 29937,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) HMP Pathway.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Hexose Monophosphate (HMP) pathway,</strong> also known as the<strong> Pentose Phosphate Pathway (PPP),</strong> is primarily involved in the <strong>production of NADPH and pentoses (5-carbon sugars) </strong>rather than the direct synthesis of<strong> high-energy phosphate compounds</strong> like <strong>ATP or GTP. NADPH </strong>is crucial for<strong> biosynthetic reactions</strong> and <strong>antioxidant defense</strong>, but the pathway <strong>itself does not</strong> directly produce<strong> high-energy phosphate</strong> <strong>compounds.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:14px\"><strong>Other Options:</strong></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. TCA cycle:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This cycle includes steps that<strong> produce high-energy phosphate compounds,</strong> such as the substrate-level phosphorylation generating<strong> GTP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glycolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glycolysis <strong>directly </strong>produces <strong>ATP </strong>through <strong>substrate-level phosphorylation in two steps.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Beta-Oxidation of Fatty Acid -</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Each cycle of <strong>beta-oxidation generates</strong> <strong>FADH2 and NADH, </strong>which contribute to <strong>ATP synthesis</strong> through <strong>oxidative phosphorylation,</strong> albeit<strong> indirectly</strong>. However, considering the overall process and its contribution to<strong> ATP generation, </strong>it&#39;s included among the pathways that produce <strong>high-energy compounds.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pathways which do not synthesize ATP are</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMP Pathway</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapaport Luebering Cycle</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uronic acid pathway</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alpha oxidation of Fatty acid</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Omega Oxidation of fatty acid</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: 253.</span></strong></span></span></p>",
    "correct_choice_id": 24838,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6341,
    "choices": [
      {
        "id": 25333,
        "text": "<p><span style=\"font-size:12.0pt;\">Oxidized form of nicotinamide adenine dinucleotide</span></p>"
      },
      {
        "id": 25334,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucose 6-phosphate</span></p>"
      },
      {
        "id": 25335,
        "text": "<p><span style=\"font-size:12.0pt;\">Ribose 5-phosphate</span></p>"
      },
      {
        "id": 25336,
        "text": "<p><span style=\"font-size:12.0pt;\">Decrease Level of Reduced Glutathione</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A middle-aged woman visited a region with known chloroquine-resistant malaria. As a prophylactic measure, she was administered primaquine. Shortly after starting the medication, she exhibited signs of hemolytic anemia and was later diagnosed with a deficiency in glucose 6-phosphate dehydrogenase (G6PD). Given the role of G6PD in cellular metabolism, what is the underlying cause of her hemolytic symptoms?</span></p>",
    "unique_key": "Q1690070",
    "question_audio": null,
    "question_video": null,
    "map_id": 29936,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Decrease Level of Reduced Glutathione&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Glucose 6-phosphate dehydrogenase (G6PD)</strong> is the <strong>rate-limiting enzyme</strong> of the <strong>pentose phosphate pathway (hexose monophosphate shunt),</strong> especially important in <strong>red blood cells.</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>G6PD\u2019s main role:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Catalyzes the conversion of <strong>glucose 6-phosphate to 6-phosphogluconolactone,</strong></span></li><li><span style=\"font-size:12.0pt;\">While reducing <strong>NADP\u207a to NADPH.</strong></span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Why is NADPH critical?</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">NADPH maintains <strong>glutathione (GSH) in its reduced form.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Reduced glutathione (GSH)</strong> is essential for <strong>neutralizing reactive oxygen species (ROS)</strong> and <strong>protecting red blood cells from oxidative damage.</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In <strong>G6PD deficiency:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">RBCs can\u2019t generate enough <strong>NADPH,</strong></span></li><li><span style=\"font-size:12.0pt;\">Leading to <strong>decreased reduced glutathione levels,</strong></span></li><li><span style=\"font-size:12.0pt;\">Making cells highly vulnerable to oxidative stress (e.g., from <strong>primaquine, sulfa drugs, fava beans</strong>),</span></li><li><span style=\"font-size:12.0pt;\">Resulting in <strong>hemolysis (breakdown of RBCs),</strong> as seen in this patient.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Oxidized form of nicotinamide adenine dinucleotide (NAD\u207a)</strong></span><br><span style=\"font-size:12.0pt;\">\u2192 NAD\u207a is used in glycolysis and the TCA cycle, not in the <strong>pentose phosphate pathway</strong> or <strong>glutathione regeneration</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Glucose 6-phosphate</strong></span><br><span style=\"font-size:12.0pt;\">\u2192 Substrate for both <strong>glycolysis</strong> and <strong>HMP shunt</strong>, but <strong>not directly involved in antioxidant defense</strong> or in the cause of hemolysis here.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Ribose 5-phosphate</strong></span><br><span style=\"font-size:12.0pt;\">\u2192 Product of the <strong>non-oxidative phase</strong> of the HMP shunt, important for <strong>nucleotide synthesis</strong>, but not relevant to <strong>oxidative stress handling</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objectives:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In <strong>G6PD deficiency</strong>, red blood cells have:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Impaired ability to handle oxidative stress</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Low NADPH levels</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Decreased reduced glutathione (GSH)</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This makes them susceptible to <strong>hemolysis</strong>, especially after exposure to <strong>oxidant drugs like primaquine</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e: p 586, 693-694.</span></p>",
    "correct_choice_id": 25336,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6339,
    "choices": [
      {
        "id": 25325,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal Gland</span></span></span></p>"
      },
      {
        "id": 25326,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver</span></span></p>"
      },
      {
        "id": 25327,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Red Blood Cells&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></p>"
      },
      {
        "id": 25328,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skeletal Muscle</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 1-year-old child with a diagnosed inborn error of the pentose phosphate pathway is brought to the clinic for a follow-up. The child has a history of hemolytic anemia and developmental delays. The pentose phosphate pathway is crucial for producing NADPH, which is essential for maintaining the reducing environment in cells. Given the importance of this pathway, which of the following organs is least likely to contain enzymes for an active pentose phosphate pathway?</span></span></span><br />\r\n&nbsp;</p>",
    "unique_key": "Q5068089",
    "question_audio": null,
    "question_video": null,
    "map_id": 29935,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Skeletal muscle</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Skeletal muscle</strong> does <strong>not</strong> have <strong>a high demand</strong> for the <strong>pentose phosphate pathway&#39;s activity</strong> under normal conditions. The <strong>pentose</strong> <strong>phosphate pathway</strong> is most <strong>active in cells </strong>that are engaged in <strong>rapid anabolic activities,</strong> such as the <strong>liver,</strong> which is involved in <strong>metabolic regulation, </strong>the <strong>adrenal glands</strong>, which <strong>synthesize steroid hormones,</strong> and <strong>red blood cells,</strong> which require<strong> NADPH</strong> to <strong>prevent</strong> <strong>oxidative damage</strong>. In <strong>contrast, skeletal muscle&#39;s energy </strong>needs are primarily met through <strong>glycolysis and oxidative phosphorylation,</strong> and it typically <strong>does not</strong> require the <strong>large amounts of NADPH </strong>produced by the<strong> pentose phosphate pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Adrenal Gland:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Has a <strong>high demand for NADPH</strong> for<strong> steroid biosynthesis,</strong> therefore has an active <strong>pentose phosphate</strong> <strong>pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Liver:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A<strong> major site</strong> of various metabolic processes including <strong>gluconeogenesis, fatty acid synthesis, and detoxification</strong>, all of which <strong>require NADPH</strong> from the<strong> pentose phosphate pathway.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Red Blood Cells:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Rely on the <strong>pentose phosphate pathway to generate NADPH,</strong> which is essential for <strong>protecting</strong> <strong>hemoglobin</strong> from <strong>oxidative damage.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMP shunt:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp; Involved in <strong>synthesis of NADPH and Pentoses.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uses of NADPH </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Reductive </strong>biosynthesis of<strong> fatty acids, cholesterol, steroid hormones &amp; bile acids. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Cofactor</strong> for <strong>glutathione reductase</strong> and <strong>MetHb reductase</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">So <strong>HMP shunt is active</strong> in:<strong> Adipose tissue, liver, RBC, ovary, testes, adrenal gland and</strong> <strong>lactating mammary gland. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sources of NADPH: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HMP</strong> (G6PD and 6 phosphogluconate dehydrogenase)</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malic enzyme</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Isocitrate dehydrogenase</strong> (Cytosolic)</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 196-200.</span></strong></span></span></p>",
    "correct_choice_id": 25328,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6359,
    "choices": [
      {
        "id": 25405,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 25406,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Citric acid cycle</span></span></span></p>"
      },
      {
        "id": 25407,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMP shunt</span></span></span></p>"
      },
      {
        "id": 25408,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty acid oxidation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the context of cellular metabolism and redox balance, which pathway is primarily responsible for the generation of NADPH, a key factor in protecting cells from oxidative stress? </span></span></p>",
    "unique_key": "Q4301621",
    "question_audio": null,
    "question_video": null,
    "map_id": 29938,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) HMP shunt </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NADPH</strong> is predominantly produced by the<strong> hexose monophosphate shunt (HMP shunt)</strong>, also known as the<strong> pentose phosphate</strong> <strong>pathway</strong>. This pathway operates <strong>parallel to glycolysis</strong> and is essential for providing the <strong>reducing power</strong> in the form of <strong>NADPH</strong> for <strong>biosynthetic reactions,</strong> <strong>antioxidant defense</strong> mechanisms, and <strong>detoxification</strong> processes, particularly in <strong>tissues actively</strong> engaged in <strong>lipid synthesis</strong>, such as the <strong>liver, adipose tissue, and adrenal glands.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glycolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While glycolysis is a <strong>central metabolic pathway</strong> for <strong>glucose breakdown,</strong> it <strong>does not</strong> produce <strong>NADPH</strong>; instead, it generates<strong> ATP and NADH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Citric acid cycle:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The citric acid cycle, also known as the <strong>Krebs cycle</strong>, is involved in <strong>cellular respiration </strong>and produces <strong>ATP,</strong> <strong>NADH, and FADH2</strong>, but <strong>not NADPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Fatty acid oxidation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fatty acid oxidation, or <strong>&beta;-oxidation,</strong> primarily generates <strong>acetyl-CoA, NADH, and FADH2</strong>, <strong>not NADPH.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NADPH</strong> is used for <strong>reductive biosynthetic pathways</strong> such as<strong> fatty acid synthesis, steroid and cholesterol synthesis </strong>and <strong>Amino acids</strong> by <strong>Glutamate dehydrogenase. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>NADPH</strong> is required for <strong>regeneration of reduced Glutathione</strong> which clears<strong> free radicals </strong>from<strong> erythrocytes and lens.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p197.</span></strong></span></span></p>",
    "correct_choice_id": 25407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6363,
    "choices": [
      {
        "id": 25421,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Serves as a source of NADPH, essential for reductive biosynthesis and detoxification.</span></span></p>"
      },
      {
        "id": 25422,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Provides Ribose 5-phosphate for nucleotide synthesis.</span></span></span></p>"
      },
      {
        "id": 25423,
        "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Plays a role in preventing the formation of methemoglobin by maintaining reduced glutathione.</span></span></p>"
      },
      {
        "id": 25424,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Is directly implicated in causing free radical injury due to its metabolic processes.</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a clinical case discussion, a medical student presents a patient with a genetic defect impacting a key metabolic pathway, leading to abnormal red blood cell function. The discussion focuses on the role of various metabolic pathways in cellular health. The student is asked to identify which of the following statements about the hexose monophosphate (HMP) shunt does not align with its known functions.</span></span></span></p>",
    "unique_key": "Q1980917",
    "question_audio": null,
    "question_video": null,
    "map_id": 29941,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Is directly implicated in causing free radical injury due to its metabolic processes.</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>HMP shunt</strong>, or <strong>pentose phosphate pathway, </strong>is<strong> not </strong>known to cause <strong>free radical injury</strong>. On the <strong>contrary,</strong> it generates<strong> NADPH,</strong> a critical <strong>cofactor </strong>in the<strong> reduction of glutathione,</strong> which in turn plays a vital role in <strong>protecting cells from oxidative stress</strong> and <strong>free</strong> <strong>radical damage.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Serves as a source of NADPH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, the HMP shunt is a <strong>major source</strong> of <strong>NADPH</strong>, which is crucial for various <strong>cellular</strong> functions including <strong>reductive biosynthesis </strong>and the <strong>detoxification of harmful substances.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Provides Ribose 5-phosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, one of the outcomes of the<strong> HMP shunt</strong> is the production of <strong>Ribose 5-phosphate,</strong> a necessary component for the <strong>synthesis of nucleotides and nucleic acids.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Plays a role in preventing the formation of methemoglobin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>True</strong>, <strong>NADPH</strong> produced by the<strong> HMP shunt </strong>maintains the <strong>reduced </strong>form of<strong> glutathione. Reduced glutathione</strong> is essential for the<strong> reduction of methemoglobin </strong>back to <strong>hemoglobin</strong>, thus <strong>preventing methemoglobinemia.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biochemical Significances of HMP Pathway</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Alternative</strong> route for <strong>metabolism of Glucose </strong>and causes<strong> complete oxidation of Glucose</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Major function is to generate </span><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NADPH and Riboses</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>No ATP</strong> is generated by this pathway</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Free radical scavenging</span></strong></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maintain<strong> RBC membrane integrity </strong>by keeping<strong> GSH in reduced state</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prevention of <strong>met-haemoglobin</strong> formation</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Detoxification </strong>by hydroxylation</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maintain the<strong> transparency of lens</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bactericidal</strong> activity of<strong> macrophages</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p197.</span></strong></span></span></p>",
    "correct_choice_id": 25424,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased"
    ]
  },
  {
    "id": 6338,
    "choices": [
      {
        "id": 25321,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 25322,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gluconeogenesis</span></span></span></p>"
      },
      {
        "id": 25323,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMP pathway</span></span></span></p>"
      },
      {
        "id": 25324,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rapaport pathway</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 28-year-old male patient with Mediterranean origin travels to Africa. During his trip, he develops symptoms of malaria and is subsequently treated with primaquine. Shortly after treatment, he presents with signs of hemolytic anemia. His medical history is significant for a specific enzyme deficiency that makes him susceptible to hemolysis when exposed to certain oxidative stressors, such as primaquine. The enzyme deficiency is involved in which of the following metabolic pathways?</span></span></span></p>",
    "unique_key": "Q9748571",
    "question_audio": null,
    "question_video": null,
    "map_id": 29934,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) HMP pathway</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The patient&#39;s condition suggests a<strong> deficiency in glucose-6-phosphate dehydrogenase</strong> (G6PD), which is a key enzyme in the<strong> hexose</strong> <strong>monophosphate (HMP) shunt</strong>, also known as the<strong> pentose phosphate pathway.</strong> This<strong> enzyme deficiency</strong> is common in the <strong>Mediterranean population</strong> and can lead to <strong>hemolytic anemia</strong> upon exposure to<strong> oxidative agents such as primaquine</strong>. The <strong>HMP</strong> <strong>pathway</strong> is responsible for <strong>producing NADPH</strong>, which is crucial for <strong>maintaining glutathione </strong>in a<strong> reduced state</strong>, thereby<strong> protecting red</strong> <strong>blood cells from oxidative damage.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glycolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>glycolysis</strong> is a <strong>central metabolic pathway</strong>, a<strong> deficiency</strong> in <strong>glycolytic enzymes</strong> typically <strong>does not</strong> result in h<strong>emolytic anemia precipitated by primaquine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Gluconeogenesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is the process of <strong>generating glucose</strong> from<strong> non-carbohydrate substrates</strong>, and <strong>deficiencies</strong> in gluconeogenesis enzymes<strong> do no</strong>t typically present with <strong>hemolytic anemia</strong> upon<strong> primaquine treatment.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Rapaport pathway:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>not </strong>a recognized<strong> metabolic pathway </strong>related to the condition described; it may be a <strong>misnomer</strong> or<strong> confusion</strong> with the <strong>Rapaport-Luebering shunt</strong>, which is involved in regulating<strong> 2,3-BPG levels in red blood cells</strong>, <strong>not</strong> directly related to<strong> oxidative stress response.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose 6 Phosphate Dehydrogenase Deficiency &ndash; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Most common </strong>enzyme <strong>deficiency</strong> in human beings.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">X-linked recessive</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Manifest as - <strong>Hemolytic Anaemia</strong> OR <strong>Methemoglobinemia</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DRUGS CAUSING HEMOLYSIS IN G6PD DEFICIENT INDIVIDUALS</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sulfonamides</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloroquine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Quinine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Primaquine</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nitrofurantoin</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 25323,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6336,
    "choices": [
      {
        "id": 25313,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycerol-3-phosphate</span></span></span></p>"
      },
      {
        "id": 25314,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sedoheptulose-7-phosphate</span></span></span></p>"
      },
      {
        "id": 25315,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glyceraldehyde-3-phosphate</span></span></span></p>"
      },
      {
        "id": 25316,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xylulose-5-phosphate</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify which of the following metabolites is not typically involved in the HMP shunt?</span></span></span></p>",
    "unique_key": "Q8652428",
    "question_audio": null,
    "question_video": null,
    "map_id": 29933,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Glycerol 3 Phosphate </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glycerol-3-phosphate</strong> is<strong> not</strong> a metabolite of the<strong> HMP shunt.</strong> It is involved in <strong>glycolysis and lipid metabolism</strong>, acting as a connection between these pathways, but it is<strong> not </strong>a <strong>part </strong>of the<strong> HMP shunt</strong>. The <strong>HMP shunt </strong>primarily <strong>produces NADPH and ribose-5-phosphate</strong> for<strong> biosynthetic reactions</strong> and <strong>does not</strong> directly utilize<strong> glycerol-3-phosphate.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sedoheptulose-7-phosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a<strong> seven-carbon sugar phosphate</strong> that is indeed an<strong> intermediate</strong> of the HMP shunt.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Glyceraldehyde-3-phosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Although it is also an<strong> intermediate in glycolysis</strong>, <strong>glyceraldehyde-3-phosphate</strong> can be produced in the <strong>HMP shunt as well.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Xylulose-5-phosphate:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a <strong>five-carbon sugar phosphate </strong>and is one of the<strong> metabolites</strong> of the<strong> HMP shunt.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metabolites in HMP Shunt Pathway</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose-6-phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6-Phosphogluconate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribulose-5-Phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xylulose-5-Phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ribose-5-Phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glyceraldehyde-3-Phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sedoheptulose-7-Phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructose-6-phosphate</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Erythrose 4 Phosphate. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p197</span></strong></span></span></p>",
    "correct_choice_id": 25313,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6361,
    "choices": [
      {
        "id": 25413,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glycolysis</span></span></span></p>"
      },
      {
        "id": 25414,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TCA Cycle</span></span></span></p>"
      },
      {
        "id": 25415,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fatty Acid Oxidation</span></span></span></p>"
      },
      {
        "id": 25416,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HMP Pathway</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following metabolic pathways is not directly involved in the generation of ATP? </span></span></span></p>",
    "unique_key": "Q5634996",
    "question_audio": null,
    "question_video": null,
    "map_id": 29939,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) HMP Pathway. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> HMP Pathway,</strong> also known as the <strong>pentose phosphate pathway,</strong> <strong>does not</strong> generate <strong>ATP.</strong> Its primary functions are to produce <strong>NADPH </strong>for <strong>reductive biosyntheses</strong> and to provide <strong>ribose-5-phosphate </strong>for <strong>nucleotide synthesis</strong>. Unlike the other pathways listed, the<strong> HMP Pathway&#39;s role</strong> is <strong>not </strong>in <strong>energy production</strong> but in<strong> biosynthesis </strong>and <strong>maintaining redox balance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Glycolysis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Glycolysis is a<strong> fundamental metabolic pathway </strong>that converts<strong> glucose to pyruvate,</strong> generating a <strong>net gain</strong> of <strong>2</strong> <strong>ATP molecules</strong> per <strong>glucose molecule.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. TCA Cycle:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The TCA Cycle, or <strong>Krebs cycle</strong>, occurs in the<strong> mitochondrial matrix </strong>and produces<strong> GTP,</strong> which is equivalent to <strong>ATP,</strong> along with <strong>NADH and FADH2</strong>, which are used in<strong> oxidative phosphorylation</strong> to generate <strong>further ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fatty Acid Oxidation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fatty acid oxidation, or <strong>&beta;-oxidation,</strong> takes place in the<strong> mitochondria, </strong>breaking down <strong>fatty acids</strong> to <strong>acetyl-CoA </strong>and generating<strong> NADH and FADH2, </strong>which are then used in the <strong>TCA cycle</strong> and <strong>oxidative phosphorylation</strong> to produce <strong>ATP.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><u><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/picture11.jpg\" style=\"height:503px; width:1000px\" /></u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p200.</span></strong></span></span></p>",
    "correct_choice_id": 25416,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6036,
    "choices": [
      {
        "id": 24114,
        "text": "<p><span style=\"font-size:12.0pt;\">Essential pentosuria</span></p>"
      },
      {
        "id": 24115,
        "text": "<p><span style=\"font-size:12.0pt;\">Essential fructosuria</span></p>"
      },
      {
        "id": 24116,
        "text": "<p><span style=\"font-size:12.0pt;\">Hereditary fructose intolerance</span></p>"
      },
      {
        "id": 24117,
        "text": "<p><span style=\"font-size:12.0pt;\">Galactosemia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old child presents to the pediatric outpatient department with a week-long fever but otherwise normal physical examination findings. To rule out an inborn error of metabolism, a urine screening test is performed, yielding the following results: Benedict\u2019s test - positive Blood Glucose -&nbsp;110 mg % Bial\u2019s test&nbsp;-&nbsp; positive Urine glucose, fructose and galactose - Negative. What is your most probable diagnosis?</span></p>",
    "unique_key": "Q5362679",
    "question_audio": null,
    "question_video": null,
    "map_id": 29849,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A) Essential pentosuria</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Essential pentosuria is a <strong>benign, inherited condition</strong> caused by a deficiency of <strong>L-xylulose reductase</strong>, an enzyme of the <strong>glucuronic acid pathway</strong>. The defect leads to the accumulation and urinary excretion of <strong>L-xylulose</strong>, a pentose sugar.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Because <strong>L-xylulose is a reducing sugar</strong>, it reacts positively with <strong>Benedict\u2019s test</strong>, even when <strong>blood glucose is normal</strong> \u2014 which is exactly what the lab findings here show.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Bial\u2019s test</strong> specifically detects <strong>pentoses</strong> and produces a characteristic <strong>blue-green color</strong>, confirming the presence of a pentose rather than a hexose (like glucose, fructose, or galactose).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Benedict\u2019s test: Positive</strong> \u2192 Reducing sugar is present.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Blood glucose: Normal (110 mg/dL)</strong> \u2192 rules out diabetes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Urine glucose, fructose, galactose: Negative</strong> \u2192 excludes common hexose sugars.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Bial\u2019s test: Positive</strong> \u2192 confirms the sugar is a pentose.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">All this points clearly to <strong>essential pentosuria</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option B \u2014 Essential Fructosuria:</strong></span><br><span style=\"font-size:12.0pt;\">Fructose would be detected in urine (fructosuria), confirmed by a <strong>positive Seliwanoff\u2019s test</strong> (specific for ketohexoses like fructose). Here, fructose is absent, ruling this out.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C \u2014 Hereditary Fructose Intolerance:</strong></span><br><span style=\"font-size:12.0pt;\">This condition involves <strong>aldolase B deficiency</strong>, leading to trapped <strong>fructose-1-phosphate</strong>. Symptoms include hypoglycemia, vomiting, liver damage when fructose is ingested, and fructose would be present in urine, but here it's <strong>negative</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D \u2014 Galactosemia:</strong></span><br><span style=\"font-size:12.0pt;\">Characterized by defective metabolism of galactose, usually due to <strong>galactose-1-phosphate uridyl transferase deficiency</strong>. Galactose would be detectable in urine (but here, it\u2019s negative) and typically presents with cataracts, hepatomegaly.</span><br><br>&nbsp;</li></ul><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Essential Pentosuria</strong> is a harmless, inherited metabolic condition characterized by the excretion of the pentose sugar <strong>L-xylulose</strong> in urine. This can lead to false-positive results on tests for reducing sugars (Benedict\u2019s) despite normal blood glucose levels. <strong>Bial\u2019s test</strong> further confirms the presence of pentoses, distinguishing it from hexoses like glucose, fructose, or galactose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e: p196, 205.</span></p>",
    "correct_choice_id": 24114,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette"
    ]
  },
  {
    "id": 9313,
    "choices": [
      {
        "id": 37219,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenine</span></p>"
      },
      {
        "id": 37220,
        "text": "<p><span style=\"font-size:12.0pt;\">Uridine</span></p>"
      },
      {
        "id": 37221,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypoxanthine</span></p>"
      },
      {
        "id": 37222,
        "text": "<p><span style=\"font-size:12.0pt;\">Thymidine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 10-year-old boy presents to the clinic with complaints of anemia, weakness, and notably lower height and weight compared to peers of his age. Upon examination, his urine sample reveals elevated levels of orotic acid. Further diagnostic tests indicate decreased activity of uridine monophosphate (UMP) synthase. Considering the underlying enzymatic deficiency and the patient's symptoms, which of the following would be the most appropriate treatment to administer?</span></p>",
    "unique_key": "Q3937321",
    "question_audio": null,
    "question_video": null,
    "map_id": 29848,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Ans. B. Uridine</strong></span><span style=\"font-size:11pt;\">&nbsp;&nbsp;&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option B.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Orotic Aciduria </strong>is a condition resulting from <strong>absence of one or both enzymes </strong>namely, <strong>OPRTase and OMP decarboxylase.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>C/F</strong>: retarded growth, megaloblastic anaemia, crystals excretion causes urinary tract obstruction.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Due to <strong>loss of feedback inhibition</strong>, <strong>orotic acid production increases drastically</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The condition is <strong>treated by feeding cytidine </strong>or <strong>uridine</strong>, which may be <strong>converted to UTP</strong>- act as <strong>feedback inhibition</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Explanations</u></strong>:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Adenine </strong>and <strong>Option C.</strong> <strong>Hypoxanthine</strong>: Hypoxanthine, guanine, and adenine are purine bases, <strong>cannot be converted to pyrimidines.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Thymidine</strong>: Although thymidine is a <strong>pyrimidine base</strong> it cannot be converted to other pyrimidines.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Hereditary orotic aciduria</strong>, a <strong>rare autosomal recessive disorder</strong> characterized by a <strong>deficiency in the enzyme UMP synthase.</strong> This enzyme is crucial in the <strong>pyrimidine synthesis pathway,</strong> and its <strong>deficiency leads to the accumulation of orotic acid</strong> in the <strong>urine</strong> and a <strong>decrease in pyrimidine synthesis</strong>, which is necessary for DNA and RNA synthesis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><u>Ref</u>: Harper 30/e: p 356-357.</strong></span></p>",
    "correct_choice_id": 37220,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6414,
    "choices": [
      {
        "id": 25625,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conjugation of bilirubin</span></span></span></p>"
      },
      {
        "id": 25626,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GAG Synthesis</span></span></span></p>"
      },
      {
        "id": 25627,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vitamin C Synthesis</span></span></span></p>"
      },
      {
        "id": 25628,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Biotransformation</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the incorrect statement regarding the involvement of the Uronic acid pathway.</span></span></p>",
    "unique_key": "Q5357414",
    "question_audio": null,
    "question_video": null,
    "map_id": 29850,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Vitamin C Synthesis </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>Uronic acid pathway cannot </strong>synthesize <strong>Vitamin C </strong>in humans and higher primates due to<strong> lack of L-Gulonolactone oxidase</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Conjugation of bilirubin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucuronic acid</strong>, derived from the <strong>Uronic acid pathway</strong>, is crucial for the <strong>conjugation of bilirubin </strong>in the liver, making it <strong>water-soluble for excretion </strong>in bile.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. GAG (Glycosaminoglycan) Synthesis:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The <strong>Uronic acid pathway </strong>provides<strong> essential components </strong>for the <strong>synthesis of glycosaminoglycans</strong>, which are important constituents of <strong>connective tissues and extracellular matrices</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Biotransformation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucuronic acid </strong>plays a significant role in the<strong> biotransformation </strong>of various substances by<strong> facilitating their excretion</strong>, <strong>enhancing</strong> the <strong>solubility of drugs, hormones, and toxins.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> Uronic acid pathway</strong> is involved in the <strong>conversion of glucose to glucuronic acid, </strong>which is a critical <strong>component</strong> in the <strong>conjugation</strong> of <strong>bilirubin</strong>, the <strong>synthesis of glycosaminoglycans (GAGs), </strong>and various <strong>biotransformation </strong>processes. However, it is <strong>not </strong>directly involved in the <strong>synthesis of Vitamin C (ascorbic acid). </strong>In humans, the <strong>synthesis of Vitamin C </strong>is <strong>not </strong>possible due to the <strong>lack of the enzyme L-gulonolactone oxidase</strong>, <strong>required </strong>for the last step of<strong> Vitamin C biosynthesis.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e p202, 203</span></strong></span></span></p>",
    "correct_choice_id": 25627,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6446,
    "choices": [
      {
        "id": 25753,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Galactose</span></span></span></p>"
      },
      {
        "id": 25754,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucose</span></span></span></p>"
      },
      {
        "id": 25755,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactose</span></span></span></p>"
      },
      {
        "id": 25756,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Xylulose</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-year-old obese girl presents with dehydration after 3 days of vomiting and diarrhoea. Her parents gave history that a sibling was diagnosed with a type of diabetes that spilled sugar into the urine but did not need treatment. </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture4_v6N5rNm.jpg\" style=\"height:164px; width:700px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition is most likely due to accumulation of which of the following?</span></span></span></p>",
    "unique_key": "Q4716600",
    "question_audio": null,
    "question_video": null,
    "map_id": 29847,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Xylulose</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>First step</strong> for diagnosis is to<strong> differentiate glucosuria </strong>due to <strong>diabetes mellitus or renal tubular</strong> problems from other <strong>sugars </strong>in<strong> urine such as galactose (galactosemia) or fructose/xylulose (essential fructosuria)</strong> - all these are <strong>reducing</strong> <strong>sugars </strong>that are <strong>positive with Clinitest </strong>but only<strong> glucose gives positive result</strong> with the <strong>glucose oxidase reagent strip.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The<strong> uronic acid pathway </strong>provides an <strong>alternate fate</strong> for glucose <strong>without </strong>generating<strong> ATP. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose 6-phosphate </strong>&rarr; <strong>glucose 1-phosphate</strong> &rarr; reacts with <strong>UTP</strong> &rarr; <strong>higher energy </strong>compound<strong> UDP-glucose </strong>&rarr; <strong>UDP-glucuronic acid</strong> (<strong>precursor for glucuronide</strong> units in <strong>proteoglycan polymers</strong>). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Unused glucuronic acid</strong> &rarr; converted to<strong> xylulose </strong>(<strong>incorrect answers</strong>&nbsp;<strong>A-C)</strong> &rarr; then to <strong>xylitol by a xylulose reductase</strong> (enzyme deficiency in essential pentosuria). </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Galactose:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Accumulation of <strong>galactose in the urine </strong>is usually associated with <strong>galactosemia, </strong>a serious condition that typically presents in <strong>infancy</strong> with symptoms like<strong> jaundice, vomiting, and hepatomegaly</strong> shortly after the introduction of<strong> lactose</strong> into the<strong> diet.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucose:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A <strong>negative urine glucose oxidase test</strong> rules out<strong> glucose</strong> as the accumulated substance. Conditions causing <strong>glucose accumulation,</strong> like <strong>diabetes mellitus,</strong> would also present with<strong> elevated blood glucose levels</strong>, which is <strong>not </strong>the case here.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Lactose:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Lactose </strong>in the <strong>urine </strong>is <strong>uncommon </strong>and would indicate a <strong>more severe disorder of galactose metabolism</strong> than essential <strong>pentosuria</strong>. It would also likely present with more severe systemic symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Essential <strong>Pentosuria is a benign </strong>condition characterized by the<strong> excretion of the pentose sugar xylulose</strong> in the<strong> urine</strong>. This diagnosis is supported by the <strong>presence of reducing sugars in the urine </strong>with<strong> normal blood glucose levels </strong>and<strong> negative glucose-specific urine</strong> <strong>tests.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 200-201</span></strong></span></span></p>",
    "correct_choice_id": 25756,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "ImageBased",
      "TreatmentBased"
    ]
  },
  {
    "id": 6444,
    "choices": [
      {
        "id": 25745,
        "text": "<p><span style=\"font-size:12pt;\">Aldolase B</span></p>"
      },
      {
        "id": 25746,
        "text": "<p><span style=\"font-size:12pt;\">Fructokinase</span></p>"
      },
      {
        "id": 25747,
        "text": "<p><span style=\"font-size:12pt;\">Galactose 1-phosphate uridylyl transferase</span></p>"
      },
      {
        "id": 25748,
        "text": "<p><span style=\"font-size:12pt;\">Galactokinase</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 6-month-old girl presents with developing cataracts, and an inability to track objects visually. Urine tests are positive for reducing sugars but negative for glucose. Which enzyme deficiency is most likely present in this patient?</span></p>",
    "unique_key": "Q7632017",
    "question_audio": null,
    "question_video": null,
    "map_id": 29998,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D)&nbsp; Galactokinase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This clinical picture is <strong>classic for galactokinase deficiency</strong>, a milder form of <strong>galactosemia</strong>, and presents primarily with:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Cataracts</strong> (due to galactitol accumulation in the lens)</span></li><li><span style=\"font-size:12.0pt;\"><strong>Positive urine test for reducing sugars</strong> (specifically <strong>galactose</strong>, not glucose)</span></li><li><span style=\"font-size:12.0pt;\">Usually <strong>no liver dysfunction</strong> or severe systemic involvement</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Biochemical mechanism:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Galactokinase</strong> is the enzyme responsible for converting <strong>galactose to galactose-1-phosphate</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In its deficiency, <strong>galactose accumulates</strong> and is <strong>shunted to galactitol</strong> by <strong>aldose reductase</strong>, especially in tissues like the lens \u2192 leads to <strong>osmotic damage and cataracts</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>No galactose-1-phosphate accumulation</strong> \u2192 hence <strong>no hepatotoxicity or severe neurological symptoms</strong> (as seen in classic galactosemia).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Aldolase B</strong> \u2013 Deficiency causes <strong>Hereditary Fructose Intolerance</strong>, leading to <strong>hypoglycemia</strong>, <strong>vomiting</strong>, and <strong>hepatomegaly</strong> upon <strong>fructose ingestion</strong>. <strong>Cataracts not a feature</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Fructokinase</strong> \u2013 Causes <strong>Essential Fructosuria</strong>, a benign condition. No systemic effects or cataracts.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option C. Galactose-1-phosphate uridylyl transferase</strong> \u2013 Deficiency causes <strong>classic galactosemia</strong>, which includes:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Liver dysfunction</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurological damage</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Cataracts</strong></span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This child has isolated early cataracts with galactosuria and no liver signs \u2014 more consistent with <strong>galactokinase deficiency</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Distinguish between <strong>types of galactose metabolism disorders</strong>:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Galactokinase deficiency</strong>: Early-onset <strong>cataracts</strong>, <strong>galactosuria</strong>, mild/no systemic symptoms.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Classic galactosemia (GALT deficiency)</strong>: <strong>Severe symptoms</strong> including <strong>hepatomegaly</strong>, <strong>vomiting</strong>, <strong>jaundice</strong>, and <strong>cataracts</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Both cause reducing substances in urine</strong>, but galactokinase deficiency is <strong>less severe and lacks liver involvement</strong>.</span></li></ul>",
    "correct_choice_id": 25748,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6434,
    "choices": [
      {
        "id": 25705,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is right but R is a wrong statement</span></span></span></p>"
      },
      {
        "id": 25706,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A </span></span></span></p>"
      },
      {
        "id": 25707,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 25708,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A): A nursing mother with classic Galactosemia is on a galactose-free diet and she is able to produce lactose in breast milk.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R): Galactose can be produced from a glucose metabolite by epimerization: </span></span></span></p>",
    "unique_key": "Q4059381",
    "question_audio": null,
    "question_video": null,
    "map_id": 29997,
    "difficulty_level": "beginner",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) A as well as R are right, and R is a correct explanation of A</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Galactosemia </strong>is a <strong>metabolic disorder</strong> that results from an <strong>inability to metabolize galactose</strong> properly, typically due to a<strong> deficiency </strong>in one of the enzymes involved in the <strong>Leloir pathway</strong>, such as<strong> galactose-1-phosphate uridylyltransferase</strong>. Despite adhering to a <strong>galactose-free diet</strong>, individuals with <strong>galactosemia,</strong> including <strong>nursing mothers</strong>, can produce <strong>lactose in breast milk </strong>because the <strong>mammary gland </strong>can <strong>synthesize galactose from glucose </strong>through the<strong> epimerization of UDP-glucose to UDP-galactose.</strong> This<strong> UDP-galactose </strong>can then be used to <strong>synthesize lactose, </strong>the main <strong>sugar in milk</strong>, ensuring that <strong>lactation</strong> is <strong>not impaired </strong>in women with <strong>galactosemia</strong> who are on a <strong>galactose-free diet.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. A is right but R is a wrong statement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is<strong> incorrect</strong> because <strong>both</strong> the <strong>assertion</strong> and the <strong>reasoning are correct,</strong> and the<strong> reasoning</strong> provides a<strong> valid explanation for the assertion.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. A is wrong, but R is a right statement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is<strong> incorrect </strong>because the <strong>assertion is indeed correct;</strong> <strong>nursing mothers</strong> with<strong> classic galactosemia</strong> on a<strong> galactose-free die</strong>t can produce <strong>lactose in breast milk </strong>due to the <strong>body&#39;s ability to synthesize galactose</strong> from <strong>glucose.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. A and R both are wrong:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is <strong>incorrect</strong> as <strong>both the assertion </strong>and the <strong>reasoning are correct</strong> and<strong> logically</strong> <strong>consistent.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;</span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Galactose</strong> can be produced from a<strong> glucose metabolite by epimerization.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Uridine diphosphate (UDP)</strong> <strong>glucose</strong> is converted to <strong>UDP-galactose </strong>by <strong>UDP hexose 4- epimerase</strong>, thereby providing the appropriate form of <strong>galactose for lactose synthesis.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></span></u><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 155, 203, 205.</span></span></strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> </span></strong></span></span></p>",
    "correct_choice_id": 25706,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6400,
    "choices": [
      {
        "id": 25569,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Galactosemia</span></span></span></p>"
      },
      {
        "id": 25570,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hereditary Fructose Intolerance</span></span></span></p>"
      },
      {
        "id": 25571,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Latent diabetes mellitus</span></span></span></p>"
      },
      {
        "id": 25572,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Crigler-Najjar Syndrome</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 9-month-old male infant is brought to the outpatient department presenting with mental retardation, delayed developmental milestones, and jaundice. Laboratory investigations reveal elevated unconjugated bilirubin and hypoglycemia (RBS &ndash; 40 mg/dl). Additionally, the urine analysis indicates aminoaciduria. The infant has been exclusively breastfed and has experienced recurrent vomiting and diarrhea since birth. Based on these findings, what is the most likely diagnosis?</span></span></span></p>",
    "unique_key": "Q4157368",
    "question_audio": null,
    "question_video": null,
    "map_id": 29996,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Galactosemia </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Galactosemia</strong> is due to <strong>deficiency</strong> of enzyme <strong>galactose-1-phosphate uridyl transferase. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Autosomal Recessive inheritance.</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Due to the<strong> block </strong>in this enzyme &rarr; <strong>galactose-1- phosphate</strong> accumulates in liver &rarr; thus <strong>inhibiting galactokinase</strong> and <strong>glycogen phosphorylase </strong>&rarr;<strong> Hypoglycemia </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Galactose-1-phosphate </strong>gets deposited in <strong>renal tubules &rarr; tubular damage </strong>&rarr; <strong>generalized amino aciduria</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Bilirubin </strong>uptake and<strong> conjugation is reduced </strong>&rarr; <strong>increased unconjugated bilirubin </strong>level in blood </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Free galactose </strong>accumulates &rarr; <strong>galactosemia &rarr; galactosuria</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features: <strong>congenital cataract (oil drop cataract), enlargement of liver, jaundice, and severe mental retardation.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hereditary Fructose Intolerance:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fructosemia&nbsp;</strong>- due to<strong> defect</strong> in <strong>Aldolase-B </strong>&rarr; <strong>fructose-1-phosphate</strong> in the diet of infants <strong>cannot </strong>be metabolized &rarr; its <strong>accumulation</strong> and <strong>inhibition of glycogen phosphorylase</strong> &rarr; accumulation of<strong> glycogen in liver </strong>and <strong>hypoglycaemia.</strong> History of <strong>aversion to sweets</strong> and <strong>history of vomiting </strong>after <strong>drinking fruit juices</strong>. C/F- <strong>Vomiting, loss of appetite,</strong> <strong>hepatomegaly and jaundice</strong>.<strong> Fructose</strong> excreted in<strong> urine</strong> gives a <strong>positive Benedict&rsquo;s test.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\">&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Latent diabetes mellitus:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> They have a<strong> slow </strong>progression of <strong>autoimmune beta cell failure</strong> with<strong> C/F</strong> similar to<strong> DM.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; Crigler-Najjar Syndrome:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>defective conjugation</strong> due to <strong>deficiency of UDP glucuronyl transferase</strong> &rarr;<strong> Unconjugated</strong> <strong>bilirubin &gt;&gt;20 mg/dl </strong>&rarr; <strong>kernicterus.</strong> History of <strong>persistent jaundice since birth</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Galactosemia</strong> is a <strong>genetic disorder</strong> characterized by the<strong> inability to metabolize galactose</strong> properly <strong>due to a deficiency</strong> in one of the <strong>enzymes</strong> involved in <strong>its metabolic pathway,</strong> most commonly<strong> galactose-1-phosphate uridyltransferase.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 155, 204</span></strong></span></span></p>",
    "correct_choice_id": 25569,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "TreatmentBased"
    ]
  },
  {
    "id": 6405,
    "choices": [
      {
        "id": 25589,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Yogurt </span></span></span></p>"
      },
      {
        "id": 25590,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Skimmed milk </span></span></span></p>"
      },
      {
        "id": 25591,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Condensed milk</span></span></span></p>"
      },
      {
        "id": 25592,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ice cream </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents to the emergency room reporting episodes of diarrhea triggered by the consumption of dairy products. This symptom is suggestive of lactose intolerance, a condition where the body lacks sufficient lactase enzyme to digest lactose, the primary sugar in milk and dairy products. Based on this information, which of the following dairy products might she be able to tolerate better compared to the others?</span></span></span></p>",
    "unique_key": "Q6987732",
    "question_audio": null,
    "question_video": null,
    "map_id": 29999,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Yogurt&nbsp;&nbsp;&nbsp;&nbsp; </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Lactose intolerance </strong>is due to<strong> deficiency of the enzyme galactosidase </strong>or<strong> lactase </strong>in the<strong> intestinal mucosa</strong> leads to <strong>failure</strong> in <strong>metabolism of lactose</strong>, the <strong>primary sugar in milk and milk products</strong> to <strong>monosaccharides, galactose and glucose</strong>. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The <strong>undigested lactose</strong> passes into the <strong>colon </strong>&rarr; metabolized by <strong>resident bacteria into CO2, H2, and H2O</strong> &rarr; resulting in C/F such as <strong>bloating, flatulence, abdominal cramping, and frothy diarrhoea. </strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>avoidance</strong> of<strong> dairy products</strong> containing<strong> lactose</strong>. Persons with<strong> lactose intolerance </strong>can tolerate <strong>yogurt </strong>and <strong>acidophilus milk better</strong> than <strong>other dairy products</strong> as the <strong>lactose</strong> in these <strong>fermented </strong>products are utilized for production of <strong>lactic acid.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong>Other Options:</strong></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Skimmed milk:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Skimmed milk contains a<strong> similar amount</strong> of<strong> lactose</strong> to <strong>whole milk </strong>and can still cause <strong>symptoms </strong>in individuals with <strong>lactose intolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Condensed milk:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Condensed milk has a <strong>high lactose content</strong> due to the <strong>removal of water.</strong> It is <strong>highly </strong>likely to cause <strong>symptoms </strong>in individuals with<strong> lactose intolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ice cream:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Ice cream typically contains<strong> high levels of lactose and fat</strong>, which can <strong>exacerbate gastrointestinal symptoms</strong> in individuals with <strong>lactose intolerance.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Yogurt </strong>is often<strong> better tolerated</strong> by those with <strong>lactose intolerance</strong> due to<strong> probiotics aiding lactose digestion, </strong>whereas<strong> skimmed milk,</strong> <strong>condensed milk, and ice cream</strong>, with their <strong>higher lactose content</strong>, are <strong>more</strong> likely to cause<strong> intolerance symptoms.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Maurice Shils, Modern Nutrition in Health and Disease, 10th edition, page 1523</span></strong></span></span></p>",
    "correct_choice_id": 25589,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6448,
    "choices": [
      {
        "id": 25761,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Galactokinase</span></span></span></p>"
      },
      {
        "id": 25762,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fructokinase </span></span></span></p>"
      },
      {
        "id": 25763,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aldolase B</span></span></span></p>"
      },
      {
        "id": 25764,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;-galactosidase </span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 6-month-old boy begins experiencing vomiting, night sweats, and tremors after the introduction of fruit juices into his diet during weaning. Physical examination reveals significant hepatomegaly. Urine tests are positive for reducing sugars but negative for glucose. Which enzyme deficiency is most likely responsible for these symptoms? </span></span></span></p>",
    "unique_key": "Q5690381",
    "question_audio": null,
    "question_video": null,
    "map_id": 30025,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Aldolase B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The above symptoms are suggestive of <strong>hereditary fructose intolerance (AR inheritance),</strong> due to <strong>deficiency of aldolase B.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Defect </strong>in <strong>aldolase-B</strong> &rarr; <strong>fructose-1-phosphate</strong> cannot be metabolized further &rarr; accumulation of <strong>fructose-1-phosphate</strong> will <strong>inhibit glycogen phosphorylase </strong>&rarr; accumulation of<strong> glycogen in liver </strong>and associated <strong>hypoglycemia.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C/F-<strong> Vomiting, loss of appetite, failure to thrive, hepatomegaly and jaundice</strong>. These symptoms are manifested when <strong>sucrose (containing fructose)</strong> is introduced in the<strong> diet of infants (6 months of age).</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Diagnosis: Fructose</strong> is<strong> excreted in urine</strong> and urine gives<strong> positive Benedict&rsquo;s test.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Treatment: Withdrawal of fructose </strong>from the <strong>diet </strong>will relieve the symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; Galactokinase:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency </strong>in <strong>galactokinase</strong> leads to <strong>galactosemia type 2,</strong> which primarily results in <strong>cataract formation </strong>but <strong>does not</strong> typically cause <strong>severe hypoglycemia or hepatomegaly</strong> in response to fructose ingestion.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Fructokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong> Fructokinase deficiency </strong>leads to essential<strong> fructosuria,</strong> a <strong>benign</strong> condition characterized by the <strong>excretion of</strong> <strong>fructose</strong> in the<strong> urine</strong> <strong>without </strong>serious metabolic disturbances or clinical symptoms.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. &beta;-Galactosidase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Deficiency in &beta;-galactosidase</strong> leads to<strong> GM1 gangliosidosis or galactosialidosis</strong>, which involve <strong>neurological symptoms</strong> and <strong>developmental delays</strong>, but <strong>not </strong>the specific reaction to <strong>fructose ingestion</strong> as described.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Hereditary Fructose Intolerance (HFI) </strong>is a condition resulting from <strong>aldolase B deficiency</strong>, characterized by <strong>adverse reactions</strong> to <strong>fructose ingestion,</strong> such as <strong>hypoglycemia, hepatomegaly, and metabolic disturbances.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 155, 202, 205.</span></strong></span></span></p>",
    "correct_choice_id": 25763,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6438,
    "choices": [
      {
        "id": 25721,
        "text": "<p><span style=\"font-size:12.0pt;\">Deficiency of aldolase B.</span></p>"
      },
      {
        "id": 25722,
        "text": "<p><span style=\"font-size:12.0pt;\">Accumulation of fructose 1-phosphate in tissues</span></p>"
      },
      {
        "id": 25723,
        "text": "<p><span style=\"font-size:12.0pt;\">Hyperglycaemia</span></p>"
      },
      {
        "id": 25724,
        "text": "<p><span style=\"font-size:12.0pt;\">Liver and kidneys are involved</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">A 4-year-old boy experiences headache, dizziness, weakness, and knee joint tenderness after consuming sugarcane juice. Following a diagnosis of Hereditary Fructose Intolerance (HFI), which of the following statements about HFI is FALSE?</span></p>",
    "unique_key": "Q7292949",
    "question_audio": null,
    "question_video": null,
    "map_id": 30023,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hyperglycaemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hyperglycaemia:</strong></span><br><span style=\"font-size:12.0pt;\"><strong>False.</strong> The opposite is true\u2014patients experience <strong>hypoglycemia</strong> because of inhibited glucose release from glycogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hereditary Fructose Intolerance (HFI)</strong> is caused by a <strong>deficiency of aldolase B,</strong> the enzyme that cleaves <strong>fructose 1-phosphate into dihydroxyacetone phosphate (DHAP) and glyceraldehyde.</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">In HFI:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Fructose 1-phosphate accumulates</strong> in tissues (especially the liver and&nbsp; &nbsp; &nbsp; &nbsp;kidneys)leading to:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12.0pt;\"><strong>Inhibition of glycogenolysis&nbsp;</strong></span></li><li><span style=\"font-size:12.0pt;\">Resulting in <strong>hypoglycemia (low blood sugar),</strong> especially after ingestion of fructose, sucrose, or sorbitol.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Clinical findings:</strong></span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Hypoglycemia, vomiting, lethargy, abdominal pain after fructose intake.</span></li><li><span style=\"font-size:12.0pt;\">Long-term exposure can cause <strong>hepatomegaly, liver dysfunction, and renal involvement.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\"><strong>Option A. Deficiency of aldolase B:</strong></span><br><span style=\"font-size:12.0pt;\"><strong>True.</strong> This is the fundamental enzymatic defect in HFI.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option B. Accumulation of fructose 1-phosphate in tissues:</strong></span><br><span style=\"font-size:12.0pt;\"><strong>True.</strong> This is the hallmark of the disease and leads to metabolic blockages.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Option D. Liver and kidneys are involved:</strong></span><br><span style=\"font-size:12.0pt;\"><strong>True.</strong> These organs are significantly affected due to accumulation of fructose 1-phosphate and its toxic effects.</span></li></ul><p><span style=\"font-size:12.0pt;\"><strong><u>&nbsp;</u></strong></span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Biochemical defect in Hereditary Fructose Intolerance</span></p><p><span style=\"font-size:12.0pt;\">Deficiency of Fructose-1,6-Bisphosphate Aldolase (Aldolase B)</span></p><p><span style=\"font-size:12.0pt;\">Deficiency of this enzyme \u2192 causes accumulation of fructose-1-phosphate \u2192 severe toxic symptoms when a patient is exposed to fructose.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clinical manifestations</span></p><p><span style=\"font-size:12.0pt;\">Patients with HFI are asymptomatic until fructose or sucrose is ingested (usually from fruit, fruit juice, or sweetened cereal).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms may occur early in life, soon after weaning formulas containing these sugars are introduced into the diet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Early clinical manifestations include jaundice, hepatomegaly, vomiting, lethargy, irritability, convulsions and hypoglycaemia. &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref</strong>: Vasudevan 9/e: p 138.</span></p>",
    "correct_choice_id": 25723,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6408,
    "choices": [
      {
        "id": 25601,
        "text": "<p><span style=\"font-size:12.0pt;\">Galactose</span></p>"
      },
      {
        "id": 25602,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucose</span></p>"
      },
      {
        "id": 25603,
        "text": "<p><span style=\"font-size:12.0pt;\">Lactose</span></p>"
      },
      {
        "id": 25604,
        "text": "<p><span style=\"font-size:12.0pt;\">Sucrose</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12pt;\">An Infant diagnosed with Hereditary Fructose Intolerance (HFI) presents with vomiting, diarrhea, abdominal pain, and hypoglycemia upon attempting weaning. Following a positive IV fructose tolerance test, dietary restriction of fructose is advised. Considering the metabolic pathway affected in HFI, which of the following substances should be restricted in the neonate's diet?</span></p>",
    "unique_key": "Q9363049",
    "question_audio": null,
    "question_video": null,
    "map_id": 30024,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Sucrose&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Hereditary fructose intolerance (Fructosemia) is due to a deficiency of aldolase B, which is found in liver, small intestine, and kidney.&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">It requires a strict dietary control of fructose (fruit sugar) and sucrose (table sugar).</span></p><p><span style=\"font-size:12.0pt;\">As sucrose is a disaccharide made of fructose and glucose, it is restricted.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp; Galactose</strong>: is a monosaccharide that is metabolized normally in this condition.&nbsp; Metabolic disorders associated with galactose metabolism&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Glucose</strong>: is metabolized normally in fructosemia.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lactose</strong>: is a disaccharide composed of galactose + glucose, should be restricted in Classical Galactosemia and in lactose intolerance.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">In Infants with Hereditary Fructose Intolerance (HFI), dietary restriction of sucrose is crucial due to its breakdown into glucose and fructose, the latter of which cannot be metabolized due to aldolase B deficiency, leading to toxic metabolite buildup and hypoglycemia. Other sugars like galactose, glucose, and lactose, which do not directly contribute to these metabolic issues, do not need to be restricted unless other specific metabolic disorders are present.</span></p><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Ref: Harper 30/e:&nbsp; p 202, 205.</span></p>",
    "correct_choice_id": 25604,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "InvestigationBased"
    ]
  },
  {
    "id": 6453,
    "choices": [
      {
        "id": 25781,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is right but R is a wrong statement</span></span></span></p>"
      },
      {
        "id": 25782,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A as well as R are right and R is a correct explanation of A </span></span></span></p>"
      },
      {
        "id": 25783,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A is wrong but R is a right statement</span></span></span></p>"
      },
      {
        "id": 25784,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A and R both are wrong</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with Hereditary Fructose Intolerance (HFI) presents with symptoms indicative of the condition. Consider the following statements:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assertion (A): Hereditary fructose intolerance (HFI) results in accumulation of fructose-6-phosphate, which is the reason behind organomegaly seen in this condition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reasoning (R): Above condition is due to aldolase B deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Choose the correct option regarding the assertion and reasoning.</span></span></span></p>",
    "unique_key": "Q4370866",
    "question_audio": null,
    "question_video": null,
    "map_id": 30026,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) A is wrong, but R is a right statement</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In<strong> Hereditary Fructose Intolerance (HFI),</strong> the <strong>deficiency </strong>of the enzyme <strong>aldolase B</strong> leads to the <strong>accumulation of fructose-1-phosphate,</strong> <strong>not fructose-6-phosphate</strong>. Aldolase B is crucial for the metabolism of<strong> fructose to glyceraldehyde and dihydroxyacetone</strong> <strong>phosphate</strong> in the <strong>liver, kidney, and intestine</strong>. The<strong> accumulation of fructose-1-phosphate</strong> is <strong>toxic</strong> and results in symptoms such as <strong>hypoglycemia, vomiting, and failure to thrive, </strong>as well as<strong> liver and renal dysfunction</strong> which can contribute to <strong>organomegaly.</strong> Therefore, the <strong>assertion is incorrect </strong>regarding the <strong>specific fructose phosphate</strong> that accumulates, while the <strong>reasoning correctly</strong> <strong>identifies aldolase B deficiency</strong> as the cause of<strong> HFI.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp; A is right but R is a wrong statement:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is<strong> incorrect </strong>because the <strong>assertion incorrectly identifies</strong> the metabolite that accumulates in HFI.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. A as well as R are right and R is a correct explanation of A:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is <strong>incorrect </strong>because the <strong>assertion incorrectly</strong> states the<strong> metabolite </strong>involved in<strong> HFI.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp; A and R both are wrong:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This option is <strong>incorrect</strong> because the <strong>reasoning statement</strong> about <strong>aldolase B deficiency </strong>is <strong>correct.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During <strong>metabolism </strong>of <strong>fructose</strong>, fructose &rarr; <strong>fructose-1-phosphate</strong> (enzyme fructokinase) &rarr; <strong>glyceraldehyde</strong> and <strong>dihydroxyacetone phosphate</strong> (aldolase B enzyme). </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Deficiency </strong>of this <strong>aldolase B</strong> &rarr; <strong>accumulation of fructose-1-phosphate</strong> in various<strong> organs</strong> leading to <strong>organomegaly.</strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e: p 202,205.</span></strong></span></span></p>",
    "correct_choice_id": 25783,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  },
  {
    "id": 6462,
    "choices": [
      {
        "id": 25817,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Deficiency of aldolase B</span></span></span></p>"
      },
      {
        "id": 25818,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excretes fructose in urine</span></span></span></p>"
      },
      {
        "id": 25819,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rare incidence</span></span></span></p>"
      },
      {
        "id": 25820,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Positive Benedict&rsquo;s test</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements about Fructosuria is NOT true?</span></span></span></p>",
    "unique_key": "Q7772961",
    "question_audio": null,
    "question_video": null,
    "map_id": 30027,
    "difficulty_level": "intermediate",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Deficiency of aldolase B</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Fructosuria</strong> is typically caused by a<strong> deficiency in the enzyme fructokinase, not</strong> <strong>aldolase B. </strong>This condition leads to the <strong>excretion </strong>of <strong>fructose in the urine</strong> because the <strong>body cannot</strong> effectively <strong>metabolize fructose into fructose-1-phosphate </strong>in the <strong>liver. </strong>As a result, <strong>fructose accumulates </strong>in the<strong> blood </strong>and is <strong>excreted in the urine. </strong>The condition is indeed rare and usually benign, and because <strong>fructose</strong> is a <strong>reducing sugar</strong>, it can produce a <strong>positive result </strong>on a <strong>Benedict&#39;s test, </strong>which tests for the<strong> presence of reducing sugars</strong> in the <strong>urine.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation:</u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B.&nbsp; Excretes fructose in urine:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is <strong>true</strong> for fructosuria due to the <strong>inability to metabolize fructose</strong> effectively.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Rare incidence:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Fructosuria </strong>is indeed a rare condition, given the <strong>specific enzyme deficiency</strong> required for its manifestation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Positive Benedict&rsquo;s test:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fructose is a <strong>reducing sugar,</strong> which means it will <strong>react with Benedict&rsquo;s reagent </strong>to produce a <strong>color</strong> <strong>change</strong>, indicating a <strong>positive test result.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a <strong>benign metabolic defect</strong> due to <strong>defect/deficiency of fructokinase.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Incidence is<strong> 1 in 130,000 births.</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">There is<strong> excretion of fructose</strong> in urine. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urine gives<strong> positive Benedict&rsquo;s and Seliwanoff&rsquo;s tests. </strong></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vasudevan 9/e: P 138.</span></strong></span></span></p>",
    "correct_choice_id": 25817,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "TreatmentBased"
    ]
  },
  {
    "id": 6423,
    "choices": [
      {
        "id": 25661,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hexokinase</span></span></span></p>"
      },
      {
        "id": 25662,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glucokinase</span></span></span></p>"
      },
      {
        "id": 25663,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sorbitol dehydrogenase</span></span></span></p>"
      },
      {
        "id": 25664,
        "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aldose reductase</span></span></span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a long history of diabetes presents with visual disturbances, including difficulty seeing and floaters. Given his elevated blood glucose levels, which enzyme is most likely responsible for his eye manifestations?</span></span></span></p>",
    "unique_key": "Q4021189",
    "question_audio": null,
    "question_video": null,
    "map_id": 30034,
    "difficulty_level": "difficult",
    "subjects_id": [
      1
    ],
    "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Aldose reductase </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Aldose reductase</strong> is the key enzyme involved in the <strong>polyol pathway</strong>, where<strong> glucose </strong>is<strong> converted to sorbitol,</strong> and then <strong>sorbitol is</strong> converted<strong> to fructose. </strong>In the context of<strong> hyperglycemia,</strong> as seen in<strong> long-term diabetes</strong>, there is an <strong>increased flux of glucose</strong> through the<strong> polyol pathway. </strong>The <strong>accumulation of sorbitol in tissues </strong>that <strong>do not </strong>require<strong> insulin for glucose uptake</strong>, such as the <strong>lens, nerves,</strong> and<strong> blood vessels of the eye,</strong> can lead to<strong> osmotic stress and subsequent damage</strong>. This is a contributing factor to <strong>diabetic</strong> <strong>complications</strong> such as <strong>cataracts, retinopathy, and other microvascular complications</strong> that can <strong>affect vision.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<u>Explanation: </u></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hexokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hexokinase catalyzes the<strong> phosphorylation of glucose to glucose-6-phosphate </strong>in most tissues and is <strong>not</strong> directly associated with the <strong>specific complications</strong> seen in the <strong>eyes due to diabetes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Glucokinase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>Glucokinase</strong> acts as a <strong>glucose sensor </strong>in the <strong>pancreas and liver</strong>, catalyzing the<strong> phosphorylation of glucose </strong>to <strong>glucose-6-phosphate</strong>. It is <strong>not</strong> directly linked to the pathogenesis of <strong>diabetic eye complications.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sorbitol dehydrogenase:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While <strong>sorbitol dehydrogenase </strong>is involved in the <strong>conversion of sorbitol to fructose</strong> in the <strong>polyol</strong> pathway, it is the accumulation of<strong> sorbitol </strong>due to the action of <strong>aldose reductase</strong> that is primarily responsible for the<strong> osmotic damage</strong> seen in<strong> diabetic complications of the eye.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glucose</strong> can enter the <strong>lens of the eye </strong>and get <strong>converted to Sorbitol </strong>with the help of <strong>aldose reductase. </strong>This enzyme is a major contributor to<strong> diabetic complication </strong>due to<strong> accumulation of sorbitol </strong>which is <strong>hygroscopic sugar </strong>and causes<strong> swelling of the eye </strong>in <strong>untreated diabetic patients</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref</span></u></strong><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Harper 30/e:&nbsp; p 205; Vasudevan 9/e: 135.</span></strong></span></span></p>",
    "correct_choice_id": 25664,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual"
    ]
  }
];
        let quizName = 'Carbohydrate Metabolism';
        const quizFilename = 'carbohydrate-metabolism-c44110bf.html';
        let hierarchy = ["Cerebellum", "qBank", "Biochemistry"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>